0001161697-23-000369.txt : 20230622 0001161697-23-000369.hdr.sgml : 20230622 20230622125216 ACCESSION NUMBER: 0001161697-23-000369 CONFORMED SUBMISSION TYPE: 10-Q PUBLIC DOCUMENT COUNT: 38 CONFORMED PERIOD OF REPORT: 20230430 FILED AS OF DATE: 20230622 DATE AS OF CHANGE: 20230622 FILER: COMPANY DATA: COMPANY CONFORMED NAME: NEUTRA CORP. CENTRAL INDEX KEY: 0001512886 STANDARD INDUSTRIAL CLASSIFICATION: MEDICINAL CHEMICALS & BOTANICAL PRODUCTS [2833] IRS NUMBER: 274505461 STATE OF INCORPORATION: WY FISCAL YEAR END: 0131 FILING VALUES: FORM TYPE: 10-Q SEC ACT: 1934 Act SEC FILE NUMBER: 000-55077 FILM NUMBER: 231032432 BUSINESS ADDRESS: STREET 1: 54 SUGAR CREEK CENTER BLVD. STREET 2: SUITE 200 CITY: SUGAR LAND STATE: TX ZIP: 77478 BUSINESS PHONE: (702) 793-4121 MAIL ADDRESS: STREET 1: 54 SUGAR CREEK CENTER BLVD. STREET 2: SUITE 200 CITY: SUGAR LAND STATE: TX ZIP: 77478 10-Q 1 form_10-q.htm FORM 10-Q QUARTERLY REPORT FOR 04-30-2023
0001512886 false 2024 Q1 --01-31 Unlimited Unlimited P3Y 0001512886 2023-02-01 2023-04-30 0001512886 2023-06-21 0001512886 2023-04-30 0001512886 2023-01-31 0001512886 us-gaap:SeriesAPreferredStockMember 2023-04-30 0001512886 us-gaap:SeriesAPreferredStockMember 2023-01-31 0001512886 us-gaap:SeriesBPreferredStockMember 2023-04-30 0001512886 us-gaap:SeriesBPreferredStockMember 2023-01-31 0001512886 us-gaap:SeriesCPreferredStockMember 2023-04-30 0001512886 us-gaap:SeriesCPreferredStockMember 2023-01-31 0001512886 us-gaap:SeriesEPreferredStockMember 2023-04-30 0001512886 us-gaap:SeriesEPreferredStockMember 2023-01-31 0001512886 us-gaap:SeriesFPreferredStockMember 2023-04-30 0001512886 us-gaap:SeriesFPreferredStockMember 2023-01-31 0001512886 us-gaap:SeriesGPreferredStockMember 2023-04-30 0001512886 us-gaap:SeriesGPreferredStockMember 2023-01-31 0001512886 2022-02-01 2023-01-31 0001512886 2022-02-01 2022-04-30 0001512886 us-gaap:CommonStockMember 2022-01-31 0001512886 us-gaap:SeriesAPreferredStockMember 2022-01-31 0001512886 us-gaap:SeriesBPreferredStockMember 2022-01-31 0001512886 us-gaap:SeriesCPreferredStockMember 2022-01-31 0001512886 us-gaap:SeriesEPreferredStockMember 2022-01-31 0001512886 us-gaap:SeriesFPreferredStockMember 2022-01-31 0001512886 us-gaap:AdditionalPaidInCapitalMember 2022-01-31 0001512886 us-gaap:RetainedEarningsMember 2022-01-31 0001512886 ntrr:StockSubscribedButNotIssuedMember 2022-01-31 0001512886 2022-01-31 0001512886 us-gaap:CommonStockMember 2023-01-31 0001512886 us-gaap:AdditionalPaidInCapitalMember 2023-01-31 0001512886 us-gaap:RetainedEarningsMember 2023-01-31 0001512886 ntrr:StockSubscribedButNotIssuedMember 2023-01-31 0001512886 us-gaap:CommonStockMember 2022-02-01 2022-04-30 0001512886 us-gaap:SeriesAPreferredStockMember 2022-02-01 2022-04-30 0001512886 us-gaap:SeriesBPreferredStockMember 2022-02-01 2022-04-30 0001512886 us-gaap:SeriesCPreferredStockMember 2022-02-01 2022-04-30 0001512886 us-gaap:SeriesEPreferredStockMember 2022-02-01 2022-04-30 0001512886 us-gaap:SeriesFPreferredStockMember 2022-02-01 2022-04-30 0001512886 us-gaap:AdditionalPaidInCapitalMember 2022-02-01 2022-04-30 0001512886 us-gaap:RetainedEarningsMember 2022-02-01 2022-04-30 0001512886 ntrr:StockSubscribedButNotIssuedMember 2022-02-01 2022-04-30 0001512886 us-gaap:CommonStockMember 2023-02-01 2023-04-30 0001512886 us-gaap:SeriesAPreferredStockMember 2023-02-01 2023-04-30 0001512886 us-gaap:SeriesBPreferredStockMember 2023-02-01 2023-04-30 0001512886 us-gaap:SeriesCPreferredStockMember 2023-02-01 2023-04-30 0001512886 us-gaap:SeriesEPreferredStockMember 2023-02-01 2023-04-30 0001512886 us-gaap:SeriesFPreferredStockMember 2023-02-01 2023-04-30 0001512886 us-gaap:AdditionalPaidInCapitalMember 2023-02-01 2023-04-30 0001512886 us-gaap:RetainedEarningsMember 2023-02-01 2023-04-30 0001512886 ntrr:StockSubscribedButNotIssuedMember 2023-02-01 2023-04-30 0001512886 us-gaap:CommonStockMember 2022-04-30 0001512886 us-gaap:SeriesAPreferredStockMember 2022-04-30 0001512886 us-gaap:SeriesBPreferredStockMember 2022-04-30 0001512886 us-gaap:SeriesCPreferredStockMember 2022-04-30 0001512886 us-gaap:SeriesEPreferredStockMember 2022-04-30 0001512886 us-gaap:SeriesFPreferredStockMember 2022-04-30 0001512886 us-gaap:AdditionalPaidInCapitalMember 2022-04-30 0001512886 us-gaap:RetainedEarningsMember 2022-04-30 0001512886 ntrr:StockSubscribedButNotIssuedMember 2022-04-30 0001512886 2022-04-30 0001512886 us-gaap:CommonStockMember 2023-04-30 0001512886 us-gaap:AdditionalPaidInCapitalMember 2023-04-30 0001512886 us-gaap:RetainedEarningsMember 2023-04-30 0001512886 ntrr:StockSubscribedButNotIssuedMember 2023-04-30 0001512886 us-gaap:SeriesGPreferredStockMember 2023-02-01 2023-04-30 0001512886 us-gaap:EquipmentMember 2023-04-30 0001512886 ntrr:MrJimMember srt:ChiefExecutiveOfficerMember 2023-04-30 0001512886 ntrr:DeityCorporationMember 2023-04-30 0001512886 us-gaap:EquipmentMember 2023-01-31 0001512886 srt:ChiefExecutiveOfficerMember 2023-02-01 2023-04-30 0001512886 srt:ChiefExecutiveOfficerMember 2022-02-01 2022-04-30 0001512886 ntrr:MrJimMember srt:ChiefExecutiveOfficerMember 2023-02-01 2023-04-30 0001512886 srt:ChiefExecutiveOfficerMember ntrr:AccountsPayableRelatedPartyAndAdvancesPayableToRelatedPartyMember 2023-04-30 0001512886 srt:ChiefExecutiveOfficerMember ntrr:AccountsPayableRelatedPartyAndAdvancesPayableToRelatedPartyMember 2023-01-31 0001512886 2022-03-11 0001512886 srt:ChiefExecutiveOfficerMember ntrr:MrJimMember 2022-01-31 0001512886 ntrr:DeityCorporationMember 2022-01-31 0001512886 us-gaap:SeriesAPreferredStockMember 2020-01-31 0001512886 us-gaap:SeriesAPreferredStockMember ntrr:VIVISCorporationMember 2020-01-01 2020-01-31 0001512886 us-gaap:SeriesBPreferredStockMember 2020-07-31 0001512886 us-gaap:SeriesBPreferredStockMember ntrr:VIVISCorporationMember 2020-07-01 2020-07-31 0001512886 us-gaap:SeriesBPreferredStockMember 2021-01-31 0001512886 us-gaap:SeriesBPreferredStockMember 2020-02-01 2021-01-31 0001512886 us-gaap:SeriesCPreferredStockMember 2020-11-30 0001512886 us-gaap:SeriesCPreferredStockMember ntrr:VIVISCorporationMember 2020-11-01 2020-11-30 0001512886 us-gaap:ConvertiblePreferredStockMember 2020-11-30 0001512886 us-gaap:SeriesCPreferredStockMember 2020-11-01 2020-11-30 0001512886 us-gaap:SeriesCPreferredStockMember 2021-01-31 0001512886 us-gaap:SeriesCPreferredStockMember 2020-02-01 2021-01-31 0001512886 us-gaap:SeriesEPreferredStockMember 2015-11-13 0001512886 us-gaap:SeriesEPreferredStockMember 2015-11-12 2015-11-13 0001512886 us-gaap:SeriesFPreferredStockMember srt:ChiefExecutiveOfficerMember 2021-01-31 0001512886 us-gaap:SeriesFPreferredStockMember 2021-01-31 0001512886 us-gaap:SeriesGPreferredStockMember 2022-04-30 0001512886 2022-02-23 0001512886 2022-02-21 2022-02-23 iso4217:USD xbrli:shares iso4217:USD xbrli:shares xbrli:pure

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 10-Q

 

(MARK ONE)

 

[X] QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the quarterly period ended April 30, 2023

 

or

 

[_] TRANSITION REPORT UNDER SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the transition period from _________ to _________

 

Commission File Number: 0-55077

 

NEUTRA CORP.

(Exact name of registrant as specified in its charter)

 

Wyoming   27-4505461
(State or other jurisdiction of Incorporation or organization)   (I.R.S. Employer Identification Number)
     
54 Sugar Creek Center Blvd., Suite 200
Sugar Land, Texas		   77478
(Address of principal executive offices)   (Zip code)

 

Registrant’s telephone number, including area code: 702-793-4121

 

Securities registered pursuant to Section 12(b) of the Act: None

 

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.

[X] Yes  [_] No

 

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).

[X] Yes  [_] No

 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

 

  Large accelerated filer [_] Accelerated filer [_]
  Non-accelerated filer [X] Smaller reporting company [X]
    Emerging growth company [_]

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.   [_]

 

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).

[_] Yes  [X] No

 

Indicate the number of shares outstanding of each of the issuer’s classes of common stock, as of the latest practicable date. As of June 21, 2023, 2,917,899,124 shares of common stock are issued and outstanding.

 

 

TABLE OF CONTENTS

 

PART I — FINANCIAL INFORMATION  
   
Item 1. Financial Statements 4
   
Consolidated Balance Sheets (unaudited) 4
   
Consolidated Statements of Operations (unaudited) 5
   
Consolidated Statements of Stockholders’ Deficit (unaudited) 6
   
Consolidated Statement of Changes in Mezzanine Equity(unaudited) 7
   
Consolidated Statements of Cash Flows (unaudited) 8
   
Notes to the Unaudited Consolidated Financial Statements 9
   
Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations 14
   
Item 3. Quantitative and Qualitative Disclosures about Market Risk 16
   
Item 4. Controls and Procedures 16
   
PART II — OTHER INFORMATION  
   
Item 1. Legal Proceedings 17
   
Item 1A. Risk Factors 17
   
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds 17
   
Item 3. Defaults upon Senior Securities 17
   
Item 4. Mine Safety Disclosures 17
   
Item 5. Other Information 17
   
Item 6. Exhibits 17
   
Signatures 18

 

- 2 -

Table of Contents

 

CAUTIONARY STATEMENT REGARDING FORWARD-LOOKING INFORMATION

 

Certain statements in this report contain or may contain forward-looking statements. These statements, identified by words such as “plan”, “anticipate”, “believe”, “estimate”, “should”, “expect” and similar expressions include our expectations and objectives regarding our future financial position, operating results and business strategy. These statements are subject to known and unknown risks, uncertainties and other factors, which may cause actual results, performance, or achievements to be materially different from any future results, performance or achievements expressed or implied by such forward - looking statements. These forward-looking statements were based on various factors and were derived utilizing numerous assumptions and other factors that could cause our actual results to differ materially from those in the forward-looking statements. These factors include, but are not limited to, our ability to secure suitable financing to continue with our existing business or change our business and conclude a merger, acquisition or combination with a business prospect, economic, political and market conditions and fluctuations, government and industry regulation, interest rate risk, U.S. and global competition, and other factors. Most of these factors are difficult to predict accurately and are generally beyond our control. You should consider the areas of risk described in connection with any forward-looking statements that may be made herein. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date of this report. Readers should carefully review this report in its entirety, including but not limited to our financial statements and the notes thereto and the risks described in our Annual Report on Form 10-K for the fiscal year ended January 31, 2023. We advise you to carefully review the reports and documents we file from time to time with the Securities and Exchange Commission (the “SEC”), particularly our quarterly reports on Form 10-Q and our current reports on Form 8-K. Except for our ongoing obligations to disclose material information under the Federal securities laws, we undertake no obligation to release publicly any revisions to any forward-looking statements, to report events or to report the occurrence of unanticipated events.

 

OTHER PERTINENT INFORMATION

 

When used in this report, the terms, “we,” the “Company,” “our,” and “us” refers to Neutra Corp., a Wyoming corporation.

 

- 3 -

Table of Contents

 

PART I — FINANCIAL INFORMATION

 

ITEM 1. FINANCIAL STATEMENTS

 

NEUTRA CORP.

CONSOLIDATED BALANCE SHEETS

(UNAUDITED)

               
    April 30,   January 31,  
    2023   2023  
    (UNAUDITED)   (AUDITED)  
               
CURRENT ASSETS              
Cash and cash equivalents   $ 3,138   $ 1,969  
Inventory     21,332     23,846  
Total current assets     24,470     25,815  
               
Property and equipment, net     29,634     49,360  
               
TOTAL ASSETS   $ 54,104   $ 75,175  
               
LIABILITIES, MEZZANINE EQUITY AND STOCKHOLDERS' DEFICIT              
Current Liabilities              
Accounts payable and accrued expenses   $ 513,016   $ 516,890  
Accounts payable to related party     278,340     233,087  
Advances payable     3,450     3,450  
Advances payable to related party     12,314     2,314  
Dividends payable on Series G preferred stock     —     2,062  
Accrued interest payable     2,035     1,836  
Total current liabilities     809,155     759,639  
               
Notes payable, related party     54,156     54,156  
               
TOTAL LIABILITIES     863,311     813,795  
               
COMMITMENTS AND CONTINGENCIES              
               
MEZZANINE EQUITY              
Series G preferred stock; $1.00 stated value, 0 shares and 35,200 shares issued and outstanding at April 30, 2023 and January 31, 2023, respectively     —     35,200  
               
STOCKHOLDERS' DEFICIT              
Common stock, $0.001 par value; unlimited shares authorized; 2,917,899,124 and 2,743,575,314 shares issued and outstanding at April 30, 2023 and January 31, 2023, respectively     2,917,899     2,743,575  
Preferred stock, $0.001 par value; 20,000,000 shares authorized:              
Series A convertible preferred stock; 50,000 shares issued and outstanding at April 30, 2023 and January 31, 2023     50     50  
Series B convertible preferred stock; 10,000 and 0 shares issued and outstanding at April 30, 2023 and January 31, 2023     10     10  
Series C convertible preferred stock; 40,000 shares issued and outstanding at April 30, 2023 and January 31, 2023     40     40  
Series E preferred stock, 1,000,000 shares issued and outstanding at April 30, 2023 and January 31, 2023     1,000     1,000  
Series F preferred stock, $0.001 par value; 1,000,000 shares issued and outstanding at April 30, 2023 and January 31, 2023     1,000     1,000  
Additional paid-in capital     7,751,840     7,889,555  
Preferred stock subscribed but not issued     50,000     50,000  
Accumulated deficit     (11,531,046 )   (11,459,050 )
               
TOTAL STOCKHOLDERS' DEFICIT     (809,207 )   (773,820 )
               
TOTAL LIABILITIES, MEZZANINE EQUITY AND STOCKHOLDERS' DEFICIT   $ 54,104   $ 75,175  

 

The accompanying footnotes are an integral part of these unaudited consolidated financial statements.

 

- 4 -

Table of Contents

 

NEUTRA CORP.

CONSOLIDATED STATEMENTS OF OPERATIONS

(UNAUDITED)

               
    Three Months Ended  
    April 30,  
    2023   2022  
               
REVENUE   $ 5,842   $ 9,662  
Cost of goods sold     3,038     4,538  
               
Gross margin     2,804     5,124  
               
OPERATING EXPENSES              
Depreciation     19,726     19,726  
Sales commissions     3,505     1,359  
General and administrative expenses     50,781     75,501  
Total operating expenses     74,012     96,586  
               
LOSS FROM OPERATIONS     (71,208 )   (91,462 )
               
OTHER INCOME (EXPENSE)              
Interest expense     (199 )   (15,734 )
Total other income (expense)     (199 )   (15,734 )
               
Net loss before income taxes     (71,407 )   (107,196 )
Provision for income taxes     (589 )   —  
NET LOSS   $ (71,996 ) $ (107,196 )
               
Dividends on Series G convertible preferred stock     —     (2,429 )
               
Net loss available to common shareholders   $ (71,996 ) $ (109,625 )
               
Net loss per common share   $ (0.00 ) $ (0.00 )
               
Weighted average shares outstanding – basic and diluted   2,910,381,521     1,824,868,256  

 

The accompanying footnotes are an integral part of these unaudited consolidated financial statements.

 

- 5 -

Table of Contents

 

NEUTRA CORP.

CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ DEFICIT

(UNAUDITED)

                                                                                       
        Series A                           Stock      
        Convertible   Series B   Series C   Series E   Series F   Additional       subscribed   Total  
    Common stock   Preferred Stock   Preferred Stock   Preferred Stock   Preferred Stock   Preferred Stock   paid-in   Accumulated   but not   Equity  
    Shares   Par   Shares   Par   Shares   Par   Shares   Par   Shares   Par   Shares   Par   capital   Deficit   issued   (Deficit)  
                                                                                       
Balance, January 31, 2022   1,782,073,799   $ 1,782,074   50,000   $ 50   10,000   $ 10   40,000   $ 40   1,000,000   $ 1,000   1,000,000   $ 1,000   $ 7,824,982   $ (10,882,188 ) $ —   $ (1,273,032 )
Common stock issued for preferred stock conversions   425,622,150     425,622   —     —   —     —   —     —   —     —   —     —     (199,110 )   —     —     226,512  
Preferred stock subscribed but not issued   —     —   —     —   —     —   —     —   —     —   —     —     —     —     50,000     50,000  
Dividends on Series G preferred stock   —     —   —     —   —     —   —     —   —     —   —     —     —     (2,429 )   —     (2,429 )
Net loss   —     —   —     —   —     —   —     —   —     —   —     —     —     (107,196 )         (107,196 )
Balance, April 30, 2022   2,207,695,949   $ 2,207,696   50,000   $ 50   10,000   $ 10   40,000   $ 40   1,000,000   $ 1,000   1,000,000   $ 1,000   $ 7,625,872   $ (10,991,813 ) $ 50,000   $ (1,106,145 )
                                                                                       
                                                                                       
                                                                                       
Balance, January 31, 2023   2,743,575,314   $ 2,743,575   50,000   $ 50   10,000   $ 10   40,000   $ 40   1,000,000   $ 1,000   1,000,000   $ 1,000   $ 7,889,555   $ (11,459,050 ) $ 50,000   $ (773,820 )
Common stock issued for preferred stock conversions   174,323,810     174,324   —     —   —     —   —     —   —     —   —     —     (137,715 )   —     —     36,609  
Net loss   —     —   —     —   —     —   —     —   —     —   —     —     —     (71,996 )   —     (71,996 )
Balance, April 30, 2023   2,917,899,124   $ 2,917,899   50,000   $ 50   10,000   $ 10   40,000   $ 40   1,000,000   $ 1,000   1,000,000   $ 1,000   $ 7,751,840   $ (11,531,046 ) $ 50,000   $ (809,207 )

 

The accompanying footnotes are an integral part of these unaudited consolidated financial statements.

 

- 6 -

Table of Contents

 

NEUTRA CORP.

CONSOLIDATED STATEMENT OF CHANGES IN MEZZANINE EQUITY

(UNAUDITED)

             
  Series G Preferred Stock  
  Shares   Amount  
         
Balance, January 31, 2023   35,200   $ 35,200  
             
Series G preferred stock converted to common stock   (35,200 )   (35,200 )
             
Balance, April 30, 2023   —   $ —  

 

The accompanying footnotes are an integral part of these unaudited consolidated financial statements.

 

- 7 -

Table of Contents

 

NEUTRA CORP.

CONSOLIDATED STATEMENTS OF CASH FLOWS

(UNAUDITED)

 

               
    Three Months Ended  
    April 30,  
    2023   2022  
               
CASH FLOW FROM OPERATING ACTIVITIES:              
Net loss   $ (71,996 ) $ (107,196 )
Adjustments to reconcile net loss to net cash used in operating activities:              
Depreciation     19,726     19,726  
Changes in operating assets and liabilities              
Inventory     2,514     (21,991 )
Accounts payable and accrued liabilities     (24,780 )   (29,976 )
Accounts payable to related party     65,506     31,334  
Accrued interest payable     199     15,435  
NET CASH USED IN OPERATING ACTIVITIES     (8,831 )   (92,668 )
               
CASH FLOWS FROM FINANCING ACTIVITIES              
Stock subscriptions received     —     50,000  
Proceeds from advance from related party     10,000     —  
Proceeds from issuance of note payable     —     60,000  
Repayments on notes payable     —     (3,200 )
NET CASH PROVIDED BY FINANCING ACTIVITIES     10,000     106,800  
               
NET CHANGE IN CASH AND CASH EQUIVALENTS     1,169     14,132  
               
Cash and cash equivalents at beginning of period     1,969     1,056  
               
Cash and cash equivalents at end of period   $ 3,138   $ 15,188  
               
Cash paid during the period for:              
Interest   $ —   $ 300  
Taxes   $ —   $ —  
               
Noncash investing and financing transactions:              
Conversion of Series G preferred stock   $ 36,609   $ 217,800  

 

The accompanying footnotes are an integral part of these unaudited consolidated financial statements.

 

- 8 -

Table of Contents

 

NEUTRA CORP.

NOTES TO THE UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS

April 30, 2023

 

Note 1. Background Information

 

Neutra Corp. was incorporated in Nevada on January 11, 2011, to market and participate in the nutraceutical space by bringing products derived from all natural and organic origins. Along with participating in the actual nutraceutical products, we plan to research and bring new technology to the nutraceutical space. Nutraceutical natural medicine is an alternative system that focuses on natural remedies and the body’s vital ability to heal and maintain itself. One of the nutraceutical sub-markets is the new thriving medical cannabis market, in which we intend to participate. We intend to entrust the manufacturing to a nutraceutical contractor to private label all of our products and to sell them under our unique brand. We have established a fiscal year end of January 31.

 

As the global cannabis market grows exponentially, it is constantly in need of better technologies and products to be more efficient in how it grows, what it grows and how it consumes cannabis and its related products. From lighting to dosage devices, from pesticide replacements to plant enhancers, Neutra Corp. is constantly combing the industry for the latest and greatest to test, prove and bring to market.

 

Note 2. Going Concern

 

For the three months ended April 30, 2023, the Company had a net loss of $71,996 and did not have positive cash flow from operations. As of April 30, 2023, the Company has negative working capital of $784,685. We have generated limited revenues to date and our activities have been primarily limited to developing our business plan and research and development of products. We will not have the necessary capital to fully develop or execute our business plan until we are able to secure additional financing. There can be no assurance that such financing will be available on suitable terms. We need to raise additional funds in order to implement our business plan. Our current cash on hand is insufficient to commercialize our products or fully develop our business strategy. If we are unable to raise adequate additional funds or if those funds are not available on terms that are acceptable to us, we will not be able to execute our business plan and we may cease operations.

 

These factors raise a substantial doubt about the Company’s ability to continue as a going concern. The accompanying financial statements do not include any adjustments to reflect the possible future effects on the recoverability and classification of assets or the amounts and classifications of liabilities that may result from the possible inability of the Company to continue as a going concern.

 

The Company does not have the resources at this time to repay its credit and debt obligations, make any payments in the form of dividends to its shareholders or fully implement its business plan. Without additional capital, the Company will not be able to remain in business.

 

Management has plans to address the Company’s financial situation as follows:

 

In the near term, management plans to continue to focus on raising the funds necessary to implement the Company’s business plan. Management will continue to seek out debt financing to obtain the capital required to meet the Company’s financial obligations. There is no assurance, however, that lenders will continue to advance capital to the Company or that the new business operations will be profitable. The possibility of failure in obtaining additional funding and the potential inability to achieve profitability raises doubts about the Company’s ability to continue as a going concern.

 

In the long term, management believes that the Company’s projects and initiatives will be successful and will provide cash flow to the Company that will be used to finance the Company’s future growth. However, there can be no assurances that the Company’s planned activities will be successful, or that the Company will ultimately attain profitability. The Company’s long-term viability depends on its ability to obtain adequate sources of debt or equity funding to meet current commitments and fund the continuation of its business operations, and the ability of the Company to achieve adequate profitability and cash flows from operations to sustain its operations.

 

Note 3. Significant Accounting Policies

 

The significant accounting policies that the Company follows are:

 

Interim Financial Statements

 

The accompanying unaudited financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”) for interim financial information and with the instructions to Form 10-Q and Regulation S-X. Accordingly, the consolidated financial statements do not include all of the information and footnotes required by GAAP for complete financial statements. In the opinion of management, all adjustments considered necessary for a fair presentation have been included and such adjustments are of a normal recurring nature. These consolidated financial statements should be read in conjunction with the consolidated financial statements for the fiscal year ended January 31, 2023 and notes thereto and other pertinent information contained in our Form 10-K that we filed with the Securities and Exchange Commission (the “SEC”).

 

The results of operations for the three month period ended April 30, 2023 are not necessarily indicative of the results to be expected for the full fiscal year ending January 31, 2024.

 

Basis of Presentation

 

The consolidated financial statements and related disclosures have been prepared pursuant to the rules and regulations of the SEC. The consolidated financial statements have been prepared using the accrual basis of accounting in accordance with GAAP.

 

Consolidated Financial Statements

 

The consolidated financial statements of the Company include the accounts of the Company and its wholly owned subsidiaries, Diamond Anvil Designs, LLC Deity Corporation and Vivis Corporation (Vivis), from the date of their formations or acquisition. Significant intercompany transactions have been eliminated in consolidation.

 

Use of Estimates

 

The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.

 

Inventory

 

Inventory is comprised of packaging and supplies and at times raw materials. Inventory is valued at cost, based on the average cost method, unless and until the net realizable value for the inventory is lower than cost, in which case an allowance is established to reduce the valuation to the net realizable value. As of April 30, 2023 and January 31, 2023, market values of all of our inventory were greater than cost, and accordingly, no such valuation allowance was recognized.

 

Property and Equipment, net

 

Property and equipment consist of equipment used to manufacture the Company’s products and is presented at cost. Depreciation is recognized over the useful life of the equipment on a straight-line basis over three years beginning when the asset is put in service. For the three months ended April 30, 2023 and 2022, the Company recognized depreciation expense of $19,726.

 

Revenue Recognition

 

The Company recognizes revenue in accordance with ASC Topic 606, Revenue From Contracts With Customers. Revenues are recognized when control of the promised goods or services is transferred to the customer in an amount that reflects the consideration the Company expects to be entitled to in exchange for transferring those goods or services. Revenue is recognized based on the following five step model:

 

• Identification of the contract with a customer
   
• Identification of the performance obligations in the contract
   
• Determination of the transaction price
   
• Allocation of the transaction price to the performance obligations in the contract
   
• Recognition of revenue when, or as, the Company satisfies a performance obligation

 

- 10 -

Table of Contents

 

Product sales are recognized all of the following criteria are satisfied: (i) a contract with an end user exists which has commercial substance; (ii) it is probable the Company will collect the amount charged to the end user; and (iii) the Company has completed its performance obligation whereby the end user has obtained control of the product. A contract with commercial substance exists once the Company receives and accepts a purchase order or once it enters into a contract with an end user. If collectability is not probable, the sale is deferred and not recognized until collection is probable or payment is received. Control of products typically transfers when title and risk of ownership of the product has transferred to the customer. Payment is received before shipment of the product. Net revenues comprise gross revenues less customer discounts and allowances, actual and expected returns. Shipping charges billed to customers are included in net sales. Various taxes on the sale of products to customers are collected by the Company as an agent and remitted to the respective taxing authority. These taxes are presented on a net basis and recorded as a liability until remitted to the respective taxing authority. The Company allows for customers to return unopened products within 10 days in certain limited circumstances. There have been no refunds processed for returned product.

 

Contract Costs

 

Costs incurred to obtain a customer contract are not material to the Company. The Company elected to apply the practical expedient to not capitalize contract costs to obtain contracts with a duration of one year or less, which are expensed and included within cost of goods and services.

 

Cost of Sales

 

Cost of sales includes all of the costs to purchase and assemble the Company’s products. Products are manufactured for the Company by third-party contractors, such costs represent the amounts invoiced by the contractors. Additionally, shipping costs are included in Cost of Sales in the Statements of Operations.

 

Earnings (Loss) per Common Share

 

We compute basic and diluted earnings per common share amounts in accordance with ASC Topic 260, Earnings per Share. The basic earnings (loss) per common share are calculated by dividing our net income available to common shareholders by the weighted average number of common shares outstanding during the year. The diluted earnings (loss) per common share are calculated by dividing our net income (loss) available to common shareholders by the diluted weighted average number of shares outstanding during the year. The diluted weighted average number of shares outstanding is the basic weighted number of shares adjusted as of the first of the year for any potentially dilutive debt or equity. There are no dilutive shares outstanding for any periods reported.

 

Commitments and Contingencies

 

The Company follows ASC 450-20, Loss Contingencies, to report accounting for contingencies. Liabilities for loss contingencies arising from claims, assessments, litigation, fines and penalties and other sources are recorded when it is probable that a liability has been incurred and the amount of the assessment can be reasonably estimated.

 

As discussed in more detail in Note 5, the Company agreed to pay 60% of all revenue from Deity Corporation to Sydney Jim, the Company’s CEO, up until a total of $250,000 is paid to Mr. Jim, at which point he will be entitled to 20% of revenue from Deity Corporation.

 

There were no other known commitments or contingencies as of April 30, 2023 and January 31, 2023.

 

Mezzanine equity

 

Where ordinary or preferred shares are determined to be conditionally redeemable upon the occurrence of certain events that are not solely within the control of the issuer, and upon such event, the shares would become redeemable at the option of the holders, they are classified as ‘mezzanine equity’ (temporary equity). The purpose of this classification is to convey that such a security may not be permanently part of equity and could result in a demand for cash, securities or other assets of the entity in the future.

 

Subsequent events

 

The Company follows the guidance in Section 855-10-50 of the FASB Accounting Standards Codification for the disclosure of subsequent events. The Company will evaluate subsequent events through the date when the financial statements were issued. Pursuant to ASU 2010-09 of the FASB Accounting Standards Codification, the Company as an SEC filer considers its financial statements issued when they are widely distributed to users, such as through filing them on EDGAR.

 

Recently Adopted Accounting Pronouncements

 

The Company does not believe that any recently issued effective pronouncements, or pronouncements issued but not yet effective, if adopted, would have a material effect on the accompanying financial statements. 

 

Note 4. Property and equipment, net

 

Property and equipment consist of the following:

 

    April 30, 2023   January 31, 2023  
Equipment   $ 236,717   $ 236,717  
Total property and equipment     236,717     236,717  
Less: accumulated depreciation     (207,083 )   (187,357 )
Property and equipment, net   $ 29,634   $ 49,360  

 

Note 5. Related Party Transactions

 

During the three months ended April 30, 2023 and 2022, we incurred salary expense of $25,000 to our CEO, Sydney Jim. In addition, we incurred commission expense of $3,505 and $1,359 during the three months ended April 30, 2023 and 2022 to Mr. Jim and owed a total of $38,101 and $34,596 in accrued commissions as of April 30, 2023 and January 31, 2023, respectively. During the three months ended Mr. Jim paid expenses of $20,253 on behalf of the Company.

 

As of April 30, 2023 and January 31, 2023, we owed Mr. Jim, or entities controlled by him, $278,340 and $233,087 which is recorded on the balance sheet in “Accounts Payable – Related Party”, respectively, and $12,314 and $2,314 in “Advances payable to related party, respectively.”

 

During the three months ended April 30, 2023, an investor advanced $10,000 to the Company. This advance is unsecured, non-interest bearing and due on demand.

 

On March 11, 2022, the Company entered into a loan agreement for $60,000 of proceeds with the holder of the Company’s Series A and B preferred stock. The loan is unsecured and bears interest at 6%. The Company will make monthly payments of $4,240 per month beginning in April 2022 through the maturity at June 18, 2023. As of April 30, 2023, the note principal balance was $54,156 and accrued interest was $2,035. The Company has not made all required monthly payments under the note agreement to date.

 

During the year ended January 31, 2022, the Company acquired the assets of Deity Corporation, a Texas corporation which the Sydney Jim, the Company’s CEO, had a controlling interest in that will produce hemp and cannabis products. The transaction was considered an asset acquisition, as there were no operations of Deity Corporation prior to the transaction. The Company received the formulas for certain hemp and cannabis-based products and a website to market the products that will be produced. In exchange, the Company will pay to Mr. Jim 60% of the revenue from Deity Corporation sales until a total of $250,000 is reached, at which point the Company will pay 20% of Deity Corporation revenue to Mr. Jim.

 

Note 6. Advances and Notes Payable

 

As of April 30, 2023 and January 31, 2023, we had amounts due under advances of $3,450 at each period. These advances are not collateralized, non-interest bearing and are due on demand.

 

On March 11, 2022, the Company entered into a loan agreement for $60,000 of proceeds with the holder of the Company’s Series A and B preferred stock. The loan is unsecured and bears interest at 6%. The Company will make monthly payments of $4,240 per month beginning in April 2022 through the maturity at June 18, 2023. As of April 30, 2023, the note principal balance was $54,156 and accrued interest was $2,035.

 

- 12 -

Table of Contents

 

Note 7. Shareholders’ Equity

 

Series A Preferred Stock. In January 2020, our board of directors designated 50,000 shares of our preferred stock as Series A Preferred Stock which rank subordinate to all shares of common stock and do not have voting rights. The Series A Preferred Stock has a stated value of $5 per share. The Series A Preferred Stock is entitled to receive dividends of 10% of the net profit of VIVIS Corporation. The holders of the Series A Preferred Stock have the option to convert each share into 800 shares of common stock of the Company. As of April 30, 2023 and January 31, 2023, there are 50,000 shares of Series A Preferred Stock outstanding.

 

Series B Preferred Stock. In July 2020, our board of directors designated 10,000 shares of our preferred stock as Series B Preferred Stock which rank subordinate to all shares of common stock and do not have voting rights. The Series B Preferred Stock has a stated value of $5 per share. The Series B Preferred Stock is entitled to receive dividends of 0.4% of the net profit of VIVIS Corporation. Holders of the Series B Preferred Stock have the option to convert each share into 800 shares of common stock. During the year ended January 31, 2021, the Company subscribed 10,000 shares of Series B Preferred Stock for cash proceeds of $50,000. The shares were issued during the year ended January 31, 2022. As of April 30, 2023 and January 31, 2023, there are 10,000 shares of Series B Preferred Stock outstanding.

 

Series C Preferred Stock. In November 2020, our board of directors designated 40,000 shares of our preferred stock as Series C Preferred Stock which rank subordinate to all shares of common stock and do not have voting rights. The Series C Preferred Stock has a stated value of $5 per share. The Series C Preferred Stock is entitled to receive dividends of 10% of the net profit of VIVIS Corporation. After the Series C Preferred Stock has received cumulative dividends of $500,000, the dividend rate will reduce to 1%. Holders of the Series C Preferred Stock have the option to convert each share into 38 shares of common stock. During the year ended January 31, 2021, the Company subscribed 40,000 shares of Series B Preferred Stock for cash proceeds of $200,000. The shares were issued during the year ended January 31, 2022. As of April 30, 2023 and January 31, 2023, there are 40,000 shares of Series C Preferred Stock outstanding.

 

Series E preferred stock issued for services

 

On November 13, 2015, our board of directors designated 1,000,000 shares of our preferred stock as Series E Preferred Stock. The Series E Preferred Stock is subordinated to our common stock. It does not receive dividends and does not participate in equity distributions. The Series E Preferred stock has 2 votes for each outstanding share of common stock in the company. As of April 30, 2023 and January 31, 2023, there are 1,000,000 shares Series E Preferred Stock outstanding. Dividends, when, as and if declared by the Board of Directors, shall be paid out of funds at the time legally available for such purposes.

 

Series F preferred stock issued for services

 

The Series F Preferred Stock is subordinated to our common stock and superior to all shares of Preferred Stock. It does not receive dividends and does not participate in equity distributions. The Series F Preferred stock retains 2/3 of the voting rights in the company. During the year ended January 31, 2021, the Company issued 1,000,000 shares of Series F Preferred Stock to Sydney Jim, our CEO, in exchange for services. As of the date of this report, there are 1,000,000 shares Series F Preferred Stock outstanding. As of April 30, 2023 and January 31, 2023, there are 1,000,000 shares of Series F Preferred Stock outstanding.

 

Series G convertible preferred stock

 

During the three months ended April 30, 2023, the Company the holder of the Series G convertible preferred stock converted 35,200 shares and accrued dividends of $1,408 into 174,323,810 shares of common stock. During the three months ended April 30, 2022, the Company accrued dividends of $2,429, and the holder of the Series G convertible preferred stock converted 217,800 shares and accrued dividends of $8,712 into 425,622,150 shares of common stock. The conversions were in accordance with the terms of the agreement and no gain or loss was recognized. As of April 30, 2023, there were no shares of Series G convertible preferred stock outstanding.

 

Preferred Stock Subscription

 

On February 23, 2022, the Company sold 10,000 shares of preferred stock not yet designated for cash proceeds of $50,000.

 

- 13 -

Table of Contents

 

ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

 

The following discussion and analysis of our financial condition and plan of operations should be read in conjunction with our financial statements and related notes appearing elsewhere herein. This discussion and analysis contains forward-looking statements including information about possible or assumed results of our financial conditions, operations, plans, objectives, and performance that involve risk, uncertainties, and assumptions. The actual results may differ materially from those anticipated in such forward-looking statements. For example, when we indicate that we expect to increase our product sales and potentially establish additional license relationships, these are forward-looking statements. The words expect, anticipate, estimate or similar expressions are also used to indicate forward-looking statements.

 

Background of our Company

 

Neutra Corp. was incorporated in Florida on January 11, 2011. On October 5, 2015, we reincorporated from Florida to Nevada. On August 16, 2019, we reincorporated from Nevada to Wyoming. The reincorporation was approved by our board of directors and by the holders of a majority of the voting rights for our common stock. There was no change in share ownership as a result of the reincorporation. Our authorized shares in the Wyoming corporation are unlimited shares of common stock and 20,000,000 shares of preferred stock.

 

We have established a fiscal year end of January 31.

 

As the global cannabis market grows exponentially, it is constantly in need of better technologies and products to be more efficient in how it grows, what it grows and how it consumes cannabis and its related products. From lighting to dosage devices, from pesticide replacements to plant enhancers, Neutra Corp. is constantly combing the industry for the latest and greatest to test, prove and bring to market.

 

We have generated limited revenues to date and our activities have been primarily limited to developing our business plan and research and development of products. We will not have the necessary capital to fully develop or execute our business plan until we are able to secure additional financing. There can be no assurance that such financing will be available on suitable terms. We need to raise additional funds in order to implement our business plan. Our current cash on hand is insufficient to commercialize our products or fully develop our business strategy. If we are unable to raise adequate additional funds or if those funds are not available on terms that are acceptable to us, we will not be able to execute our business plan and we may cease operations.

 

Plan of Operations

 

We believe we do not have adequate funds to fully execute our business plan for the next twelve months unless we obtain additional funding. However, should we not raise this capital, we will allocate our funding to first assure that all State, Federal and SEC requirements are met.

 

As of April 30, 2023, we had cash on hand of $3,138.

 

We intend to pursue capital through public or private financing, as well as borrowing and other sources in order to finance our business activities. We cannot guarantee that additional funding will be available on favorable terms, if at all. If adequate funds are not available, then our ability to continue our operations may be significantly hindered.

 

Critical Accounting Policies

 

We prepare our consolidated financial statements in conformity with GAAP, which requires management to make certain estimates and apply judgments. We base our estimates and judgments on historical experience, current trends, and other factors that management believes to be important at the time the consolidated financial statements are prepared. On a regular basis, we review our accounting policies and how they are applied and disclosed in our consolidated financial statements.

 

While we believe that the historical experience, current trends and other factors considered support the preparation of our consolidated financial statements in conformity with GAAP, actual results could differ from our estimates and such differences could be material.

 

For a full description of our critical accounting policies, please refer to Item 7, “Management’s Discussion and Analysis of Financial Condition and Results of Operations” in our Annual Report for the year ended January 31, 2022 on Form 10-K.

 

- 14 -

Table of Contents

 

Results of Operations

 

Three months ended April 30, 2023 compared to the three months ended April 30, 2022

 

Revenue and Cost of Goods Sold

 

During the three months ended April 30, 2023, we recognized revenue of $5,842 and cost of goods sold of $3,038 related to the sales of CBD products. During the three months ended April 30, 2022, we recognized revenue of $9,662 and cost of goods sold of $4,538. The decrease in revenue compared to the prior year is due a slowdown from current economic conditions.

 

Depreciation

 

We recognized depreciation of $19,726 for the three months ended April 30, 2023 and 2022 related to the Company’s property and equipment.

 

General and Administrative Expenses

 

We recognized general and administrative expenses of $50,781 and $75,501 for the three months ended April 30, 2023 and 2022, respectively. The decrease is primarily related to the decrease in wages and professional fees.

 

Interest Expense

 

Interest expense was $199 and $15,734 for the three months ended April 30, 2023 and 2022, respectively. The decrease in interest expense was related to the settlement of outstanding convertible notes payable in the prior year.

 

Net Loss

 

We incurred a net loss of $71,996 for the three months ended April 30, 2023 as compared to $107,196 for the comparable period of 2022.

 

Liquidity and Capital Resources

 

At April 30, 2023, we had cash on hand of $3,138. We have negative working capital of $784,685. Net cash used in operating activities for the three months ended April 30, 2023 was $8,831. The Company had net cash provided by financing activities of $10,000 for the three months ended April 30, 2023, with $10,000 of proceeds from advances from related party. Cash on hand is adequate to fund our operations for less than six months. We do not expect to achieve positive cash flow from operating activities in the near future. We will require additional cash in order to implement our business plan. There is no guarantee that we will be able to attain fund when we need them or that funds will be available on terms that are acceptable to us. We have no material commitments for capital expenditures as of April 30, 2023.

 

Additional Financing

 

Additional financing is required to continue operations. Although actively searching for available capital, we do not have any current arrangements for additional outside sources of financing and cannot provide any assurance that such financing will be available.

 

Off Balance Sheet Arrangements

 

We do not have any off-balance sheet arrangements that have or are reasonably likely to have a current or future effect on our financial condition, changes in financial condition, revenues or expenses, results of operations, liquidity, capital expenditures or capital resources that is material to investors.

 

- 15 -

Table of Contents

 

ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

 

This item is not applicable to smaller reporting companies.

 

ITEM 4. CONTROLS AND PROCEDURES

 

Management’s Report on Internal Control over Financial Reporting

 

We carried out an evaluation, under the supervision and with the participation of our management, including our principal executive officer and principal financial officer, of the effectiveness of our disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) as of April 30, 2023. Based upon that evaluation, our principal executive officer and principal financial officer concluded that, as of April 30, 2023, our disclosure controls and procedures were not effective to ensure that information required to be disclosed in reports filed by us under the Securities Exchange Act of 1934 is recorded, processed, summarized and reported within the required time periods and is accumulated and communicated to our management, including our principal executive officer and principal financial officer, as appropriate to allow timely decisions regarding required disclosure.

 

1. As of April 30, 2023, we did not maintain effective controls over the control environment. Specifically, we have not developed and effectively communicated to our employees our accounting policies and procedures. This has resulted in inconsistent practices. Further, the Board of Directors does not currently have any independent members and no director qualifies as an audit committee financial expert as defined in Item 407(d)(5)(ii) of Regulation S-K. Since these entity level programs have a pervasive effect across the organization, management has determined that these circumstances constitute a material weakness.
   
2. As of April 30, 2023, we did not maintain effective controls over financial statement disclosure. Specifically, controls were not designed and in place to ensure that all disclosures required were originally addressed in our financial statements. Accordingly, management has determined that this control deficiency constitutes a material weakness.
   
3. As of April 30, 2023, we did not maintain effective controls over transactions with related parties. Specifically, controls were not designed and in place to ensure that all transactions with related parties were captured and tracked in our financial statements. The Company has no formal process related to the identification and approval of related party transactions. Management has determined that this control deficiency constitutes a material weakness.

 

Our management, including our principal executive officer and principal financial officer, who is the same person, does not expect that our disclosure controls and procedures or our internal controls will prevent all error or fraud. A control system, no matter how well conceived and operated, can provide only reasonable, not absolute, assurance that the objectives of the control system are met. Further, the design of a control system must reflect the fact that there are resource constraints and the benefits of controls must be considered relative to their costs. Due to the inherent limitations in all control systems, no evaluation of controls can provide absolute assurance that all control issues and instances of fraud, if any, have been detected.

 

Change in Internal Controls Over Financial Reporting

 

There was no change in our internal controls over financial reporting that occurred during the period covered by this report, which has materially affected, or is reasonably likely to materially affect, our internal controls over financial reporting.

 

- 16 -

Table of Contents

 

PART II — OTHER INFORMATION

 

ITEM 1. LEGAL PROCEEDINGS

 

We know of no material, active or pending legal proceedings against us, nor are we involved as a plaintiff in any material proceedings or pending litigation. There are no proceedings in which any of our directors, officers or affiliates, or any registered beneficial shareholder are an adverse party or has a material interest adverse to us.

 

ITEM 1A. RISK FACTORS

 

This item is not applicable to smaller reporting companies.

 

ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS

 

None.

 

ITEM 3. DEFAULTS UPON SENIOR SECURITIES

 

We have not defaulted upon senior securities.

 

ITEM 4. MINE SAFETY DISCLOSURES

 

This item is not applicable to the Company.

 

ITEM 5. OTHER INFORMATION

 

None.

 

ITEM 6. EXHIBITS

 

Exhibit No. Description
3.1 Articles of Incorporation (1)
3.2 Bylaws (1)
14.1 Code of Ethics (1)
21 Subsidiaries of the Registrant (2)
31.1 Rule 13(a)-14(a)/15(d)-14(a) Certification of principal executive officer and principal financial and accounting officer. (2)
32.1 Section 1350 Certification of principal executive officer and principal financial accounting officer. (2)
101.INS Inline XBRL Instance Document – the instance document does not appear in the Interactive Data File because XBRL tags are embedded within the Inline XBRL document. (3)
101.SCH Inline XBRL Taxonomy Extension Schema Document (3)
101.CAL Inline XBRL Taxonomy Extension Calculation Linkbase Document (3)
101.DEF Inline XBRL Taxonomy Extension Definition Linkbase Document (3)
101.LAB Inline XBRL Taxonomy Extension Label Linkbase Document (3)
101.PRE Inline XBRL Taxonomy Extension Presentation Linkbase Document (3)
104 Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101). (3)

__________

(1) Incorporated by reference to our Form S-1 filed with the Securities and Exchange Commission on February 24, 2011.
(2) Filed or furnished herewith.
(3) In accordance with Regulation S-T, the Interactive Data Files in Exhibit 101 to the Quarterly Report on Form 10-Q shall be deemed “furnished” and not “filed.”

 

- 17 -

Table of Contents

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

 

  Neutra Corp.
   
   
Date: June 22, 2023 BY: /s/ Sydney Jim
  Sydney Jim
 

President, Secretary, Treasurer, Principal Executive Officer,

Principal Financial and Accounting Officer, and Sole Director

 

- 18 -

 EX-21 2 ex_21.htm SUBSIDIARIES OF THE REGISTRANT

 

Exhibit 21

 

SUBSIDIARIES OF THE REGISTRANT

 

 

Diamond Anvil Designs, LLC, a Texas limited-liability corporation, is a wholly owned subsidiary of Neutra Corp.

 

Vivis Corporation, a Wyoming corporation, is a wholly owned subsidiary of Neutra Corp.

 

Deity Corporation, a Texas corporation, is a wholly owned subsidiary of Neutra Corp.

 

 EX-31 3 ex_31-1.htm RULE 13(A)-14(A)/15(D)-14(A) CERTIFICATION

 

Exhibit 31.1

 

RULE 13A-14(A)/15D-14(A) CERTIFICATION

 

I, Sydney Jim, certify that:

 

1. I have reviewed this quarterly report on Form 10-Q for the period ended April 30, 2023 of Neutra Corp.

 

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

 

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

 

4. I am responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15-d-15(f)) for the registrant and have:

 

a. Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

 

b. Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

 

c. Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

 

d. Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

 

5. I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

 

a. All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

 

b. Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

 

   
Date: June 22, 2023 BY: /s/ Sydney Jim
  Sydney Jim
  President, Secretary, Treasurer, Principal Executive Officer,
Principal Financial and Accounting Officer and Sole Director

 

 EX-32 4 ex_32-1.htm SECTION 1350 CERTIFICATION

 

Exhibit 32.1

 

SECTION 1350 CERTIFICATION

 

In connection with the quarterly report of Neutra Corp. (the “Company”) on Form 10-Q for the period ended April 30, 2023 as filed with the Securities and Exchange Commission (the “Report”), I, Sydney Jim, President of the Company, certify, pursuant to 18 U.S.C. SS. 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:

 

1. The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
   
2. The information contained in the Report fairly presents, in all material respects, the financial condition and result of operations of the Company.

 

 

Date: June 22, 2023 BY: /s/ Sydney Jim
  Sydney Jim
  President, Secretary, Treasurer, Principal Executive Officer,
Principal Financial and Accounting Officer and Sole Director

 

A signed original of this written statement required by Section 906, or other document authenticating, acknowledging, or otherwise adopting the signature that appears in typed form within the electronic version of this written statement has been provided to the Company and will be retained by the Company and furnished to the Securities and Exchange Commission or its staff upon request.

 

 EX-101.SCH 5 ntrr-20230430.xsd INLINE XBRL SCHEMA FILE 00000001 - Document - Cover link:presentationLink link:calculationLink link:definitionLink 00000002 - Statement - CONSOLIDATED BALANCE SHEETS (UNAUDITED) link:presentationLink link:calculationLink link:definitionLink 00000003 - Statement - CONSOLIDATED BALANCE SHEETS (UNAUDITED) (Parenthetical) link:presentationLink link:calculationLink link:definitionLink 00000004 - Statement - CONSOLIDATED STATEMENTS OF OPERATIONS (UNAUDITED) link:presentationLink link:calculationLink link:definitionLink 00000005 - Statement - CONSOLIDATED STATEMENTS OF STOCKHOLDERS' DEFICIT (UNAUDITED) link:presentationLink link:calculationLink link:definitionLink 00000006 - Statement - CONSOLIDATED STATEMENT OF CHANGES IN MEZZANINE EQUITY (UNAUDITED) link:presentationLink link:calculationLink link:definitionLink 00000007 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED) link:presentationLink link:calculationLink link:definitionLink 00000008 - Disclosure - Background Information link:presentationLink link:calculationLink link:definitionLink 00000009 - Disclosure - Going Concern link:presentationLink link:calculationLink link:definitionLink 00000010 - Disclosure - Significant Accounting Policies link:presentationLink link:calculationLink link:definitionLink 00000011 - Disclosure - Property and equipment, net link:presentationLink link:calculationLink link:definitionLink 00000012 - Disclosure - Related Party Transactions link:presentationLink link:calculationLink link:definitionLink 00000013 - Disclosure - Advances and Notes Payable link:presentationLink link:calculationLink link:definitionLink 00000014 - Disclosure - Shareholders’ Equity link:presentationLink link:calculationLink link:definitionLink 00000015 - Disclosure - Significant Accounting Policies (Policies) link:presentationLink link:calculationLink link:definitionLink 00000016 - Disclosure - Property and equipment, net (Tables) link:presentationLink link:calculationLink link:definitionLink 00000017 - Disclosure - Going Concern (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000018 - Disclosure - Significant Accounting Policies (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000019 - Disclosure - Property and equipment consist of the following: (Details) link:presentationLink link:calculationLink link:definitionLink 00000020 - Disclosure - Related Party Transactions (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000021 - Disclosure - Advances and Notes Payable (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000022 - Disclosure - Shareholders’ Equity (Details Narrative) link:presentationLink link:calculationLink link:definitionLink EX-101.CAL 6 ntrr-20230430_cal.xml INLINE XBRL CALCULATION FILE EX-101.DEF 7 ntrr-20230430_def.xml INLINE XBRL DEFINITION FILE EX-101.LAB 8 ntrr-20230430_lab.xml INLINE XBRL LABEL FILE Class of Stock [Axis] Series A Preferred Stock [Member] Series B Preferred Stock [Member] Series C Preferred Stock [Member] Series E Preferred Stock [Member] Series F Preferred Stock [Member] Series G Preferred Stock [Member] Equity Components [Axis] Common Stock [Member] Additional Paid-in Capital [Member] Retained Earnings [Member] Stock Subscribed but Not Issued [Member] Long-Lived Tangible Asset [Axis] Equipment [Member] Related Party, Type [Axis] Mr Jim [Member] Title of Individual [Axis] Chief Executive Officer [Member] Deity Corporation [Member] Balance Sheet Location [Axis] Accounts Payable Related Party and Advances Payable to Related Party [Member] Consolidated Entities [Axis] VIVIS Corporation [Member] Convertible Preferred Stock [Member] Cover [Abstract] Document Type Amendment Flag Amendment Description Document Registration Statement Document Annual Report Document Quarterly Report Document Transition Report Document Shell Company Report Document Shell Company Event Date Document Period Start Date Document Period End Date Document Fiscal Period Focus Document Fiscal Year Focus Current Fiscal Year End Date Entity File Number Entity Registrant Name Entity Central Index Key Entity Primary SIC Number Entity Tax Identification Number Entity Incorporation, State or Country Code Entity Address, Address Line One Entity Address, Address Line Two Entity Address, Address Line Three Entity Address, City or Town Entity Address, State or Province Entity Address, Country Entity Address, Postal Zip Code Country Region City Area Code Local Phone Number Extension Written Communications Soliciting Material Pre-commencement Tender Offer Pre-commencement Issuer Tender Offer Title of 12(b) Security No Trading Symbol Flag Trading Symbol Security Exchange Name Title of 12(g) Security Security Reporting Obligation Annual Information Form Audited Annual Financial Statements Entity Well-known Seasoned Issuer Entity Voluntary Filers Entity Current Reporting Status Entity Interactive Data Current Entity Filer Category Entity Small Business Entity Emerging Growth Company Elected Not To Use the Extended Transition Period Document Accounting Standard Other Reporting Standard Item Number Entity Shell Company Entity Public Float Entity Bankruptcy Proceedings, Reporting Current Entity Common Stock, Shares Outstanding Documents Incorporated by Reference [Text Block] Statement [Table] Statement [Line Items] CURRENT ASSETS Cash and cash equivalents Inventory Total current assets Property and equipment, net TOTAL ASSETS LIABILITIES, MEZZANINE EQUITY AND STOCKHOLDERS' DEFICIT Current Liabilities Accounts payable and accrued expenses Accounts payable to related party Advances payable Advances payable to related party Dividends payable on Series G preferred stock Accrued interest payable Total current liabilities Notes payable, related party TOTAL LIABILITIES COMMITMENTS AND CONTINGENCIES MEZZANINE EQUITY Series G preferred stock; $1.00 stated value, 0 shares and 35,200 shares issued and outstanding at April 30, 2023 and January 31, 2023, respectively STOCKHOLDERS' DEFICIT Common stock, $0.001 par value; unlimited shares authorized; 2,917,899,124 and 2,743,575,314 shares issued and outstanding at April 30, 2023 and January 31, 2023, respectively Preferred stock, value Additional paid-in capital Preferred stock subscribed but not issued Accumulated deficit TOTAL STOCKHOLDERS' DEFICIT TOTAL LIABILITIES, MEZZANINE EQUITY AND STOCKHOLDERS' DEFICIT Preferred stock, par value (in dollars per share) Preferred stock, issued Preferred stock, outstanding Common stock, par value (in dollars per share) Common stock, shares authorized, unlimited Common stock, issued Common stock, outstanding Preferred stock, authorized Income Statement [Abstract] REVENUE Cost of goods sold Gross margin OPERATING EXPENSES Depreciation Sales commissions General and administrative expenses Total operating expenses LOSS FROM OPERATIONS OTHER INCOME (EXPENSE) Interest expense Total other income (expense) Net loss before income taxes Provision for income taxes NET LOSS Dividends on Series G convertible preferred stock Net loss available to common shareholders Net loss per common share Weighted average shares outstanding – basic and diluted Beginning balance, value Beginning balance (in shares) Common stock issued for preferred stock conversions Common stock issued for preferred stock conversions (in shares) Preferred stock subscribed but not issued Dividends on Series G preferred stock Net loss Ending balance, value Ending balance (in shares) Series G preferred stock converted to common stock Series G Preferred Stock Converted to Common Stock Statement of Cash Flows [Abstract] CASH FLOW FROM OPERATING ACTIVITIES: Adjustments to reconcile net loss to net cash used in operating activities: Depreciation Changes in operating assets and liabilities Inventory Accounts payable and accrued liabilities Accounts payable to related party Accrued interest payable NET CASH USED IN OPERATING ACTIVITIES CASH FLOWS FROM FINANCING ACTIVITIES Stock subscriptions received Proceeds from advance from related party Proceeds from issuance of note payable Repayments on notes payable NET CASH PROVIDED BY FINANCING ACTIVITIES NET CHANGE IN CASH AND CASH EQUIVALENTS Cash and cash equivalents at beginning of period Cash and cash equivalents at end of period Cash paid during the period for: Interest Taxes Noncash investing and financing transactions: Conversion of Series G preferred stock Organization, Consolidation and Presentation of Financial Statements [Abstract] Background Information Going Concern Accounting Policies [Abstract] Significant Accounting Policies Property, Plant and Equipment [Abstract] Property and equipment, net Related Party Transactions [Abstract] Related Party Transactions Debt Disclosure [Abstract] Advances and Notes Payable Equity [Abstract] Shareholders’ Equity Interim Financial Statements Basis of Presentation Consolidated Financial Statements Use of Estimates Inventory Property and Equipment, net Revenue [Policy Text Block] Earnings (Loss) per Common Share Commitments and Contingencies Mezzanine equity Subsequent events Recently Adopted Accounting Pronouncements Property and equipment consist of the following: Net loss Working capital Property, Plant and Equipment [Table] Property, Plant and Equipment [Line Items] Valuation allowance recognized Useful life Revenue, remaining performance obligation, percentage Total property and equipment Less: accumulated depreciation Schedule of Related Party Transactions, by Related Party [Table] Related Party Transaction [Line Items] Salary expense Commission expense Unpaid compensation Expenses paid Due to related party Advanced receive from investor Loan agreement Unsecured loan interest Monthly interest payment Principal amount balance Accrued interest Unsecured Loan Intrest Monthly Intrest Payment Loan agreement Schedule of Stock by Class [Table] Class of Stock [Line Items] Preferred stock, dividend rate, percentage Prefered stock converted into common stock Number of shares sold Cash proceeds Shares outstanding Cumulative dividends received Description of voting rights Prefered stock converted into common stock Accrured dividends Dividends payable Cash proceeds The element represents mezzanine equity policy text block. The element represents recently adopted accounting pronouncements policy text block. The element represents unpaid compensation. The element represents accounts payable related party and advances payable to related party member. The element represents mr jim member. The element represents deity corporation member. The element represents advances payable. The element represents v i v i s corporation member. The element represents prefered stock converted into common stock. The element represents dividends payable current and noncurrent1. The element represents prefered stock converted into common stock1. The element represents loan agreement. The element represents unsecured loan intrest. The element represents monthly intrest payment. The element represents advances payable to related party. The element represents series g preferred stock. The element represents stock subscribed but not issued member. The element represents deemed dividend on series g preferred stock. The element represents series g preferred stock converted to common stock. The element represents stock subscriptions received. The element represents proceeds from advance from related party. The element represents series g preferred stock converted to common stock1. The element represents working capital. The element represents earnings loss per share basic and diluted. The element represents total weighted average number of share outstanding basic and diluted. The element represents conversionof series G preferred stock. The element represents other liability current related party. The element represents preferred stock shares outstanding1. The element represents expenses paid on companys behalf. The element represents interim financial statements policy text block. Assets, Current Assets Liabilities, Current Liabilities Equity, Attributable to Parent Liabilities and Equity Gross Profit Other Nonoperating Income (Expense) Operating Income (Loss) Interest Expense Nonoperating Income (Expense) Income Tax Expense (Benefit) Dividends, Preferred Stock Shares, Outstanding Stock Issued During Period, Value, Issued for Services Depreciation [Default Label] Increase (Decrease) in Inventories Increase (Decrease) in Accounts Payable, Related Parties Increase (Decrease) in Interest Payable, Net Net Cash Provided by (Used in) Operating Activities Repayments of Notes Payable Net Cash Provided by (Used in) Financing Activities Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations Property, Plant and Equipment Disclosure [Text Block] Inventory Finished Goods, Policy [Policy Text Block] Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment Prefered Stock Converted into Common Stock Proceeds from Issuance of Preferred Stock and Preference Stock EX-101.PRE 9 ntrr-20230430_pre.xml INLINE XBRL PRESENTATION FILE XML 10 R1.htm IDEA: XBRL DOCUMENT v3.23.2
Cover - shares
 3 Months Ended
Apr. 30, 2023
Jun. 21, 2023
Cover [Abstract]    
Document Type 10-Q  
Amendment Flag false  
Document Quarterly Report true  
Document Transition Report false  
Document Period End Date Apr. 30, 2023  
Document Fiscal Period Focus Q1  
Document Fiscal Year Focus 2024  
Current Fiscal Year End Date --01-31  
Entity File Number 0-55077  
Entity Registrant Name NEUTRA CORP.  
Entity Central Index Key 0001512886  
Entity Tax Identification Number 27-4505461  
Entity Incorporation, State or Country Code WY  
Entity Address, Address Line One 54 Sugar Creek Center Blvd.  
Entity Address, Address Line Two Suite 200  
Entity Address, City or Town Sugar Land  
Entity Address, State or Province TX  
Entity Address, Postal Zip Code 77478  
City Area Code 702  
Local Phone Number 793-4121  
Entity Current Reporting Status Yes  
Entity Interactive Data Current Yes  
Entity Filer Category Non-accelerated Filer  
Entity Small Business true  
Entity Emerging Growth Company false  
Entity Shell Company false  
Entity Common Stock, Shares Outstanding   2,917,899,124
XML 11 R2.htm IDEA: XBRL DOCUMENT v3.23.2
CONSOLIDATED BALANCE SHEETS (UNAUDITED) - USD ($)
Apr. 30, 2023
Jan. 31, 2023
CURRENT ASSETS    
Cash and cash equivalents $ 3,138 $ 1,969
Inventory 21,332 23,846
Total current assets 24,470 25,815
Property and equipment, net 29,634 49,360
TOTAL ASSETS 54,104 75,175
Current Liabilities    
Accounts payable and accrued expenses 513,016 516,890
Accounts payable to related party 278,340 233,087
Advances payable 3,450 3,450
Advances payable to related party 12,314 2,314
Dividends payable on Series G preferred stock 2,062
Accrued interest payable 2,035 1,836
Total current liabilities 809,155 759,639
Notes payable, related party 54,156 54,156
TOTAL LIABILITIES 863,311 813,795
Series G preferred stock; $1.00 stated value, 0 shares and 35,200 shares issued and outstanding at April 30, 2023 and January 31, 2023, respectively 35,200
STOCKHOLDERS' DEFICIT    
Common stock, $0.001 par value; unlimited shares authorized; 2,917,899,124 and 2,743,575,314 shares issued and outstanding at April 30, 2023 and January 31, 2023, respectively 2,917,899 2,743,575
Additional paid-in capital 7,751,840 7,889,555
Preferred stock subscribed but not issued 50,000 50,000
Accumulated deficit (11,531,046) (11,459,050)
TOTAL STOCKHOLDERS' DEFICIT (809,207) (773,820)
TOTAL LIABILITIES, MEZZANINE EQUITY AND STOCKHOLDERS' DEFICIT 54,104 75,175
Series A Preferred Stock [Member]    
STOCKHOLDERS' DEFICIT    
Preferred stock, value 50 50
TOTAL STOCKHOLDERS' DEFICIT 50 50
Series B Preferred Stock [Member]    
STOCKHOLDERS' DEFICIT    
Preferred stock, value 10 10
TOTAL STOCKHOLDERS' DEFICIT 10 10
Series C Preferred Stock [Member]    
STOCKHOLDERS' DEFICIT    
Preferred stock, value 40 40
TOTAL STOCKHOLDERS' DEFICIT 40 40
Series E Preferred Stock [Member]    
STOCKHOLDERS' DEFICIT    
Preferred stock, value 1,000 1,000
TOTAL STOCKHOLDERS' DEFICIT 1,000 1,000
Series F Preferred Stock [Member]    
STOCKHOLDERS' DEFICIT    
Preferred stock, value 1,000 1,000
TOTAL STOCKHOLDERS' DEFICIT $ 1,000 $ 1,000
XML 12 R3.htm IDEA: XBRL DOCUMENT v3.23.2
CONSOLIDATED BALANCE SHEETS (UNAUDITED) (Parenthetical) - $ / shares
 3 Months Ended 12 Months Ended
Apr. 30, 2023
Jan. 31, 2023
Statement [Line Items]    
Preferred stock, par value (in dollars per share) $ 0.001 $ 0.001
Common stock, par value (in dollars per share) $ 0.001 $ 0.001
Common stock, shares authorized, unlimited Unlimited Unlimited
Common stock, issued 2,917,899,124 2,743,575,314
Common stock, outstanding 2,917,899,124 2,743,575,314
Preferred stock, authorized 20,000,000 20,000,000
Series G Preferred Stock [Member]    
Statement [Line Items]    
Preferred stock, par value (in dollars per share) $ 1.00 $ 1.00
Preferred stock, issued 0 35,200
Preferred stock, outstanding 0 35,200
Series A Preferred Stock [Member]    
Statement [Line Items]    
Preferred stock, issued 50,000 50,000
Preferred stock, outstanding 50,000 50,000
Series B Preferred Stock [Member]    
Statement [Line Items]    
Preferred stock, issued 10,000 0
Preferred stock, outstanding 10,000 0
Series C Preferred Stock [Member]    
Statement [Line Items]    
Preferred stock, issued 40,000 40,000
Preferred stock, outstanding 40,000 40,000
Series E Preferred Stock [Member]    
Statement [Line Items]    
Preferred stock, issued 1,000,000 1,000,000
Preferred stock, outstanding 1,000,000 1,000,000
Series F Preferred Stock [Member]    
Statement [Line Items]    
Preferred stock, par value (in dollars per share) $ 0.001 $ 0.001
Preferred stock, issued 1,000,000 1,000,000
Preferred stock, outstanding 1,000,000 1,000,000
XML 13 R4.htm IDEA: XBRL DOCUMENT v3.23.2
CONSOLIDATED STATEMENTS OF OPERATIONS (UNAUDITED) - USD ($)
 3 Months Ended
Apr. 30, 2023
Apr. 30, 2022
Income Statement [Abstract]    
REVENUE $ 5,842 $ 9,662
Cost of goods sold 3,038 4,538
Gross margin 2,804 5,124
OPERATING EXPENSES    
Depreciation 19,726 19,726
Sales commissions 3,505 1,359
General and administrative expenses 50,781 75,501
Total operating expenses 74,012 96,586
LOSS FROM OPERATIONS (71,208) (91,462)
OTHER INCOME (EXPENSE)    
Interest expense (199) (15,734)
Total other income (expense) (199) (15,734)
Net loss before income taxes (71,407) (107,196)
Provision for income taxes (589)
NET LOSS (71,996) (107,196)
Dividends on Series G convertible preferred stock (2,429)
Net loss available to common shareholders $ (71,996) $ (109,625)
Net loss per common share $ (0.00) $ (0.00)
Weighted average shares outstanding – basic and diluted 2,910,381,521 1,824,868,256
XML 14 R5.htm IDEA: XBRL DOCUMENT v3.23.2
CONSOLIDATED STATEMENTS OF STOCKHOLDERS' DEFICIT (UNAUDITED) - USD ($)
 3 Months Ended
Apr. 30, 2023
Apr. 30, 2022
Common Stock [Member]    
Statement [Line Items]    
Beginning balance, value $ 2,743,575 $ 1,782,074
Beginning balance (in shares) 2,743,575,314 1,782,073,799
Common stock issued for preferred stock conversions $ 174,324 $ 425,622
Common stock issued for preferred stock conversions (in shares) 174,323,810 425,622,150
Preferred stock subscribed but not issued  
Dividends on Series G preferred stock  
Net loss
Ending balance, value $ 2,917,899 $ 2,207,696
Ending balance (in shares) 2,917,899,124 2,207,695,949
Additional Paid-in Capital [Member]    
Statement [Line Items]    
Beginning balance, value $ 7,889,555 $ 7,824,982
Common stock issued for preferred stock conversions (137,715) (199,110)
Preferred stock subscribed but not issued  
Dividends on Series G preferred stock  
Net loss
Ending balance, value 7,751,840 7,625,872
Retained Earnings [Member]    
Statement [Line Items]    
Beginning balance, value (11,459,050) (10,882,188)
Common stock issued for preferred stock conversions
Preferred stock subscribed but not issued  
Dividends on Series G preferred stock   (2,429)
Net loss (71,996) (107,196)
Ending balance, value (11,531,046) (10,991,813)
Stock Subscribed but Not Issued [Member]    
Statement [Line Items]    
Beginning balance, value 50,000
Common stock issued for preferred stock conversions
Preferred stock subscribed but not issued   50,000
Dividends on Series G preferred stock  
Net loss  
Ending balance, value 50,000 50,000
Series A Preferred Stock [Member]    
Statement [Line Items]    
Beginning balance, value $ 50 $ 50
Beginning balance (in shares) 50,000 50,000
Common stock issued for preferred stock conversions
Preferred stock subscribed but not issued  
Dividends on Series G preferred stock  
Net loss
Ending balance, value $ 50 $ 50
Ending balance (in shares) 50,000 50,000
Series B Preferred Stock [Member]    
Statement [Line Items]    
Beginning balance, value $ 10 $ 10
Beginning balance (in shares) 10,000 10,000
Common stock issued for preferred stock conversions
Preferred stock subscribed but not issued  
Dividends on Series G preferred stock  
Net loss
Ending balance, value $ 10 $ 10
Ending balance (in shares) 10,000 10,000
Series C Preferred Stock [Member]    
Statement [Line Items]    
Beginning balance, value $ 40 $ 40
Beginning balance (in shares) 40,000 40,000
Common stock issued for preferred stock conversions
Preferred stock subscribed but not issued  
Dividends on Series G preferred stock  
Net loss
Ending balance, value $ 40 $ 40
Ending balance (in shares) 40,000 40,000
Series E Preferred Stock [Member]    
Statement [Line Items]    
Beginning balance, value $ 1,000 $ 1,000
Beginning balance (in shares) 1,000,000 1,000,000
Common stock issued for preferred stock conversions
Preferred stock subscribed but not issued  
Dividends on Series G preferred stock  
Net loss
Ending balance, value $ 1,000 $ 1,000
Ending balance (in shares) 1,000,000 1,000,000
Series F Preferred Stock [Member]    
Statement [Line Items]    
Beginning balance, value $ 1,000 $ 1,000
Beginning balance (in shares) 1,000,000 1,000,000
Common stock issued for preferred stock conversions
Preferred stock subscribed but not issued  
Dividends on Series G preferred stock  
Net loss
Ending balance, value $ 1,000 $ 1,000
Ending balance (in shares) 1,000,000 1,000,000
Beginning balance, value $ (773,820) $ (1,273,032)
Common stock issued for preferred stock conversions 36,609 226,512
Preferred stock subscribed but not issued   50,000
Dividends on Series G preferred stock   (2,429)
Net loss (71,996) (107,196)
Ending balance, value $ (809,207) $ (1,106,145)
XML 15 R6.htm IDEA: XBRL DOCUMENT v3.23.2
CONSOLIDATED STATEMENT OF CHANGES IN MEZZANINE EQUITY (UNAUDITED) - Series G Preferred Stock [Member]
 3 Months Ended
Apr. 30, 2023
USD ($)
shares
Statement [Line Items]  
Beginning balance, value | $ $ 35,200
Beginning balance (in shares) | shares 35,200
Series G preferred stock converted to common stock | $ $ (35,200)
Series G Preferred Stock Converted to Common Stock | shares (35,200)
Ending balance, value | $
Ending balance (in shares) | shares
XML 16 R7.htm IDEA: XBRL DOCUMENT v3.23.2
CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED) - USD ($)
 3 Months Ended
Apr. 30, 2023
Apr. 30, 2022
CASH FLOW FROM OPERATING ACTIVITIES:    
Net loss $ (71,996) $ (107,196)
Adjustments to reconcile net loss to net cash used in operating activities:    
Depreciation 19,726 19,726
Changes in operating assets and liabilities    
Inventory 2,514 (21,991)
Accounts payable and accrued liabilities (24,780) (29,976)
Accounts payable to related party 65,506 31,334
Accrued interest payable 199 15,435
NET CASH USED IN OPERATING ACTIVITIES (8,831) (92,668)
CASH FLOWS FROM FINANCING ACTIVITIES    
Stock subscriptions received 50,000
Proceeds from advance from related party 10,000
Proceeds from issuance of note payable 60,000
Repayments on notes payable (3,200)
NET CASH PROVIDED BY FINANCING ACTIVITIES 10,000 106,800
NET CHANGE IN CASH AND CASH EQUIVALENTS 1,169 14,132
Cash and cash equivalents at beginning of period 1,969 1,056
Cash and cash equivalents at end of period 3,138 15,188
Cash paid during the period for:    
Interest 300
Taxes
Noncash investing and financing transactions:    
Conversion of Series G preferred stock $ 36,609 $ 217,800
XML 17 R8.htm IDEA: XBRL DOCUMENT v3.23.2
Background Information
 3 Months Ended
Apr. 30, 2023
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
Background Information

Note 1. Background Information

 

Neutra Corp. was incorporated in Nevada on January 11, 2011, to market and participate in the nutraceutical space by bringing products derived from all natural and organic origins. Along with participating in the actual nutraceutical products, we plan to research and bring new technology to the nutraceutical space. Nutraceutical natural medicine is an alternative system that focuses on natural remedies and the body’s vital ability to heal and maintain itself. One of the nutraceutical sub-markets is the new thriving medical cannabis market, in which we intend to participate. We intend to entrust the manufacturing to a nutraceutical contractor to private label all of our products and to sell them under our unique brand. We have established a fiscal year end of January 31.

 

As the global cannabis market grows exponentially, it is constantly in need of better technologies and products to be more efficient in how it grows, what it grows and how it consumes cannabis and its related products. From lighting to dosage devices, from pesticide replacements to plant enhancers, Neutra Corp. is constantly combing the industry for the latest and greatest to test, prove and bring to market.
XML 18 R9.htm IDEA: XBRL DOCUMENT v3.23.2
Going Concern
 3 Months Ended
Apr. 30, 2023
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
Going Concern

Note 2. Going Concern

 

For the three months ended April 30, 2023, the Company had a net loss of $71,996 and did not have positive cash flow from operations. As of April 30, 2023, the Company has negative working capital of $784,685. We have generated limited revenues to date and our activities have been primarily limited to developing our business plan and research and development of products. We will not have the necessary capital to fully develop or execute our business plan until we are able to secure additional financing. There can be no assurance that such financing will be available on suitable terms. We need to raise additional funds in order to implement our business plan. Our current cash on hand is insufficient to commercialize our products or fully develop our business strategy. If we are unable to raise adequate additional funds or if those funds are not available on terms that are acceptable to us, we will not be able to execute our business plan and we may cease operations.

 

These factors raise a substantial doubt about the Company’s ability to continue as a going concern. The accompanying financial statements do not include any adjustments to reflect the possible future effects on the recoverability and classification of assets or the amounts and classifications of liabilities that may result from the possible inability of the Company to continue as a going concern.

 

The Company does not have the resources at this time to repay its credit and debt obligations, make any payments in the form of dividends to its shareholders or fully implement its business plan. Without additional capital, the Company will not be able to remain in business.

 

Management has plans to address the Company’s financial situation as follows:

 

In the near term, management plans to continue to focus on raising the funds necessary to implement the Company’s business plan. Management will continue to seek out debt financing to obtain the capital required to meet the Company’s financial obligations. There is no assurance, however, that lenders will continue to advance capital to the Company or that the new business operations will be profitable. The possibility of failure in obtaining additional funding and the potential inability to achieve profitability raises doubts about the Company’s ability to continue as a going concern.

 

In the long term, management believes that the Company’s projects and initiatives will be successful and will provide cash flow to the Company that will be used to finance the Company’s future growth. However, there can be no assurances that the Company’s planned activities will be successful, or that the Company will ultimately attain profitability. The Company’s long-term viability depends on its ability to obtain adequate sources of debt or equity funding to meet current commitments and fund the continuation of its business operations, and the ability of the Company to achieve adequate profitability and cash flows from operations to sustain its operations.
XML 19 R10.htm IDEA: XBRL DOCUMENT v3.23.2
Significant Accounting Policies
 3 Months Ended
Apr. 30, 2023
Accounting Policies [Abstract]  
Significant Accounting Policies

Note 3. Significant Accounting Policies

 

The significant accounting policies that the Company follows are:

 

Interim Financial Statements

 

The accompanying unaudited financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”) for interim financial information and with the instructions to Form 10-Q and Regulation S-X. Accordingly, the consolidated financial statements do not include all of the information and footnotes required by GAAP for complete financial statements. In the opinion of management, all adjustments considered necessary for a fair presentation have been included and such adjustments are of a normal recurring nature. These consolidated financial statements should be read in conjunction with the consolidated financial statements for the fiscal year ended January 31, 2023 and notes thereto and other pertinent information contained in our Form 10-K that we filed with the Securities and Exchange Commission (the “SEC”).

 

The results of operations for the three month period ended April 30, 2023 are not necessarily indicative of the results to be expected for the full fiscal year ending January 31, 2024.

 

Basis of Presentation

 

The consolidated financial statements and related disclosures have been prepared pursuant to the rules and regulations of the SEC. The consolidated financial statements have been prepared using the accrual basis of accounting in accordance with GAAP.

 

Consolidated Financial Statements

 

The consolidated financial statements of the Company include the accounts of the Company and its wholly owned subsidiaries, Diamond Anvil Designs, LLC Deity Corporation and Vivis Corporation (Vivis), from the date of their formations or acquisition. Significant intercompany transactions have been eliminated in consolidation.

 

Use of Estimates

 

The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.

 

Inventory

 

Inventory is comprised of packaging and supplies and at times raw materials. Inventory is valued at cost, based on the average cost method, unless and until the net realizable value for the inventory is lower than cost, in which case an allowance is established to reduce the valuation to the net realizable value. As of April 30, 2023 and January 31, 2023, market values of all of our inventory were greater than cost, and accordingly, no such valuation allowance was recognized.

 

Property and Equipment, net

 

Property and equipment consist of equipment used to manufacture the Company’s products and is presented at cost. Depreciation is recognized over the useful life of the equipment on a straight-line basis over three years beginning when the asset is put in service. For the three months ended April 30, 2023 and 2022, the Company recognized depreciation expense of $19,726.

 

Revenue Recognition

 

The Company recognizes revenue in accordance with ASC Topic 606, Revenue From Contracts With Customers. Revenues are recognized when control of the promised goods or services is transferred to the customer in an amount that reflects the consideration the Company expects to be entitled to in exchange for transferring those goods or services. Revenue is recognized based on the following five step model:

 

• Identification of the contract with a customer
   
• Identification of the performance obligations in the contract
   
• Determination of the transaction price
   
• Allocation of the transaction price to the performance obligations in the contract
   
• Recognition of revenue when, or as, the Company satisfies a performance obligation

 

Product sales are recognized all of the following criteria are satisfied: (i) a contract with an end user exists which has commercial substance; (ii) it is probable the Company will collect the amount charged to the end user; and (iii) the Company has completed its performance obligation whereby the end user has obtained control of the product. A contract with commercial substance exists once the Company receives and accepts a purchase order or once it enters into a contract with an end user. If collectability is not probable, the sale is deferred and not recognized until collection is probable or payment is received. Control of products typically transfers when title and risk of ownership of the product has transferred to the customer. Payment is received before shipment of the product. Net revenues comprise gross revenues less customer discounts and allowances, actual and expected returns. Shipping charges billed to customers are included in net sales. Various taxes on the sale of products to customers are collected by the Company as an agent and remitted to the respective taxing authority. These taxes are presented on a net basis and recorded as a liability until remitted to the respective taxing authority. The Company allows for customers to return unopened products within 10 days in certain limited circumstances. There have been no refunds processed for returned product.

 

Contract Costs

 

Costs incurred to obtain a customer contract are not material to the Company. The Company elected to apply the practical expedient to not capitalize contract costs to obtain contracts with a duration of one year or less, which are expensed and included within cost of goods and services.

 

Cost of Sales

 

Cost of sales includes all of the costs to purchase and assemble the Company’s products. Products are manufactured for the Company by third-party contractors, such costs represent the amounts invoiced by the contractors. Additionally, shipping costs are included in Cost of Sales in the Statements of Operations.

 

Earnings (Loss) per Common Share

 

We compute basic and diluted earnings per common share amounts in accordance with ASC Topic 260, Earnings per Share. The basic earnings (loss) per common share are calculated by dividing our net income available to common shareholders by the weighted average number of common shares outstanding during the year. The diluted earnings (loss) per common share are calculated by dividing our net income (loss) available to common shareholders by the diluted weighted average number of shares outstanding during the year. The diluted weighted average number of shares outstanding is the basic weighted number of shares adjusted as of the first of the year for any potentially dilutive debt or equity. There are no dilutive shares outstanding for any periods reported.

 

Commitments and Contingencies

 

The Company follows ASC 450-20, Loss Contingencies, to report accounting for contingencies. Liabilities for loss contingencies arising from claims, assessments, litigation, fines and penalties and other sources are recorded when it is probable that a liability has been incurred and the amount of the assessment can be reasonably estimated.

 

As discussed in more detail in Note 5, the Company agreed to pay 60% of all revenue from Deity Corporation to Sydney Jim, the Company’s CEO, up until a total of $250,000 is paid to Mr. Jim, at which point he will be entitled to 20% of revenue from Deity Corporation.

 

There were no other known commitments or contingencies as of April 30, 2023 and January 31, 2023.

 

Mezzanine equity

 

Where ordinary or preferred shares are determined to be conditionally redeemable upon the occurrence of certain events that are not solely within the control of the issuer, and upon such event, the shares would become redeemable at the option of the holders, they are classified as ‘mezzanine equity’ (temporary equity). The purpose of this classification is to convey that such a security may not be permanently part of equity and could result in a demand for cash, securities or other assets of the entity in the future.

 

Subsequent events

 

The Company follows the guidance in Section 855-10-50 of the FASB Accounting Standards Codification for the disclosure of subsequent events. The Company will evaluate subsequent events through the date when the financial statements were issued. Pursuant to ASU 2010-09 of the FASB Accounting Standards Codification, the Company as an SEC filer considers its financial statements issued when they are widely distributed to users, such as through filing them on EDGAR.

 

Recently Adopted Accounting Pronouncements

 

The Company does not believe that any recently issued effective pronouncements, or pronouncements issued but not yet effective, if adopted, would have a material effect on the accompanying financial statements. 

 
XML 20 R11.htm IDEA: XBRL DOCUMENT v3.23.2
Property and equipment, net
 3 Months Ended
Apr. 30, 2023
Property, Plant and Equipment [Abstract]  
Property and equipment, net

Note 4. Property and equipment, net

 

Property and equipment consist of the following:

 

    April 30, 2023   January 31, 2023  
Equipment   $ 236,717   $ 236,717  
Total property and equipment     236,717     236,717  
Less: accumulated depreciation     (207,083 )   (187,357 )
Property and equipment, net   $ 29,634   $ 49,360  

 
XML 21 R12.htm IDEA: XBRL DOCUMENT v3.23.2
Related Party Transactions
 3 Months Ended
Apr. 30, 2023
Related Party Transactions [Abstract]  
Related Party Transactions

Note 5. Related Party Transactions

 

During the three months ended April 30, 2023 and 2022, we incurred salary expense of $25,000 to our CEO, Sydney Jim. In addition, we incurred commission expense of $3,505 and $1,359 during the three months ended April 30, 2023 and 2022 to Mr. Jim and owed a total of $38,101 and $34,596 in accrued commissions as of April 30, 2023 and January 31, 2023, respectively. During the three months ended Mr. Jim paid expenses of $20,253 on behalf of the Company.

 

As of April 30, 2023 and January 31, 2023, we owed Mr. Jim, or entities controlled by him, $278,340 and $233,087 which is recorded on the balance sheet in “Accounts Payable – Related Party”, respectively, and $12,314 and $2,314 in “Advances payable to related party, respectively.”

 

During the three months ended April 30, 2023, an investor advanced $10,000 to the Company. This advance is unsecured, non-interest bearing and due on demand.

 

On March 11, 2022, the Company entered into a loan agreement for $60,000 of proceeds with the holder of the Company’s Series A and B preferred stock. The loan is unsecured and bears interest at 6%. The Company will make monthly payments of $4,240 per month beginning in April 2022 through the maturity at June 18, 2023. As of April 30, 2023, the note principal balance was $54,156 and accrued interest was $2,035. The Company has not made all required monthly payments under the note agreement to date.

 

During the year ended January 31, 2022, the Company acquired the assets of Deity Corporation, a Texas corporation which the Sydney Jim, the Company’s CEO, had a controlling interest in that will produce hemp and cannabis products. The transaction was considered an asset acquisition, as there were no operations of Deity Corporation prior to the transaction. The Company received the formulas for certain hemp and cannabis-based products and a website to market the products that will be produced. In exchange, the Company will pay to Mr. Jim 60% of the revenue from Deity Corporation sales until a total of $250,000 is reached, at which point the Company will pay 20% of Deity Corporation revenue to Mr. Jim.
XML 22 R13.htm IDEA: XBRL DOCUMENT v3.23.2
Advances and Notes Payable
 3 Months Ended
Apr. 30, 2023
Debt Disclosure [Abstract]  
Advances and Notes Payable

Note 6. Advances and Notes Payable

 

As of April 30, 2023 and January 31, 2023, we had amounts due under advances of $3,450 at each period. These advances are not collateralized, non-interest bearing and are due on demand.

 

On March 11, 2022, the Company entered into a loan agreement for $60,000 of proceeds with the holder of the Company’s Series A and B preferred stock. The loan is unsecured and bears interest at 6%. The Company will make monthly payments of $4,240 per month beginning in April 2022 through the maturity at June 18, 2023. As of April 30, 2023, the note principal balance was $54,156 and accrued interest was $2,035.
XML 23 R14.htm IDEA: XBRL DOCUMENT v3.23.2
Shareholders’ Equity
 3 Months Ended
Apr. 30, 2023
Equity [Abstract]  
Shareholders’ Equity

Note 7. Shareholders’ Equity

 

Series A Preferred Stock. In January 2020, our board of directors designated 50,000 shares of our preferred stock as Series A Preferred Stock which rank subordinate to all shares of common stock and do not have voting rights. The Series A Preferred Stock has a stated value of $5 per share. The Series A Preferred Stock is entitled to receive dividends of 10% of the net profit of VIVIS Corporation. The holders of the Series A Preferred Stock have the option to convert each share into 800 shares of common stock of the Company. As of April 30, 2023 and January 31, 2023, there are 50,000 shares of Series A Preferred Stock outstanding.

 

Series B Preferred Stock. In July 2020, our board of directors designated 10,000 shares of our preferred stock as Series B Preferred Stock which rank subordinate to all shares of common stock and do not have voting rights. The Series B Preferred Stock has a stated value of $5 per share. The Series B Preferred Stock is entitled to receive dividends of 0.4% of the net profit of VIVIS Corporation. Holders of the Series B Preferred Stock have the option to convert each share into 800 shares of common stock. During the year ended January 31, 2021, the Company subscribed 10,000 shares of Series B Preferred Stock for cash proceeds of $50,000. The shares were issued during the year ended January 31, 2022. As of April 30, 2023 and January 31, 2023, there are 10,000 shares of Series B Preferred Stock outstanding.

 

Series C Preferred Stock. In November 2020, our board of directors designated 40,000 shares of our preferred stock as Series C Preferred Stock which rank subordinate to all shares of common stock and do not have voting rights. The Series C Preferred Stock has a stated value of $5 per share. The Series C Preferred Stock is entitled to receive dividends of 10% of the net profit of VIVIS Corporation. After the Series C Preferred Stock has received cumulative dividends of $500,000, the dividend rate will reduce to 1%. Holders of the Series C Preferred Stock have the option to convert each share into 38 shares of common stock. During the year ended January 31, 2021, the Company subscribed 40,000 shares of Series B Preferred Stock for cash proceeds of $200,000. The shares were issued during the year ended January 31, 2022. As of April 30, 2023 and January 31, 2023, there are 40,000 shares of Series C Preferred Stock outstanding.

 

Series E preferred stock issued for services

 

On November 13, 2015, our board of directors designated 1,000,000 shares of our preferred stock as Series E Preferred Stock. The Series E Preferred Stock is subordinated to our common stock. It does not receive dividends and does not participate in equity distributions. The Series E Preferred stock has 2 votes for each outstanding share of common stock in the company. As of April 30, 2023 and January 31, 2023, there are 1,000,000 shares Series E Preferred Stock outstanding. Dividends, when, as and if declared by the Board of Directors, shall be paid out of funds at the time legally available for such purposes.

 

Series F preferred stock issued for services

 

The Series F Preferred Stock is subordinated to our common stock and superior to all shares of Preferred Stock. It does not receive dividends and does not participate in equity distributions. The Series F Preferred stock retains 2/3 of the voting rights in the company. During the year ended January 31, 2021, the Company issued 1,000,000 shares of Series F Preferred Stock to Sydney Jim, our CEO, in exchange for services. As of the date of this report, there are 1,000,000 shares Series F Preferred Stock outstanding. As of April 30, 2023 and January 31, 2023, there are 1,000,000 shares of Series F Preferred Stock outstanding.

 

Series G convertible preferred stock

 

During the three months ended April 30, 2023, the Company the holder of the Series G convertible preferred stock converted 35,200 shares and accrued dividends of $1,408 into 174,323,810 shares of common stock. During the three months ended April 30, 2022, the Company accrued dividends of $2,429, and the holder of the Series G convertible preferred stock converted 217,800 shares and accrued dividends of $8,712 into 425,622,150 shares of common stock. The conversions were in accordance with the terms of the agreement and no gain or loss was recognized. As of April 30, 2023, there were no shares of Series G convertible preferred stock outstanding.

 

Preferred Stock Subscription

 

On February 23, 2022, the Company sold 10,000 shares of preferred stock not yet designated for cash proceeds of $50,000.
XML 24 R15.htm IDEA: XBRL DOCUMENT v3.23.2
Significant Accounting Policies (Policies)
 3 Months Ended
Apr. 30, 2023
Accounting Policies [Abstract]  
Interim Financial Statements

Interim Financial Statements

 

The accompanying unaudited financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”) for interim financial information and with the instructions to Form 10-Q and Regulation S-X. Accordingly, the consolidated financial statements do not include all of the information and footnotes required by GAAP for complete financial statements. In the opinion of management, all adjustments considered necessary for a fair presentation have been included and such adjustments are of a normal recurring nature. These consolidated financial statements should be read in conjunction with the consolidated financial statements for the fiscal year ended January 31, 2023 and notes thereto and other pertinent information contained in our Form 10-K that we filed with the Securities and Exchange Commission (the “SEC”).

 

The results of operations for the three month period ended April 30, 2023 are not necessarily indicative of the results to be expected for the full fiscal year ending January 31, 2024.
Basis of Presentation

Basis of Presentation

 

The consolidated financial statements and related disclosures have been prepared pursuant to the rules and regulations of the SEC. The consolidated financial statements have been prepared using the accrual basis of accounting in accordance with GAAP.
Consolidated Financial Statements

Consolidated Financial Statements

 

The consolidated financial statements of the Company include the accounts of the Company and its wholly owned subsidiaries, Diamond Anvil Designs, LLC Deity Corporation and Vivis Corporation (Vivis), from the date of their formations or acquisition. Significant intercompany transactions have been eliminated in consolidation.
Use of Estimates

Use of Estimates

 

The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.
Inventory

Inventory

 

Inventory is comprised of packaging and supplies and at times raw materials. Inventory is valued at cost, based on the average cost method, unless and until the net realizable value for the inventory is lower than cost, in which case an allowance is established to reduce the valuation to the net realizable value. As of April 30, 2023 and January 31, 2023, market values of all of our inventory were greater than cost, and accordingly, no such valuation allowance was recognized.
Property and Equipment, net

Property and Equipment, net

 

Property and equipment consist of equipment used to manufacture the Company’s products and is presented at cost. Depreciation is recognized over the useful life of the equipment on a straight-line basis over three years beginning when the asset is put in service. For the three months ended April 30, 2023 and 2022, the Company recognized depreciation expense of $19,726.
Revenue [Policy Text Block]

Revenue Recognition

 

The Company recognizes revenue in accordance with ASC Topic 606, Revenue From Contracts With Customers. Revenues are recognized when control of the promised goods or services is transferred to the customer in an amount that reflects the consideration the Company expects to be entitled to in exchange for transferring those goods or services. Revenue is recognized based on the following five step model:

 

• Identification of the contract with a customer
   
• Identification of the performance obligations in the contract
   
• Determination of the transaction price
   
• Allocation of the transaction price to the performance obligations in the contract
   
• Recognition of revenue when, or as, the Company satisfies a performance obligation

 

Product sales are recognized all of the following criteria are satisfied: (i) a contract with an end user exists which has commercial substance; (ii) it is probable the Company will collect the amount charged to the end user; and (iii) the Company has completed its performance obligation whereby the end user has obtained control of the product. A contract with commercial substance exists once the Company receives and accepts a purchase order or once it enters into a contract with an end user. If collectability is not probable, the sale is deferred and not recognized until collection is probable or payment is received. Control of products typically transfers when title and risk of ownership of the product has transferred to the customer. Payment is received before shipment of the product. Net revenues comprise gross revenues less customer discounts and allowances, actual and expected returns. Shipping charges billed to customers are included in net sales. Various taxes on the sale of products to customers are collected by the Company as an agent and remitted to the respective taxing authority. These taxes are presented on a net basis and recorded as a liability until remitted to the respective taxing authority. The Company allows for customers to return unopened products within 10 days in certain limited circumstances. There have been no refunds processed for returned product.

 

Contract Costs

 

Costs incurred to obtain a customer contract are not material to the Company. The Company elected to apply the practical expedient to not capitalize contract costs to obtain contracts with a duration of one year or less, which are expensed and included within cost of goods and services.

 

Cost of Sales

 

Cost of sales includes all of the costs to purchase and assemble the Company’s products. Products are manufactured for the Company by third-party contractors, such costs represent the amounts invoiced by the contractors. Additionally, shipping costs are included in Cost of Sales in the Statements of Operations.

 
Earnings (Loss) per Common Share

Earnings (Loss) per Common Share

 

We compute basic and diluted earnings per common share amounts in accordance with ASC Topic 260, Earnings per Share. The basic earnings (loss) per common share are calculated by dividing our net income available to common shareholders by the weighted average number of common shares outstanding during the year. The diluted earnings (loss) per common share are calculated by dividing our net income (loss) available to common shareholders by the diluted weighted average number of shares outstanding during the year. The diluted weighted average number of shares outstanding is the basic weighted number of shares adjusted as of the first of the year for any potentially dilutive debt or equity. There are no dilutive shares outstanding for any periods reported.
Commitments and Contingencies

Commitments and Contingencies

 

The Company follows ASC 450-20, Loss Contingencies, to report accounting for contingencies. Liabilities for loss contingencies arising from claims, assessments, litigation, fines and penalties and other sources are recorded when it is probable that a liability has been incurred and the amount of the assessment can be reasonably estimated.

 

As discussed in more detail in Note 5, the Company agreed to pay 60% of all revenue from Deity Corporation to Sydney Jim, the Company’s CEO, up until a total of $250,000 is paid to Mr. Jim, at which point he will be entitled to 20% of revenue from Deity Corporation.

 

There were no other known commitments or contingencies as of April 30, 2023 and January 31, 2023.
Mezzanine equity

Mezzanine equity

 

Where ordinary or preferred shares are determined to be conditionally redeemable upon the occurrence of certain events that are not solely within the control of the issuer, and upon such event, the shares would become redeemable at the option of the holders, they are classified as ‘mezzanine equity’ (temporary equity). The purpose of this classification is to convey that such a security may not be permanently part of equity and could result in a demand for cash, securities or other assets of the entity in the future.
Subsequent events

Subsequent events

 

The Company follows the guidance in Section 855-10-50 of the FASB Accounting Standards Codification for the disclosure of subsequent events. The Company will evaluate subsequent events through the date when the financial statements were issued. Pursuant to ASU 2010-09 of the FASB Accounting Standards Codification, the Company as an SEC filer considers its financial statements issued when they are widely distributed to users, such as through filing them on EDGAR.
Recently Adopted Accounting Pronouncements

Recently Adopted Accounting Pronouncements

 

The Company does not believe that any recently issued effective pronouncements, or pronouncements issued but not yet effective, if adopted, would have a material effect on the accompanying financial statements. 
XML 25 R16.htm IDEA: XBRL DOCUMENT v3.23.2
Property and equipment, net (Tables)
 3 Months Ended
Apr. 30, 2023
Property, Plant and Equipment [Abstract]  
Property and equipment consist of the following:

Property and equipment consist of the following:

 

    April 30, 2023   January 31, 2023  
Equipment   $ 236,717   $ 236,717  
Total property and equipment     236,717     236,717  
Less: accumulated depreciation     (207,083 )   (187,357 )
Property and equipment, net   $ 29,634   $ 49,360  
XML 26 R17.htm IDEA: XBRL DOCUMENT v3.23.2
Going Concern (Details Narrative) - USD ($)
 3 Months Ended
Apr. 30, 2023
Apr. 30, 2022
Organization, Consolidation and Presentation of Financial Statements [Abstract]    
Net loss $ 71,996 $ 107,196
Working capital $ 784,685  
XML 27 R18.htm IDEA: XBRL DOCUMENT v3.23.2
Significant Accounting Policies (Details Narrative) - USD ($)
 3 Months Ended
Apr. 30, 2023
Apr. 30, 2022
Jan. 31, 2023
Jan. 31, 2022
Property, Plant and Equipment [Line Items]        
Valuation allowance recognized $ 0   $ 0  
Depreciation 19,726 $ 19,726    
Preferred stock subscribed but not issued $ 50,000   $ 50,000  
Mr Jim [Member] | Chief Executive Officer [Member]        
Property, Plant and Equipment [Line Items]        
Revenue, remaining performance obligation, percentage 60.00%     60.00%
Preferred stock subscribed but not issued $ 250,000     $ 250,000
Deity Corporation [Member]        
Property, Plant and Equipment [Line Items]        
Revenue, remaining performance obligation, percentage 20.00%     20.00%
Equipment [Member]        
Property, Plant and Equipment [Line Items]        
Useful life 3 years      
XML 28 R19.htm IDEA: XBRL DOCUMENT v3.23.2
Property and equipment consist of the following: (Details) - USD ($)
Apr. 30, 2023
Jan. 31, 2023
Property, Plant and Equipment [Line Items]    
Total property and equipment $ 236,717 $ 236,717
Less: accumulated depreciation (207,083) (187,357)
Property and equipment, net 29,634 49,360
Equipment [Member]    
Property, Plant and Equipment [Line Items]    
Total property and equipment $ 236,717 $ 236,717
XML 29 R20.htm IDEA: XBRL DOCUMENT v3.23.2
Related Party Transactions (Details Narrative) - USD ($)
 3 Months Ended
Apr. 30, 2023
Apr. 30, 2022
Jan. 31, 2023
Mar. 11, 2022
Jan. 31, 2022
Related Party Transaction [Line Items]          
Advances payable to related party $ 12,314   $ 2,314    
Advanced receive from investor $ 10,000      
Loan agreement       $ 60,000  
Unsecured loan interest 6.00%     6.00%  
Monthly interest payment $ 4,240     $ 4,240  
Principal amount balance 54,156        
Accrued interest 2,035        
Preferred stock subscribed but not issued $ 50,000   50,000    
Deity Corporation [Member]          
Related Party Transaction [Line Items]          
Revenue, remaining performance obligation, percentage 20.00%       20.00%
Chief Executive Officer [Member]          
Related Party Transaction [Line Items]          
Salary expense $ 25,000 25,000      
Commission expense 3,505 1,359      
Unpaid compensation 38,101 $ 34,596      
Chief Executive Officer [Member] | Accounts Payable Related Party and Advances Payable to Related Party [Member]          
Related Party Transaction [Line Items]          
Due to related party 278,340   233,087    
Advances payable to related party 12,314   $ 2,314    
Chief Executive Officer [Member] | Mr Jim [Member]          
Related Party Transaction [Line Items]          
Expenses paid $ 20,253        
Revenue, remaining performance obligation, percentage 60.00%       60.00%
Preferred stock subscribed but not issued $ 250,000       $ 250,000
XML 30 R21.htm IDEA: XBRL DOCUMENT v3.23.2
Advances and Notes Payable (Details Narrative) - USD ($)
 3 Months Ended
Apr. 30, 2023
Jan. 31, 2023
Mar. 11, 2022
Debt Disclosure [Abstract]      
Advances payable $ 3,450 $ 3,450  
Loan agreement     $ 60,000
Unsecured Loan Intrest 6.00%   6.00%
Monthly Intrest Payment $ 4,240   $ 4,240
Loan agreement 54,156    
Accrued interest $ 2,035    
XML 31 R22.htm IDEA: XBRL DOCUMENT v3.23.2
Shareholders’ Equity (Details Narrative) - USD ($)
 1 Months Ended 3 Months Ended 12 Months Ended
Feb. 23, 2022
Nov. 13, 2015
Nov. 30, 2020
Jul. 31, 2020
Jan. 31, 2020
Apr. 30, 2023
Jan. 31, 2021
Jan. 31, 2023
Apr. 30, 2022
Class of Stock [Line Items]                  
Preferred stock, par value (in dollars per share)           $ 0.001   $ 0.001  
Number of shares sold 10,000                
Cash proceeds $ 50,000                
Series A Preferred Stock [Member]                  
Class of Stock [Line Items]                  
Preferred stock, issued         50,000 50,000   50,000  
Preferred stock, par value (in dollars per share)         $ 5        
Prefered stock converted into common stock         800        
Preferred stock, outstanding           50,000   50,000  
Series A Preferred Stock [Member] | VIVIS Corporation [Member]                  
Class of Stock [Line Items]                  
Preferred stock, dividend rate, percentage         10.00%        
Series B Preferred Stock [Member]                  
Class of Stock [Line Items]                  
Preferred stock, issued       10,000   10,000   0  
Preferred stock, par value (in dollars per share)       $ 5          
Prefered stock converted into common stock       800          
Preferred stock, outstanding           10,000   0  
Number of shares sold             10,000    
Cash proceeds             $ 50,000    
Shares outstanding           10,000   10,000  
Series B Preferred Stock [Member] | VIVIS Corporation [Member]                  
Class of Stock [Line Items]                  
Preferred stock, dividend rate, percentage       0.40%          
Series C Preferred Stock [Member]                  
Class of Stock [Line Items]                  
Preferred stock, issued     40,000     40,000   40,000  
Preferred stock, par value (in dollars per share)     $ 5            
Preferred stock, dividend rate, percentage     1.00%            
Prefered stock converted into common stock     38            
Preferred stock, outstanding           40,000   40,000  
Number of shares sold             40,000    
Cash proceeds             $ 200,000    
Shares outstanding           40,000   40,000  
Series C Preferred Stock [Member] | VIVIS Corporation [Member]                  
Class of Stock [Line Items]                  
Preferred stock, dividend rate, percentage     10.00%            
Convertible Preferred Stock [Member]                  
Class of Stock [Line Items]                  
Cumulative dividends received     $ 500,000            
Series E Preferred Stock [Member]                  
Class of Stock [Line Items]                  
Preferred stock, issued   1,000,000       1,000,000   1,000,000  
Preferred stock, outstanding           1,000,000   1,000,000  
Description of voting rights   The Series E Preferred stock has 2 votes for each outstanding share of common stock in the company.              
Series F Preferred Stock [Member]                  
Class of Stock [Line Items]                  
Preferred stock, issued           1,000,000   1,000,000  
Preferred stock, par value (in dollars per share)           $ 0.001   $ 0.001  
Preferred stock, outstanding           1,000,000 1,000,000 1,000,000  
Description of voting rights           The Series F Preferred stock retains 2/3 of the voting rights in the company.      
Series F Preferred Stock [Member] | Chief Executive Officer [Member]                  
Class of Stock [Line Items]                  
Preferred stock, issued             1,000,000    
Series G Preferred Stock [Member]                  
Class of Stock [Line Items]                  
Preferred stock, issued           0   35,200  
Preferred stock, par value (in dollars per share)           $ 1.00   $ 1.00  
Prefered stock converted into common stock           174,323,810     425,622,150
Preferred stock, outstanding           0   35,200  
Prefered stock converted into common stock           35,200     217,800
Accrured dividends           $ 1,408     $ 8,712
Dividends payable                 $ 2,429
XML 32 form_10-q_htm.xml IDEA: XBRL DOCUMENT 0001512886 2023-02-01 2023-04-30 0001512886 2023-06-21 0001512886 2023-04-30 0001512886 2023-01-31 0001512886 us-gaap:SeriesAPreferredStockMember 2023-04-30 0001512886 us-gaap:SeriesAPreferredStockMember 2023-01-31 0001512886 us-gaap:SeriesBPreferredStockMember 2023-04-30 0001512886 us-gaap:SeriesBPreferredStockMember 2023-01-31 0001512886 us-gaap:SeriesCPreferredStockMember 2023-04-30 0001512886 us-gaap:SeriesCPreferredStockMember 2023-01-31 0001512886 us-gaap:SeriesEPreferredStockMember 2023-04-30 0001512886 us-gaap:SeriesEPreferredStockMember 2023-01-31 0001512886 us-gaap:SeriesFPreferredStockMember 2023-04-30 0001512886 us-gaap:SeriesFPreferredStockMember 2023-01-31 0001512886 us-gaap:SeriesGPreferredStockMember 2023-04-30 0001512886 us-gaap:SeriesGPreferredStockMember 2023-01-31 0001512886 2022-02-01 2023-01-31 0001512886 2022-02-01 2022-04-30 0001512886 us-gaap:CommonStockMember 2022-01-31 0001512886 us-gaap:SeriesAPreferredStockMember 2022-01-31 0001512886 us-gaap:SeriesBPreferredStockMember 2022-01-31 0001512886 us-gaap:SeriesCPreferredStockMember 2022-01-31 0001512886 us-gaap:SeriesEPreferredStockMember 2022-01-31 0001512886 us-gaap:SeriesFPreferredStockMember 2022-01-31 0001512886 us-gaap:AdditionalPaidInCapitalMember 2022-01-31 0001512886 us-gaap:RetainedEarningsMember 2022-01-31 0001512886 ntrr:StockSubscribedButNotIssuedMember 2022-01-31 0001512886 2022-01-31 0001512886 us-gaap:CommonStockMember 2023-01-31 0001512886 us-gaap:AdditionalPaidInCapitalMember 2023-01-31 0001512886 us-gaap:RetainedEarningsMember 2023-01-31 0001512886 ntrr:StockSubscribedButNotIssuedMember 2023-01-31 0001512886 us-gaap:CommonStockMember 2022-02-01 2022-04-30 0001512886 us-gaap:SeriesAPreferredStockMember 2022-02-01 2022-04-30 0001512886 us-gaap:SeriesBPreferredStockMember 2022-02-01 2022-04-30 0001512886 us-gaap:SeriesCPreferredStockMember 2022-02-01 2022-04-30 0001512886 us-gaap:SeriesEPreferredStockMember 2022-02-01 2022-04-30 0001512886 us-gaap:SeriesFPreferredStockMember 2022-02-01 2022-04-30 0001512886 us-gaap:AdditionalPaidInCapitalMember 2022-02-01 2022-04-30 0001512886 us-gaap:RetainedEarningsMember 2022-02-01 2022-04-30 0001512886 ntrr:StockSubscribedButNotIssuedMember 2022-02-01 2022-04-30 0001512886 us-gaap:CommonStockMember 2023-02-01 2023-04-30 0001512886 us-gaap:SeriesAPreferredStockMember 2023-02-01 2023-04-30 0001512886 us-gaap:SeriesBPreferredStockMember 2023-02-01 2023-04-30 0001512886 us-gaap:SeriesCPreferredStockMember 2023-02-01 2023-04-30 0001512886 us-gaap:SeriesEPreferredStockMember 2023-02-01 2023-04-30 0001512886 us-gaap:SeriesFPreferredStockMember 2023-02-01 2023-04-30 0001512886 us-gaap:AdditionalPaidInCapitalMember 2023-02-01 2023-04-30 0001512886 us-gaap:RetainedEarningsMember 2023-02-01 2023-04-30 0001512886 ntrr:StockSubscribedButNotIssuedMember 2023-02-01 2023-04-30 0001512886 us-gaap:CommonStockMember 2022-04-30 0001512886 us-gaap:SeriesAPreferredStockMember 2022-04-30 0001512886 us-gaap:SeriesBPreferredStockMember 2022-04-30 0001512886 us-gaap:SeriesCPreferredStockMember 2022-04-30 0001512886 us-gaap:SeriesEPreferredStockMember 2022-04-30 0001512886 us-gaap:SeriesFPreferredStockMember 2022-04-30 0001512886 us-gaap:AdditionalPaidInCapitalMember 2022-04-30 0001512886 us-gaap:RetainedEarningsMember 2022-04-30 0001512886 ntrr:StockSubscribedButNotIssuedMember 2022-04-30 0001512886 2022-04-30 0001512886 us-gaap:CommonStockMember 2023-04-30 0001512886 us-gaap:AdditionalPaidInCapitalMember 2023-04-30 0001512886 us-gaap:RetainedEarningsMember 2023-04-30 0001512886 ntrr:StockSubscribedButNotIssuedMember 2023-04-30 0001512886 us-gaap:SeriesGPreferredStockMember 2023-02-01 2023-04-30 0001512886 us-gaap:EquipmentMember 2023-04-30 0001512886 srt:ChiefExecutiveOfficerMember ntrr:MrJimMember 2023-04-30 0001512886 ntrr:DeityCorporationMember 2023-04-30 0001512886 us-gaap:EquipmentMember 2023-01-31 0001512886 srt:ChiefExecutiveOfficerMember 2023-02-01 2023-04-30 0001512886 srt:ChiefExecutiveOfficerMember 2022-02-01 2022-04-30 0001512886 srt:ChiefExecutiveOfficerMember ntrr:MrJimMember 2023-02-01 2023-04-30 0001512886 srt:ChiefExecutiveOfficerMember ntrr:AccountsPayableRelatedPartyAndAdvancesPayableToRelatedPartyMember 2023-04-30 0001512886 srt:ChiefExecutiveOfficerMember ntrr:AccountsPayableRelatedPartyAndAdvancesPayableToRelatedPartyMember 2023-01-31 0001512886 2022-03-11 0001512886 srt:ChiefExecutiveOfficerMember ntrr:MrJimMember 2022-01-31 0001512886 ntrr:DeityCorporationMember 2022-01-31 0001512886 us-gaap:SeriesAPreferredStockMember 2020-01-31 0001512886 ntrr:VIVISCorporationMember us-gaap:SeriesAPreferredStockMember 2020-01-01 2020-01-31 0001512886 us-gaap:SeriesBPreferredStockMember 2020-07-31 0001512886 ntrr:VIVISCorporationMember us-gaap:SeriesBPreferredStockMember 2020-07-01 2020-07-31 0001512886 us-gaap:SeriesBPreferredStockMember 2021-01-31 0001512886 us-gaap:SeriesBPreferredStockMember 2020-02-01 2021-01-31 0001512886 us-gaap:SeriesCPreferredStockMember 2020-11-30 0001512886 ntrr:VIVISCorporationMember us-gaap:SeriesCPreferredStockMember 2020-11-01 2020-11-30 0001512886 us-gaap:ConvertiblePreferredStockMember 2020-11-30 0001512886 us-gaap:SeriesCPreferredStockMember 2020-11-01 2020-11-30 0001512886 us-gaap:SeriesCPreferredStockMember 2021-01-31 0001512886 us-gaap:SeriesCPreferredStockMember 2020-02-01 2021-01-31 0001512886 us-gaap:SeriesEPreferredStockMember 2015-11-13 0001512886 us-gaap:SeriesEPreferredStockMember 2015-11-12 2015-11-13 0001512886 srt:ChiefExecutiveOfficerMember us-gaap:SeriesFPreferredStockMember 2021-01-31 0001512886 us-gaap:SeriesFPreferredStockMember 2021-01-31 0001512886 us-gaap:SeriesGPreferredStockMember 2022-04-30 0001512886 2022-02-23 0001512886 2022-02-21 2022-02-23 iso4217:USD shares iso4217:USD shares pure 0001512886 false 2024 Q1 --01-31 Unlimited Unlimited P3Y 10-Q true 2023-04-30 false 0-55077 NEUTRA CORP. WY 27-4505461 54 Sugar Creek Center Blvd. Suite 200 Sugar Land TX 77478 702 793-4121 Yes Yes Non-accelerated Filer true false false 2917899124 3138 1969 21332 23846 24470 25815 29634 49360 54104 75175 513016 516890 278340 233087 3450 3450 12314 2314 2062 2035 1836 809155 759639 54156 54156 863311 813795 1.00 1.00 0 0 35200 35200 35200 0.001 0.001 2917899124 2917899124 2743575314 2743575314 2917899 2743575 0.001 0.001 20000000 20000000 50000 50000 50000 50000 50 50 10000 10000 0 0 10 10 40000 40000 40000 40000 40 40 1000000 1000000 1000000 1000000 1000 1000 0.001 0.001 1000000 1000000 1000000 1000000 1000 1000 7751840 7889555 50000 50000 -11531046 -11459050 -809207 -773820 54104 75175 5842 9662 3038 4538 2804 5124 19726 19726 3505 1359 50781 75501 -74012 -96586 -71208 -91462 199 15734 -199 -15734 -71407 -107196 589 -71996 -107196 2429 -71996 -109625 -0.00 -0.00 2910381521 1824868256 1782073799 1782074 50000 50 10000 10 40000 40 1000000 1000 1000000 1000 7824982 -10882188 -1273032 425622150 425622 -199110 226512 50000 50000 -2429 -2429 -107196 -107196 2207695949 2207696 50000 50 10000 10 40000 40 1000000 1000 1000000 1000 7625872 -10991813 50000 -1106145 2743575314 2743575 50000 50 10000 10 40000 40 1000000 1000 1000000 1000 7889555 -11459050 50000 -773820 174323810 174324 -137715 36609 -71996 -71996 2917899124 2917899 50000 50 10000 10 40000 40 1000000 1000 1000000 1000 7751840 -11531046 50000 -809207 35200 35200 -35200 -35200 -71996 -107196 19726 19726 -2514 21991 -24780 -29976 65506 31334 199 15435 -8831 -92668 50000 10000 60000 3200 10000 106800 1169 14132 1969 1056 3138 15188 300 36609 217800 <p id="xdx_80E_eus-gaap--NatureOfOperations_z2fhThb8dNH7" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Note 1. <span id="xdx_82C_z6kgBNGG0Zz9">Background Information</span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Neutra Corp. was incorporated in Nevada on January 11, 2011, to market and participate in the nutraceutical space by bringing products derived from all natural and organic origins. Along with participating in the actual nutraceutical products, we plan to research and bring new technology to the nutraceutical space. Nutraceutical natural medicine is an alternative system that focuses on natural remedies and the body’s vital ability to heal and maintain itself. One of the nutraceutical sub-markets is the new thriving medical cannabis market, in which we intend to participate. We intend to entrust the manufacturing to a nutraceutical contractor to private label all of our products and to sell them under our unique brand. We have established a fiscal year end of January 31.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">As the global cannabis market grows exponentially, it is constantly in need of better technologies and products to be more efficient in how it grows, what it grows and how it consumes cannabis and its related products. From lighting to dosage devices, from pesticide replacements to plant enhancers, Neutra Corp. is constantly combing the industry for the latest and greatest to test, prove and bring to market.</p> <p id="xdx_804_eus-gaap--SubstantialDoubtAboutGoingConcernTextBlock_zFRg0l4Gp4ti" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Note 2. <span id="xdx_82F_zoikPxA08pL5">Going Concern</span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">For the three months ended April 30, 2023, the Company had a net loss of $<span id="xdx_90A_eus-gaap--NetIncomeLoss_iN_di_c20230201__20230430_z2b5lNGOJ7h" title="Net loss">71,996</span> and did not have positive cash flow from operations. As of April 30, 2023, the Company has negative working capital of $<span id="xdx_901_ecustom--WorkingCapital_iI_c20230430_zwZ1LzESIHFl" title="Working capital">784,685</span>. We have generated limited revenues to date and our activities have been primarily limited to developing our business plan and research and development of products. We will not have the necessary capital to fully develop or execute our business plan until we are able to secure additional financing. There can be no assurance that such financing will be available on suitable terms. We need to raise additional funds in order to implement our business plan. Our current cash on hand is insufficient to commercialize our products or fully develop our business strategy. If we are unable to raise adequate additional funds or if those funds are not available on terms that are acceptable to us, we will not be able to execute our business plan and we may cease operations.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">These factors raise a substantial doubt about the Company’s ability to continue as a going concern. The accompanying financial statements do not include any adjustments to reflect the possible future effects on the recoverability and classification of assets or the amounts and classifications of liabilities that may result from the possible inability of the Company to continue as a going concern.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company does not have the resources at this time to repay its credit and debt obligations, make any payments in the form of dividends to its shareholders or fully implement its business plan. Without additional capital, the Company will not be able to remain in business.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Management has plans to address the Company’s financial situation as follows:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">In the near term, management plans to continue to focus on raising the funds necessary to implement the Company’s business plan. Management will continue to seek out debt financing to obtain the capital required to meet the Company’s financial obligations. There is no assurance, however, that lenders will continue to advance capital to the Company or that the new business operations will be profitable. The possibility of failure in obtaining additional funding and the potential inability to achieve profitability raises doubts about the Company’s ability to continue as a going concern.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">In the long term, management believes that the Company’s projects and initiatives will be successful and will provide cash flow to the Company that will be used to finance the Company’s future growth. However, there can be no assurances that the Company’s planned activities will be successful, or that the Company will ultimately attain profitability. The Company’s long-term viability depends on its ability to obtain adequate sources of debt or equity funding to meet current commitments and fund the continuation of its business operations, and the ability of the Company to achieve adequate profitability and cash flows from operations to sustain its operations.</p> -71996 784685 <p id="xdx_800_eus-gaap--SignificantAccountingPoliciesTextBlock_zdecGelu9dE4" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Note 3. <span id="xdx_829_zxu4tagxnT0i">Significant Accounting Policies</span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The significant accounting policies that the Company follows are:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p id="xdx_842_ecustom--InterimFinancialStatementsPolicyTextBlock_zPO9cCb6cXOg" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><span><span id="xdx_86E_z3zRFY4r2HG6">Interim Financial Statements</span></span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The accompanying unaudited financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”) for interim financial information and with the instructions to Form 10-Q and Regulation S-X. Accordingly, the consolidated financial statements do not include all of the information and footnotes required by GAAP for complete financial statements. In the opinion of management, all adjustments considered necessary for a fair presentation have been included and such adjustments are of a normal recurring nature. These consolidated financial statements should be read in conjunction with the consolidated financial statements for the fiscal year ended January 31, 2023 and notes thereto and other pertinent information contained in our Form 10-K that we filed with the Securities and Exchange Commission (the “SEC”).</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The results of operations for the three month period ended April 30, 2023 are not necessarily indicative of the results to be expected for the full fiscal year ending January 31, 2024.</p> <p id="xdx_856_zTa2r3RPfByl" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p id="xdx_84A_eus-gaap--BasisOfAccountingPolicyPolicyTextBlock_zVF7v4gS40h4" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><span id="xdx_867_zxCE8h2igZEi">Basis of Presentation</span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The consolidated financial statements and related disclosures have been prepared pursuant to the rules and regulations of the SEC. The consolidated financial statements have been prepared using the accrual basis of accounting in accordance with GAAP.</p> <p id="xdx_855_zK3UkClngVmh" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p id="xdx_842_eus-gaap--ConsolidationPolicyTextBlock_zpokeaGN3Y94" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><span id="xdx_863_zto0kZF4IBvl">Consolidated Financial Statements</span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The consolidated financial statements of the Company include the accounts of the Company and its wholly owned subsidiaries, Diamond Anvil Designs, LLC Deity Corporation and Vivis Corporation (Vivis), from the date of their formations or acquisition. Significant intercompany transactions have been eliminated in consolidation.</p> <p id="xdx_85B_zc7ppX5yqgp" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p id="xdx_840_eus-gaap--UseOfEstimates_zL1euv0qvpu1" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><span id="xdx_869_zLs3E0R61NSl">Use of Estimates</span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.</p> <p id="xdx_85A_z1KuwurNhUC5" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p id="xdx_84D_eus-gaap--InventoryFinishedGoodsPolicy_zm2kto8PPwje" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><span id="xdx_862_zhkmChkfmMwd">Inventory</span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Inventory is comprised of packaging and supplies and at times raw materials. Inventory is valued at cost, based on the average cost method, unless and until the net realizable value for the inventory is lower than cost, in which case an allowance is established to reduce the valuation to the net realizable value. As of April 30, 2023 and January 31, 2023, market values of all of our inventory were greater than cost, and accordingly, <span id="xdx_901_eus-gaap--InventoryValuationReserves_iI_do_c20230430_zgz1Y0IvC02i" title="Valuation allowance recognized"><span id="xdx_904_eus-gaap--InventoryValuationReserves_iI_do_c20230131_zVkkY9ka7pP9" title="Valuation allowance recognized">no</span></span> such valuation allowance was recognized.</p> <p id="xdx_852_zEgwS6pFevYe" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p id="xdx_84D_eus-gaap--PropertyPlantAndEquipmentPolicyTextBlock_zJM2qUEOT7i5" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><span id="xdx_868_zZMMhpaGKgQk">Property and Equipment, net</span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Property and equipment consist of equipment used to manufacture the Company’s products and is presented at cost. Depreciation is recognized over the useful life of the equipment on a straight-line basis over <span id="xdx_90D_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dxL_c20230430__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--EquipmentMember_zIL7JxcVQ3q" title="Useful life::XDX::P3Y"><span style="-sec-ix-hidden: xdx2ixbrl0542">three</span></span> years beginning when the asset is put in service. For the three months ended April 30, 2023 and 2022, the Company recognized depreciation expense of $<span id="xdx_906_eus-gaap--DepreciationAndAmortization_c20230201__20230430_zUr0AeWnU7e4" title="Depreciation"><span id="xdx_900_eus-gaap--DepreciationAndAmortization_c20220201__20220430_zHHCTRUpWyod" title="Depreciation">19,726</span></span>.</p> <p id="xdx_852_zEpSXk9bRhq9" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p id="xdx_846_eus-gaap--RevenueRecognitionPolicyTextBlock_zq5O24YltdCd" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><span id="xdx_862_z6mac3RZhcpj">Revenue Recognition</span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">The Company recognizes revenue in accordance with ASC Topic 606, Revenue From Contracts With Customers. Revenues are recognized when control of the promised goods or services is transferred to the customer in an amount that reflects the consideration the Company expects to be entitled to in exchange for transferring those goods or services. Revenue is recognized based on the following five step model:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 7.5in; background-color: white; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 0.5in; text-align: center">•</td> <td style="width: 7in">Identification of the contract with a customer</td></tr> <tr style="vertical-align: top"> <td style="text-align: center"> </td> <td> </td></tr> <tr style="vertical-align: top"> <td style="text-align: center">•</td> <td>Identification of the performance obligations in the contract</td></tr> <tr style="vertical-align: top"> <td style="text-align: center"> </td> <td> </td></tr> <tr style="vertical-align: top"> <td style="text-align: center">•</td> <td>Determination of the transaction price</td></tr> <tr style="vertical-align: top"> <td style="text-align: center"> </td> <td> </td></tr> <tr style="vertical-align: top"> <td style="text-align: center">•</td> <td>Allocation of the transaction price to the performance obligations in the contract</td></tr> <tr style="vertical-align: top"> <td style="text-align: center"> </td> <td> </td></tr> <tr style="vertical-align: top"> <td style="text-align: center">•</td> <td>Recognition of revenue when, or as, the Company satisfies a performance obligation</td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">Product sales are recognized all of the following criteria are satisfied: (i) a contract with an end user exists which has commercial substance; (ii) it is probable the Company will collect the amount charged to the end user; and (iii) the Company has completed its performance obligation whereby the end user has obtained control of the product. A contract with commercial substance exists once the Company receives and accepts a purchase order or once it enters into a contract with an end user. If collectability is not probable, the sale is deferred and not recognized until collection is probable or payment is received. Control of products typically transfers when title and risk of ownership of the product has transferred to the customer. Payment is received before shipment of the product. Net revenues comprise gross revenues less customer discounts and allowances, actual and expected returns. Shipping charges billed to customers are included in net sales. Various taxes on the sale of products to customers are collected by the Company as an agent and remitted to the respective taxing authority. These taxes are presented on a net basis and recorded as a liability until remitted to the respective taxing authority. The Company allows for customers to return unopened products within 10 days in certain limited circumstances. There have been no refunds processed for returned product.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i>Contract Costs</i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i> </i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Costs incurred to obtain a customer contract are not material to the Company. The Company elected to apply the practical expedient to not capitalize contract costs to obtain contracts with a duration of one year or less, which are expensed and included within cost of goods and services.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i> </i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i>Cost of Sales</i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i> </i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Cost of sales includes all of the costs to purchase and assemble the Company’s products. Products are manufactured for the Company by third-party contractors, such costs represent the amounts invoiced by the contractors. Additionally, shipping costs are included in Cost of Sales in the Statements of Operations.</p> <p id="xdx_864_ziqWBGZr6lr5" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p id="xdx_842_eus-gaap--EarningsPerSharePolicyTextBlock_zvzBRUBuxNLh" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><span id="xdx_86E_zP5qT6SP6ina">Earnings (Loss) per Common Share</span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">We compute basic and diluted earnings per common share amounts in accordance with ASC Topic 260, <i>Earnings per Share</i>. The basic earnings (loss) per common share are calculated by dividing our net income available to common shareholders by the weighted average number of common shares outstanding during the year. The diluted earnings (loss) per common share are calculated by dividing our net income (loss) available to common shareholders by the diluted weighted average number of shares outstanding during the year. The diluted weighted average number of shares outstanding is the basic weighted number of shares adjusted as of the first of the year for any potentially dilutive debt or equity. There are no dilutive shares outstanding for any periods reported.</p> <p id="xdx_859_zt3A6ZeMS3Aj" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p id="xdx_843_eus-gaap--CommitmentsAndContingenciesPolicyTextBlock_zlFUXdyAmEf3" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><span id="xdx_862_zuAPmyWi5Cx">Commitments and Contingencies</span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company follows ASC 450-20, <i>Loss Contingencies</i>, to report accounting for contingencies. Liabilities for loss contingencies arising from claims, assessments, litigation, fines and penalties and other sources are recorded when it is probable that a liability has been incurred and the amount of the assessment can be reasonably estimated.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">As discussed in more detail in Note 5, the Company agreed to pay <span id="xdx_90E_eus-gaap--RevenueRemainingPerformanceObligationPercentage_iI_pid_dp_uPure_c20230430__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--MrJimMember__srt--TitleOfIndividualAxis__srt--ChiefExecutiveOfficerMember_zJE9QDWSrpLc" title="Revenue, remaining performance obligation, percentage">60</span>% of all revenue from Deity Corporation to Sydney Jim, the Company’s CEO, up until a total of $<span id="xdx_90A_eus-gaap--PreferredStockSharesSubscribedButUnissuedValue_iI_pid_uUSD_c20230430__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--MrJimMember__srt--TitleOfIndividualAxis__srt--ChiefExecutiveOfficerMember_z2H5nKb45tFi" title="Preferred stock subscribed but not issued">250,000</span> is paid to Mr. Jim, at which point he will be entitled to <span id="xdx_909_eus-gaap--RevenueRemainingPerformanceObligationPercentage_iI_pid_dp_uPure_c20230430__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--DeityCorporationMember_z0GmAXNHgF4b" title="Revenue, remaining performance obligation, percentage">20</span>% of revenue from Deity Corporation.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">There were no other known commitments or contingencies as of April 30, 2023 and January 31, 2023.</p> <p id="xdx_85D_zneeMcwX9kei" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p id="xdx_844_ecustom--MezzanineEquityPolicyTextBlock_zLyutGnDSV78" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><span id="xdx_864_zjoFj5f1LE79">Mezzanine equity</span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Where ordinary or preferred shares are determined to be conditionally redeemable upon the occurrence of certain events that are not solely within the control of the issuer, and upon such event, the shares would become redeemable at the option of the holders, they are classified as ‘mezzanine equity’ (temporary equity). The purpose of this classification is to convey that such a security may not be permanently part of equity and could result in a demand for cash, securities or other assets of the entity in the future.</p> <p id="xdx_85E_zQxFh0elzGu7" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p id="xdx_848_eus-gaap--SubsequentEventsPolicyPolicyTextBlock_zRPmkL3nH0Ce" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="background-color: white"><b><span id="xdx_860_zZISvwwsrFd">Subsequent events</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="background-color: white">The Company follows the guidance in Section 855-10-50 of the FASB Accounting Standards Codification for the disclosure of subsequent events. The Company will evaluate subsequent events through the date when the financial statements were issued. Pursuant to ASU 2010-09 of the FASB Accounting Standards Codification, the Company as an SEC filer considers its financial statements issued when they are widely distributed to users, such as through filing them on EDGAR.</span></p> <p id="xdx_854_zVx5vNdjKknj" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p id="xdx_849_ecustom--RecentlyAdoptedAccountingPronouncementsPolicyTextBlock_zdcxJjFBLs75" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><span id="xdx_867_zwHcfpSVpk99">Recently Adopted Accounting Pronouncements</span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company does not believe that any recently issued effective pronouncements, or pronouncements issued but not yet effective, if adopted, would have a material effect on the accompanying financial statements. </p> <p id="xdx_85B_zHNulXqVJxni" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p id="xdx_842_ecustom--InterimFinancialStatementsPolicyTextBlock_zPO9cCb6cXOg" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><span><span id="xdx_86E_z3zRFY4r2HG6">Interim Financial Statements</span></span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The accompanying unaudited financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”) for interim financial information and with the instructions to Form 10-Q and Regulation S-X. Accordingly, the consolidated financial statements do not include all of the information and footnotes required by GAAP for complete financial statements. In the opinion of management, all adjustments considered necessary for a fair presentation have been included and such adjustments are of a normal recurring nature. These consolidated financial statements should be read in conjunction with the consolidated financial statements for the fiscal year ended January 31, 2023 and notes thereto and other pertinent information contained in our Form 10-K that we filed with the Securities and Exchange Commission (the “SEC”).</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The results of operations for the three month period ended April 30, 2023 are not necessarily indicative of the results to be expected for the full fiscal year ending January 31, 2024.</p> <p id="xdx_84A_eus-gaap--BasisOfAccountingPolicyPolicyTextBlock_zVF7v4gS40h4" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><span id="xdx_867_zxCE8h2igZEi">Basis of Presentation</span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The consolidated financial statements and related disclosures have been prepared pursuant to the rules and regulations of the SEC. The consolidated financial statements have been prepared using the accrual basis of accounting in accordance with GAAP.</p> <p id="xdx_842_eus-gaap--ConsolidationPolicyTextBlock_zpokeaGN3Y94" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><span id="xdx_863_zto0kZF4IBvl">Consolidated Financial Statements</span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The consolidated financial statements of the Company include the accounts of the Company and its wholly owned subsidiaries, Diamond Anvil Designs, LLC Deity Corporation and Vivis Corporation (Vivis), from the date of their formations or acquisition. Significant intercompany transactions have been eliminated in consolidation.</p> <p id="xdx_840_eus-gaap--UseOfEstimates_zL1euv0qvpu1" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><span id="xdx_869_zLs3E0R61NSl">Use of Estimates</span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.</p> <p id="xdx_84D_eus-gaap--InventoryFinishedGoodsPolicy_zm2kto8PPwje" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><span id="xdx_862_zhkmChkfmMwd">Inventory</span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Inventory is comprised of packaging and supplies and at times raw materials. Inventory is valued at cost, based on the average cost method, unless and until the net realizable value for the inventory is lower than cost, in which case an allowance is established to reduce the valuation to the net realizable value. As of April 30, 2023 and January 31, 2023, market values of all of our inventory were greater than cost, and accordingly, <span id="xdx_901_eus-gaap--InventoryValuationReserves_iI_do_c20230430_zgz1Y0IvC02i" title="Valuation allowance recognized"><span id="xdx_904_eus-gaap--InventoryValuationReserves_iI_do_c20230131_zVkkY9ka7pP9" title="Valuation allowance recognized">no</span></span> such valuation allowance was recognized.</p> 0 0 <p id="xdx_84D_eus-gaap--PropertyPlantAndEquipmentPolicyTextBlock_zJM2qUEOT7i5" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><span id="xdx_868_zZMMhpaGKgQk">Property and Equipment, net</span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Property and equipment consist of equipment used to manufacture the Company’s products and is presented at cost. Depreciation is recognized over the useful life of the equipment on a straight-line basis over <span id="xdx_90D_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dxL_c20230430__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--EquipmentMember_zIL7JxcVQ3q" title="Useful life::XDX::P3Y"><span style="-sec-ix-hidden: xdx2ixbrl0542">three</span></span> years beginning when the asset is put in service. For the three months ended April 30, 2023 and 2022, the Company recognized depreciation expense of $<span id="xdx_906_eus-gaap--DepreciationAndAmortization_c20230201__20230430_zUr0AeWnU7e4" title="Depreciation"><span id="xdx_900_eus-gaap--DepreciationAndAmortization_c20220201__20220430_zHHCTRUpWyod" title="Depreciation">19,726</span></span>.</p> 19726 19726 <p id="xdx_846_eus-gaap--RevenueRecognitionPolicyTextBlock_zq5O24YltdCd" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><span id="xdx_862_z6mac3RZhcpj">Revenue Recognition</span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">The Company recognizes revenue in accordance with ASC Topic 606, Revenue From Contracts With Customers. Revenues are recognized when control of the promised goods or services is transferred to the customer in an amount that reflects the consideration the Company expects to be entitled to in exchange for transferring those goods or services. Revenue is recognized based on the following five step model:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 7.5in; background-color: white; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 0.5in; text-align: center">•</td> <td style="width: 7in">Identification of the contract with a customer</td></tr> <tr style="vertical-align: top"> <td style="text-align: center"> </td> <td> </td></tr> <tr style="vertical-align: top"> <td style="text-align: center">•</td> <td>Identification of the performance obligations in the contract</td></tr> <tr style="vertical-align: top"> <td style="text-align: center"> </td> <td> </td></tr> <tr style="vertical-align: top"> <td style="text-align: center">•</td> <td>Determination of the transaction price</td></tr> <tr style="vertical-align: top"> <td style="text-align: center"> </td> <td> </td></tr> <tr style="vertical-align: top"> <td style="text-align: center">•</td> <td>Allocation of the transaction price to the performance obligations in the contract</td></tr> <tr style="vertical-align: top"> <td style="text-align: center"> </td> <td> </td></tr> <tr style="vertical-align: top"> <td style="text-align: center">•</td> <td>Recognition of revenue when, or as, the Company satisfies a performance obligation</td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">Product sales are recognized all of the following criteria are satisfied: (i) a contract with an end user exists which has commercial substance; (ii) it is probable the Company will collect the amount charged to the end user; and (iii) the Company has completed its performance obligation whereby the end user has obtained control of the product. A contract with commercial substance exists once the Company receives and accepts a purchase order or once it enters into a contract with an end user. If collectability is not probable, the sale is deferred and not recognized until collection is probable or payment is received. Control of products typically transfers when title and risk of ownership of the product has transferred to the customer. Payment is received before shipment of the product. Net revenues comprise gross revenues less customer discounts and allowances, actual and expected returns. Shipping charges billed to customers are included in net sales. Various taxes on the sale of products to customers are collected by the Company as an agent and remitted to the respective taxing authority. These taxes are presented on a net basis and recorded as a liability until remitted to the respective taxing authority. The Company allows for customers to return unopened products within 10 days in certain limited circumstances. There have been no refunds processed for returned product.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i>Contract Costs</i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i> </i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Costs incurred to obtain a customer contract are not material to the Company. The Company elected to apply the practical expedient to not capitalize contract costs to obtain contracts with a duration of one year or less, which are expensed and included within cost of goods and services.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i> </i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i>Cost of Sales</i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i> </i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Cost of sales includes all of the costs to purchase and assemble the Company’s products. Products are manufactured for the Company by third-party contractors, such costs represent the amounts invoiced by the contractors. Additionally, shipping costs are included in Cost of Sales in the Statements of Operations.</p> <p id="xdx_864_ziqWBGZr6lr5" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p id="xdx_842_eus-gaap--EarningsPerSharePolicyTextBlock_zvzBRUBuxNLh" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><span id="xdx_86E_zP5qT6SP6ina">Earnings (Loss) per Common Share</span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">We compute basic and diluted earnings per common share amounts in accordance with ASC Topic 260, <i>Earnings per Share</i>. The basic earnings (loss) per common share are calculated by dividing our net income available to common shareholders by the weighted average number of common shares outstanding during the year. The diluted earnings (loss) per common share are calculated by dividing our net income (loss) available to common shareholders by the diluted weighted average number of shares outstanding during the year. The diluted weighted average number of shares outstanding is the basic weighted number of shares adjusted as of the first of the year for any potentially dilutive debt or equity. There are no dilutive shares outstanding for any periods reported.</p> <p id="xdx_843_eus-gaap--CommitmentsAndContingenciesPolicyTextBlock_zlFUXdyAmEf3" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><span id="xdx_862_zuAPmyWi5Cx">Commitments and Contingencies</span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company follows ASC 450-20, <i>Loss Contingencies</i>, to report accounting for contingencies. Liabilities for loss contingencies arising from claims, assessments, litigation, fines and penalties and other sources are recorded when it is probable that a liability has been incurred and the amount of the assessment can be reasonably estimated.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">As discussed in more detail in Note 5, the Company agreed to pay <span id="xdx_90E_eus-gaap--RevenueRemainingPerformanceObligationPercentage_iI_pid_dp_uPure_c20230430__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--MrJimMember__srt--TitleOfIndividualAxis__srt--ChiefExecutiveOfficerMember_zJE9QDWSrpLc" title="Revenue, remaining performance obligation, percentage">60</span>% of all revenue from Deity Corporation to Sydney Jim, the Company’s CEO, up until a total of $<span id="xdx_90A_eus-gaap--PreferredStockSharesSubscribedButUnissuedValue_iI_pid_uUSD_c20230430__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--MrJimMember__srt--TitleOfIndividualAxis__srt--ChiefExecutiveOfficerMember_z2H5nKb45tFi" title="Preferred stock subscribed but not issued">250,000</span> is paid to Mr. Jim, at which point he will be entitled to <span id="xdx_909_eus-gaap--RevenueRemainingPerformanceObligationPercentage_iI_pid_dp_uPure_c20230430__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--DeityCorporationMember_z0GmAXNHgF4b" title="Revenue, remaining performance obligation, percentage">20</span>% of revenue from Deity Corporation.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">There were no other known commitments or contingencies as of April 30, 2023 and January 31, 2023.</p> 0.60 250000 0.20 <p id="xdx_844_ecustom--MezzanineEquityPolicyTextBlock_zLyutGnDSV78" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><span id="xdx_864_zjoFj5f1LE79">Mezzanine equity</span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Where ordinary or preferred shares are determined to be conditionally redeemable upon the occurrence of certain events that are not solely within the control of the issuer, and upon such event, the shares would become redeemable at the option of the holders, they are classified as ‘mezzanine equity’ (temporary equity). The purpose of this classification is to convey that such a security may not be permanently part of equity and could result in a demand for cash, securities or other assets of the entity in the future.</p> <p id="xdx_848_eus-gaap--SubsequentEventsPolicyPolicyTextBlock_zRPmkL3nH0Ce" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="background-color: white"><b><span id="xdx_860_zZISvwwsrFd">Subsequent events</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="background-color: white">The Company follows the guidance in Section 855-10-50 of the FASB Accounting Standards Codification for the disclosure of subsequent events. The Company will evaluate subsequent events through the date when the financial statements were issued. Pursuant to ASU 2010-09 of the FASB Accounting Standards Codification, the Company as an SEC filer considers its financial statements issued when they are widely distributed to users, such as through filing them on EDGAR.</span></p> <p id="xdx_849_ecustom--RecentlyAdoptedAccountingPronouncementsPolicyTextBlock_zdcxJjFBLs75" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><span id="xdx_867_zwHcfpSVpk99">Recently Adopted Accounting Pronouncements</span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company does not believe that any recently issued effective pronouncements, or pronouncements issued but not yet effective, if adopted, would have a material effect on the accompanying financial statements. </p> <p id="xdx_807_eus-gaap--PropertyPlantAndEquipmentDisclosureTextBlock_zyTYGpidjuUf" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Note 4. <span id="xdx_827_zRLWbab7umEi">Property and equipment, net</span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p id="xdx_893_eus-gaap--PropertyPlantAndEquipmentTextBlock_zn4983C7pYE6" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span id="xdx_8B3_z2jxgG4W4wQj">Property and equipment consist of the following:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 4.5in; border-collapse: collapse"> <tr style="vertical-align: bottom; background-color: white"> <td> </td> <td> </td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"><b>April 30, 2023</b></td> <td> </td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"><b>January 31, 2023</b></td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: #E1FFFF"> <td style="width: 139.05pt">Equipment</td> <td style="width: 0.1in"> </td> <td style="width: 7.7pt">$</td> <td id="xdx_98F_eus-gaap--PropertyPlantAndEquipmentGross_iI_c20230430__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--EquipmentMember_zUFvKY25KEa8" style="width: 72.35pt; text-align: right" title="Equipment">236,717</td> <td style="width: 0.2in"> </td> <td style="width: 8pt">$</td> <td id="xdx_984_eus-gaap--PropertyPlantAndEquipmentGross_iI_c20230131__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--EquipmentMember_zxtG1FESaQHi" style="width: 72.05pt; text-align: right" title="Equipment">236,717</td> <td style="width: 0.1in"> </td></tr> <tr style="vertical-align: bottom"> <td style="background-color: white">Total property and equipment</td> <td style="background-color: white"> </td> <td style="border-top: black 1pt solid; background-color: white"> </td> <td id="xdx_98D_eus-gaap--PropertyPlantAndEquipmentGross_iI_c20230430_zsRsiTmhBN5g" style="border-top: black 1pt solid; text-align: right" title="Total property and equipment">236,717</td> <td style="background-color: white"> </td> <td style="border-top: black 1pt solid; background-color: white"> </td> <td id="xdx_98E_eus-gaap--PropertyPlantAndEquipmentGross_iI_c20230131_zdciMNnximg3" style="border-top: black 1pt solid; background-color: white; text-align: right" title="Total property and equipment">236,717</td> <td style="background-color: white"> </td></tr> <tr style="vertical-align: bottom; background-color: #E1FFFF"> <td>Less: accumulated depreciation</td> <td> </td> <td> </td> <td id="xdx_985_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_iNI_di_c20230430_z81gC1dIXRW3" style="text-align: right" title="Less: accumulated depreciation">(207,083</td> <td>)</td> <td> </td> <td id="xdx_984_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_iNI_di_c20230131_zVgevYvQCpEh" style="text-align: right" title="Less: accumulated depreciation">(187,357</td> <td>)</td></tr> <tr style="vertical-align: bottom"> <td style="background-color: white">Property and equipment, net</td> <td style="background-color: white"> </td> <td style="border-top: black 1pt solid; border-bottom: black 2.25pt double; background-color: white">$</td> <td id="xdx_982_eus-gaap--PropertyPlantAndEquipmentNet_iI_c20230430_znAVKxLYM2A4" style="border-top: black 1pt solid; border-bottom: black 2.25pt double; text-align: right" title="Property and equipment, net">29,634</td> <td style="background-color: white"> </td> <td style="border-top: black 1pt solid; border-bottom: black 2.25pt double; background-color: white">$</td> <td id="xdx_98D_eus-gaap--PropertyPlantAndEquipmentNet_iI_c20230131_zjUAJRPlRCcc" style="border-top: black 1pt solid; border-bottom: black 2.25pt double; background-color: white; text-align: right" title="Property and equipment, net">49,360</td> <td style="background-color: white"> </td></tr> </table> <p id="xdx_8A6_z5EvNZLH3Byd" style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p> <p id="xdx_893_eus-gaap--PropertyPlantAndEquipmentTextBlock_zn4983C7pYE6" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span id="xdx_8B3_z2jxgG4W4wQj">Property and equipment consist of the following:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 4.5in; border-collapse: collapse"> <tr style="vertical-align: bottom; background-color: white"> <td> </td> <td> </td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"><b>April 30, 2023</b></td> <td> </td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"><b>January 31, 2023</b></td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: #E1FFFF"> <td style="width: 139.05pt">Equipment</td> <td style="width: 0.1in"> </td> <td style="width: 7.7pt">$</td> <td id="xdx_98F_eus-gaap--PropertyPlantAndEquipmentGross_iI_c20230430__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--EquipmentMember_zUFvKY25KEa8" style="width: 72.35pt; text-align: right" title="Equipment">236,717</td> <td style="width: 0.2in"> </td> <td style="width: 8pt">$</td> <td id="xdx_984_eus-gaap--PropertyPlantAndEquipmentGross_iI_c20230131__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--EquipmentMember_zxtG1FESaQHi" style="width: 72.05pt; text-align: right" title="Equipment">236,717</td> <td style="width: 0.1in"> </td></tr> <tr style="vertical-align: bottom"> <td style="background-color: white">Total property and equipment</td> <td style="background-color: white"> </td> <td style="border-top: black 1pt solid; background-color: white"> </td> <td id="xdx_98D_eus-gaap--PropertyPlantAndEquipmentGross_iI_c20230430_zsRsiTmhBN5g" style="border-top: black 1pt solid; text-align: right" title="Total property and equipment">236,717</td> <td style="background-color: white"> </td> <td style="border-top: black 1pt solid; background-color: white"> </td> <td id="xdx_98E_eus-gaap--PropertyPlantAndEquipmentGross_iI_c20230131_zdciMNnximg3" style="border-top: black 1pt solid; background-color: white; text-align: right" title="Total property and equipment">236,717</td> <td style="background-color: white"> </td></tr> <tr style="vertical-align: bottom; background-color: #E1FFFF"> <td>Less: accumulated depreciation</td> <td> </td> <td> </td> <td id="xdx_985_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_iNI_di_c20230430_z81gC1dIXRW3" style="text-align: right" title="Less: accumulated depreciation">(207,083</td> <td>)</td> <td> </td> <td id="xdx_984_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_iNI_di_c20230131_zVgevYvQCpEh" style="text-align: right" title="Less: accumulated depreciation">(187,357</td> <td>)</td></tr> <tr style="vertical-align: bottom"> <td style="background-color: white">Property and equipment, net</td> <td style="background-color: white"> </td> <td style="border-top: black 1pt solid; border-bottom: black 2.25pt double; background-color: white">$</td> <td id="xdx_982_eus-gaap--PropertyPlantAndEquipmentNet_iI_c20230430_znAVKxLYM2A4" style="border-top: black 1pt solid; border-bottom: black 2.25pt double; text-align: right" title="Property and equipment, net">29,634</td> <td style="background-color: white"> </td> <td style="border-top: black 1pt solid; border-bottom: black 2.25pt double; background-color: white">$</td> <td id="xdx_98D_eus-gaap--PropertyPlantAndEquipmentNet_iI_c20230131_zjUAJRPlRCcc" style="border-top: black 1pt solid; border-bottom: black 2.25pt double; background-color: white; text-align: right" title="Property and equipment, net">49,360</td> <td style="background-color: white"> </td></tr> </table> 236717 236717 236717 236717 207083 187357 29634 49360 <p id="xdx_800_eus-gaap--RelatedPartyTransactionsDisclosureTextBlock_zGi7Q3ZocNyg" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Note 5. <span id="xdx_82A_zTcWrl6Mqck6">Related Party Transactions</span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">During the three months ended April 30, 2023 and 2022, we incurred salary expense of $<span id="xdx_90A_eus-gaap--SalariesAndWages_c20230201__20230430__srt--TitleOfIndividualAxis__srt--ChiefExecutiveOfficerMember_zo64LP2jzjS7" title="Salary expense"><span id="xdx_905_eus-gaap--SalariesAndWages_c20220201__20220430__srt--TitleOfIndividualAxis__srt--ChiefExecutiveOfficerMember_z01Dn8UuodA4" title="Salary expense">25,000</span></span> to our CEO, Sydney Jim. In addition, we incurred commission expense of $<span id="xdx_909_eus-gaap--CostsAndExpensesRelatedParty_c20230201__20230430__srt--TitleOfIndividualAxis__srt--ChiefExecutiveOfficerMember_zMpXVr2TEsNk" title="Commission expense">3,505</span> and $<span id="xdx_90F_eus-gaap--CostsAndExpensesRelatedParty_c20220201__20220430__srt--TitleOfIndividualAxis__srt--ChiefExecutiveOfficerMember_z7GfE29bzxS2" title="Commission expense">1,359</span> during the three months ended April 30, 2023 and 2022 to Mr. Jim and owed a total of $<span id="xdx_90A_ecustom--UnpaidCompensation_c20230201__20230430__srt--TitleOfIndividualAxis__srt--ChiefExecutiveOfficerMember_z8ufGXjx7Xad" title="Unpaid compensation">38,101</span> and $<span id="xdx_908_ecustom--UnpaidCompensation_c20220201__20220430__srt--TitleOfIndividualAxis__srt--ChiefExecutiveOfficerMember_zYW3P6MIYyxc" title="Unpaid compensation">34,596</span> in accrued commissions as of April 30, 2023 and January 31, 2023, respectively. During the three months ended Mr. Jim paid expenses of $<span id="xdx_902_ecustom--ExpensesPaidOnCompanysBehalf_c20230201__20230430__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--MrJimMember__srt--TitleOfIndividualAxis__srt--ChiefExecutiveOfficerMember_zNWeGfjzbdV4" title="Expenses paid">20,253</span> on behalf of the Company.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">As of April 30, 2023 and January 31, 2023, we owed Mr. Jim, or entities controlled by him, $<span id="xdx_903_ecustom--OtherLiabilityCurrentRelatedParty_iI_c20230430__srt--TitleOfIndividualAxis__srt--ChiefExecutiveOfficerMember__us-gaap--BalanceSheetLocationAxis__custom--AccountsPayableRelatedPartyAndAdvancesPayableToRelatedPartyMember_zB21zIrbpp8j" title="Due to related party">278,340</span> and $<span id="xdx_908_ecustom--OtherLiabilityCurrentRelatedParty_iI_c20230131__srt--TitleOfIndividualAxis__srt--ChiefExecutiveOfficerMember__us-gaap--BalanceSheetLocationAxis__custom--AccountsPayableRelatedPartyAndAdvancesPayableToRelatedPartyMember_zQbHJcP02Bqi" title="Due to related party">233,087</span> which is recorded on the balance sheet in “Accounts Payable – Related Party”, respectively, and $<span id="xdx_90D_ecustom--AdvancesPayableToRelatedParty_iI_c20230430__srt--TitleOfIndividualAxis__srt--ChiefExecutiveOfficerMember__us-gaap--BalanceSheetLocationAxis__custom--AccountsPayableRelatedPartyAndAdvancesPayableToRelatedPartyMember_zhc3MNwq38A9" title="Advances payable to related party">12,314</span> and $<span id="xdx_90B_ecustom--AdvancesPayableToRelatedParty_iI_c20230131__srt--TitleOfIndividualAxis__srt--ChiefExecutiveOfficerMember__us-gaap--BalanceSheetLocationAxis__custom--AccountsPayableRelatedPartyAndAdvancesPayableToRelatedPartyMember_z3cd2LcCF7Ka" title="Advances payable to related party">2,314</span> in “Advances payable to related party, respectively.”</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">During the three months ended April 30, 2023, an investor advanced $<span id="xdx_90E_ecustom--ProceedsFromAdvanceFromRelatedParty_c20230201__20230430_zxcRNkWK8gg2" title="Advanced receive from investor">10,000</span> to the Company. This advance is unsecured, non-interest bearing and due on demand.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On March 11, 2022, the Company entered into a loan agreement for $<span id="xdx_906_ecustom--LoanAgreement_iI_c20220311_zDdkw4OB8zw3" title="Loan agreement">60,000</span> of proceeds with the holder of the Company’s Series A and B preferred stock. The loan is unsecured and bears interest at <span id="xdx_907_ecustom--UnsecuredLoanIntrest_iI_pid_dp_uPure_c20220311_zCzs4OUdQ63k" title="Unsecured loan interest">6</span>%. The Company will make monthly payments of $<span id="xdx_904_ecustom--MonthlyIntrestPayment_iI_c20220311_z1SgOpI9eUK4" title="Monthly interest payment">4,240</span> per month beginning in April 2022 through the maturity at June 18, 2023. As of April 30, 2023, the note principal balance was $<span id="xdx_90B_eus-gaap--InvestmentOwnedBalancePrincipalAmount_iI_c20230430_zXI5tFx6DwJk" title="Principal amount balance">54,156</span> and accrued interest was $<span id="xdx_907_eus-gaap--FinancingReceivableAccruedInterestWriteoff_c20230201__20230430_zRhx3cLCUaNg" title="Accrued interest">2,035</span>. The Company has not made all required monthly payments under the note agreement to date.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">During the year ended January 31, 2022, the Company acquired the assets of Deity Corporation, a Texas corporation which the Sydney Jim, the Company’s CEO, had a controlling interest in that will produce hemp and cannabis products. The transaction was considered an asset acquisition, as there were no operations of Deity Corporation prior to the transaction. The Company received the formulas for certain hemp and cannabis-based products and a website to market the products that will be produced. In exchange, the Company will pay to Mr. Jim <span id="xdx_905_eus-gaap--RevenueRemainingPerformanceObligationPercentage_iI_pid_dp_uPure_c20220131__srt--TitleOfIndividualAxis__srt--ChiefExecutiveOfficerMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--MrJimMember_z1g1pY1te9c8" title="Revenue, remaining performance obligation, percentage">60</span>% of the revenue from Deity Corporation sales until a total of $<span id="xdx_908_eus-gaap--PreferredStockSharesSubscribedButUnissuedValue_iI_c20220131__srt--TitleOfIndividualAxis__srt--ChiefExecutiveOfficerMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--MrJimMember_zGHQTZKtibu" title="Preferred stock subscribed but not issued">250,000</span> is reached, at which point the Company will pay <span id="xdx_902_eus-gaap--RevenueRemainingPerformanceObligationPercentage_iI_pid_dp_uPure_c20220131__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--DeityCorporationMember_zRyB8SulwO2k" title="Revenue, remaining performance obligation, percentage">20</span>% of Deity Corporation revenue to Mr. Jim.</p> 25000 25000 3505 1359 38101 34596 20253 278340 233087 12314 2314 10000 60000 0.06 4240 54156 2035 0.60 250000 0.20 <p id="xdx_808_eus-gaap--DebtDisclosureTextBlock_zif8an9ngyX9" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Note 6. <span id="xdx_82E_zaaUcCLGhixb">Advances and Notes Payable</span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">As of April 30, 2023 and January 31, 2023, we had amounts due under advances of $<span id="xdx_90E_ecustom--AdvancesPayable_iI_c20230430_zbSSvff9p1O7" title="Advances payable"><span id="xdx_90F_ecustom--AdvancesPayable_iI_c20230131_zKSmKLe6CK6a" title="Advances payable">3,450</span></span> at each period. These advances are not collateralized, non-interest bearing and are due on demand.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On March 11, 2022, the Company entered into a loan agreement for $<span id="xdx_90D_ecustom--LoanAgreement_iI_c20220311_zrFcRgVZYOn2" title="Loan agreement">60,000</span> of proceeds with the holder of the Company’s Series A and B preferred stock. The loan is unsecured and bears interest at <span id="xdx_906_ecustom--UnsecuredLoanIntrest_iI_dp_c20230430_zOceZKVpsi83">6</span>%. The Company will make monthly payments of $<span id="xdx_90B_ecustom--MonthlyIntrestPayment_iI_c20230430_z24sZyHWFYG6">4,240</span> per month beginning in April 2022 through the maturity at June 18, 2023. As of April 30, 2023, the note principal balance was $<span id="xdx_90A_eus-gaap--InvestmentOwnedBalancePrincipalAmount_iI_c20230430_z4S43hIGxAyh" title="Loan agreement">54,156</span> and accrued interest was $<span id="xdx_90C_eus-gaap--FinancingReceivableAccruedInterestWriteoff_c20230201__20230430_zCNGjWqdvx92" title="Accrued interest">2,035</span>.</p> 3450 3450 60000 0.06 4240 54156 2035 <p id="xdx_80D_eus-gaap--StockholdersEquityNoteDisclosureTextBlock_zgWLaeJyfbek" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Note 7. <span id="xdx_828_zsmbNdCFBbqc">Shareholders’ Equity</span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><i>Series A Preferred Stock.</i></b> In January 2020, our board of directors designated <span id="xdx_908_eus-gaap--PreferredStockSharesIssued_iI_pid_uShares_c20200131__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesAPreferredStockMember_zU6fCwdGxefd" title="Preferred stock, issued">50,000</span> shares of our preferred stock as Series A Preferred Stock which rank subordinate to all shares of common stock and do not have voting rights. The Series A Preferred Stock has a stated value of $<span id="xdx_90A_eus-gaap--PreferredStockParOrStatedValuePerShare_iI_pid_uUSDPShares_c20200131__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesAPreferredStockMember_zD3CIn1T3rdg" title="Preferred stock, par value (in dollars per share)">5</span> per share. The Series A Preferred Stock is entitled to receive dividends of <span id="xdx_90A_eus-gaap--PreferredStockDividendRatePercentage_pid_dp_uPure_c20200101__20200131__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesAPreferredStockMember__srt--ConsolidatedEntitiesAxis__custom--VIVISCorporationMember_zD0Ft1A8dryj" title="Preferred stock, dividend rate, percentage">10</span>% of the net profit of VIVIS Corporation. The holders of the Series A Preferred Stock have the option to convert each share into <span id="xdx_900_ecustom--PreferedStockConvertedIntoCommonStock_iI_pid_uShares_c20200131__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesAPreferredStockMember_zIoLv9PX28i9" title="Prefered stock converted into common stock">800</span> shares of common stock of the Company. As of April 30, 2023 and January 31, 2023, there are <span id="xdx_90A_eus-gaap--PreferredStockSharesOutstanding_iI_pid_uShares_c20230430__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesAPreferredStockMember_zVtNBY7GsCBj" title="Preferred stock, outstanding"><span id="xdx_907_eus-gaap--PreferredStockSharesOutstanding_iI_pid_uShares_c20230131__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesAPreferredStockMember_zjkFjOqZFS1f" title="Preferred stock, outstanding">50,000</span></span> shares of Series A Preferred Stock outstanding.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><i>Series B Preferred Stock.</i></b> In July 2020, our board of directors designated <span id="xdx_909_eus-gaap--PreferredStockSharesIssued_iI_pid_uShares_c20200731__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesBPreferredStockMember_ziVVerFCabV6">10,000</span> shares of our preferred stock as Series B Preferred Stock which rank subordinate to all shares of common stock and do not have voting rights. The Series B Preferred Stock has a stated value of $<span id="xdx_905_eus-gaap--PreferredStockParOrStatedValuePerShare_iI_pid_uUSDPShares_c20200731__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesBPreferredStockMember_zwOuwoEeMZhf">5</span> per share. The Series B Preferred Stock is entitled to receive dividends of <span id="xdx_908_eus-gaap--PreferredStockDividendRatePercentage_pid_dp_uPure_c20200701__20200731__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesBPreferredStockMember__srt--ConsolidatedEntitiesAxis__custom--VIVISCorporationMember_z0i9SwSKcVK8">0.4</span>% of the net profit of VIVIS Corporation. Holders of the Series B Preferred Stock have the option to convert each share into <span id="xdx_90F_ecustom--PreferedStockConvertedIntoCommonStock_iI_pid_uShares_c20200731__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesBPreferredStockMember_zzBTbEhgnPo8">800</span> shares of common stock. During the year ended January 31, 2021, the Company subscribed <span id="xdx_904_eus-gaap--PreferredStockShareSubscriptions_iI_pid_uShares_c20210131__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesBPreferredStockMember_zKCAvV8M2Wud" title="Subscription of stock">10,000</span> shares of Series B Preferred Stock for cash proceeds of $<span id="xdx_90D_eus-gaap--ProceedsFromRepaymentsOfDebt_c20200201__20210131__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesBPreferredStockMember_zpGh5nyWVhm4" title="Cash proceeds">50,000</span>. The shares were issued during the year ended January 31, 2022. As of April 30, 2023 and January 31, 2023, there are <span id="xdx_907_ecustom--PreferredStockSharesOutstanding1_iI_pid_uShares_c20230430__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesBPreferredStockMember_zcuPM5vaQwVd" title="Shares outstanding"><span id="xdx_90B_ecustom--PreferredStockSharesOutstanding1_iI_pid_uShares_c20230131__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesBPreferredStockMember_zEN35sH6Lj4l" title="Shares outstanding">10,000</span></span> shares of Series B Preferred Stock outstanding.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><i>Series C Preferred Stock.</i></b> In November 2020, our board of directors designated <span id="xdx_90F_eus-gaap--PreferredStockSharesIssued_iI_pid_uShares_c20201130__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesCPreferredStockMember_zFsK7Jdel6Q1">40,000</span> shares of our preferred stock as Series C Preferred Stock which rank subordinate to all shares of common stock and do not have voting rights. The Series C Preferred Stock has a stated value of $<span id="xdx_90A_eus-gaap--PreferredStockParOrStatedValuePerShare_iI_pid_uUSDPShares_c20201130__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesCPreferredStockMember_zri2ccMS7bvj">5</span> per share. The Series C Preferred Stock is entitled to receive dividends of <span id="xdx_900_eus-gaap--PreferredStockDividendRatePercentage_pid_dp_uPure_c20201101__20201130__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesCPreferredStockMember__srt--ConsolidatedEntitiesAxis__custom--VIVISCorporationMember_zpkwzsAjjjic">10</span>% of the net profit of VIVIS Corporation. After the Series C Preferred Stock has received cumulative dividends of $<span id="xdx_908_eus-gaap--CumulativeDividends_iI_c20201130__us-gaap--StatementClassOfStockAxis__us-gaap--ConvertiblePreferredStockMember_zkNqKbRzdyBe" title="Cumulative dividends received">500,000</span>, the dividend rate will reduce to <span id="xdx_90B_eus-gaap--PreferredStockDividendRatePercentage_pid_dp_uPure_c20201101__20201130__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesCPreferredStockMember_zPSJnAVNJt2a">1</span>%. Holders of the Series C Preferred Stock have the option to convert each share into <span id="xdx_90C_ecustom--PreferedStockConvertedIntoCommonStock_iI_pid_uShares_c20201130__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesCPreferredStockMember_zM4mrEEAH4Kl">38</span> shares of common stock. During the year ended January 31, 2021, the Company subscribed <span id="xdx_90E_eus-gaap--PreferredStockShareSubscriptions_iI_pid_uShares_c20210131__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesCPreferredStockMember_za7LxABz6ig8" title="Shares subscriptions">40,000</span> shares of Series B Preferred Stock for cash proceeds of $<span id="xdx_900_eus-gaap--ProceedsFromRepaymentsOfDebt_c20200201__20210131__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesCPreferredStockMember_zHhAo0MQDSlb">200,000</span>. The shares were issued during the year ended January 31, 2022. As of April 30, 2023 and January 31, 2023, there are <span id="xdx_909_ecustom--PreferredStockSharesOutstanding1_iI_pid_uShares_c20230430__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesCPreferredStockMember_zXffkf08rq2"><span id="xdx_90F_ecustom--PreferredStockSharesOutstanding1_iI_pid_uShares_c20230131__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesCPreferredStockMember_zrXmDVBuTe24">40,000</span></span> shares of Series C Preferred Stock outstanding.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><i>Series E preferred stock issued for services</i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On November 13, 2015, our board of directors designated <span id="xdx_900_eus-gaap--PreferredStockSharesIssued_iI_pid_uShares_c20151113__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesEPreferredStockMember_zBtht5OIrMyg">1,000,000</span> shares of our preferred stock as Series E Preferred Stock. The Series E Preferred Stock is subordinated to our common stock. It does not receive dividends and does not participate in equity distributions. <span id="xdx_909_eus-gaap--PreferredStockVotingRights_c20151112__20151113__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesEPreferredStockMember_z6MnKjFlAFg1" title="Description of voting rights">The Series E Preferred stock has 2 votes for each outstanding share of common stock in the company.</span> As of April 30, 2023 and January 31, 2023, there are <span id="xdx_904_eus-gaap--PreferredStockSharesOutstanding_iI_pid_uShares_c20230430__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesEPreferredStockMember_zk5x7qGUPnNd"><span id="xdx_905_eus-gaap--PreferredStockSharesOutstanding_iI_pid_uShares_c20230131__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesEPreferredStockMember_z4f2esfGJOP3">1,000,000</span></span> shares Series E Preferred Stock outstanding. Dividends, when, as and if declared by the Board of Directors, shall be paid out of funds at the time legally available for such purposes.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><i>Series F preferred stock issued for services</i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Series F Preferred Stock is subordinated to our common stock and superior to all shares of Preferred Stock. It does not receive dividends and does not participate in equity distributions. <span id="xdx_905_eus-gaap--PreferredStockVotingRights_c20230201__20230430__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesFPreferredStockMember_zAqFTxIsxMYh" title="Description of voting rights">The Series F Preferred stock retains 2/3 of the voting rights in the company.</span> During the year ended January 31, 2021, the Company issued <span id="xdx_90A_eus-gaap--PreferredStockSharesIssued_iI_pid_uShares_c20210131__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesFPreferredStockMember__srt--TitleOfIndividualAxis__srt--ChiefExecutiveOfficerMember_zU1ijjW3VbH5" title="Preferred stock, issued">1,000,000</span> shares of Series F Preferred Stock to Sydney Jim, our CEO, in exchange for services. As of the date of this report, there are <span id="xdx_903_eus-gaap--PreferredStockSharesOutstanding_iI_pid_uShares_c20210131__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesFPreferredStockMember_zBzJeyufcAu4" title="Preferred stock, outstanding">1,000,000</span> shares Series F Preferred Stock outstanding. As of April 30, 2023 and January 31, 2023, there are <span id="xdx_904_eus-gaap--PreferredStockSharesOutstanding_iI_pid_uShares_c20230430__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesFPreferredStockMember_zKDCUwvo1YEa" title="Preferred stock, outstanding"><span id="xdx_90B_eus-gaap--PreferredStockSharesOutstanding_iI_pid_uShares_c20230131__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesFPreferredStockMember_zmLPu70NGfG5" title="Preferred stock, outstanding">1,000,000</span></span> shares of Series F Preferred Stock outstanding.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><i>Series G convertible preferred stock</i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">During the three months ended April 30, 2023, the Company the holder of the Series G convertible preferred stock converted <span id="xdx_903_ecustom--PreferedStockConvertedIntoCommonStock1_iI_pid_uShares_c20230430__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesGPreferredStockMember_z1QzhwQgblK2" title="Prefered stock converted into common stock">35,200</span> shares and accrued dividends of $<span id="xdx_90E_ecustom--DividendsPayableCurrentAndNoncurrent1_iI_pp0p0_c20230430__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesGPreferredStockMember_zWDv1qAPp0T6" title="Accrured dividends">1,408</span> into <span id="xdx_90D_ecustom--PreferedStockConvertedIntoCommonStock_iI_pid_uShares_c20230430__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesGPreferredStockMember_zSPqsdbk4Bk4">174,323,810</span> shares of common stock. During the three months ended April 30, 2022, the Company accrued dividends of $<span id="xdx_906_eus-gaap--DividendsPayableCurrentAndNoncurrent_iI_pid_c20220430__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesGPreferredStockMember_z2B7ILDvY7bg" title="Dividends payable">2,429</span>, and the holder of the Series G convertible preferred stock converted <span id="xdx_90C_ecustom--PreferedStockConvertedIntoCommonStock1_iI_pid_uShares_c20220430__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesGPreferredStockMember_zdzuj4seBNQi">217,800</span> shares and accrued dividends of $<span id="xdx_90A_ecustom--DividendsPayableCurrentAndNoncurrent1_iI_pid_c20220430__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesGPreferredStockMember_z0DDHkIFIN65">8,712</span> into <span id="xdx_903_ecustom--PreferedStockConvertedIntoCommonStock_iI_pid_uShares_c20220430__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesGPreferredStockMember_z0qNXK2tYcyg">425,622,150</span> shares of common stock. The conversions were in accordance with the terms of the agreement and no gain or loss was recognized. As of April 30, 2023, there were no shares of Series G convertible preferred stock outstanding.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Preferred Stock Subscription</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On February 23, 2022, the Company sold <span id="xdx_90A_eus-gaap--PreferredStockShareSubscriptions_iI_pid_uShares_c20220223_zxB3MCe4KPJj" title="Number of shares sold">10,000</span> shares of preferred stock not yet designated for cash proceeds of $<span id="xdx_900_eus-gaap--ProceedsFromIssuanceOfPreferredStockAndPreferenceStock_c20220221__20220223_zxHWfZdaSgCa" title="Cash proceeds">50,000</span>.</p> 50000 5 0.10 800 50000 50000 10000 5 0.004 800 10000 50000 10000 10000 40000 5 0.10 500000 0.01 38 40000 200000 40000 40000 1000000 The Series E Preferred stock has 2 votes for each outstanding share of common stock in the company. 1000000 1000000 The Series F Preferred stock retains 2/3 of the voting rights in the company. 1000000 1000000 1000000 1000000 35200 1408 174323810 2429 217800 8712 425622150 10000 50000 EXCEL 33 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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end XML 34 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 35 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 36 FilingSummary.xml IDEA: XBRL DOCUMENT 3.23.2 html 96 144 1 false 17 0 false 4 false false R1.htm 00000001 - Document - Cover Sheet http://neutracorp.com/role/Cover Cover Cover 1 false false R2.htm 00000002 - Statement - CONSOLIDATED BALANCE SHEETS (UNAUDITED) Sheet http://neutracorp.com/role/ConsolidatedBalanceSheets CONSOLIDATED BALANCE SHEETS (UNAUDITED) Statements 2 false false R3.htm 00000003 - Statement - CONSOLIDATED BALANCE SHEETS (UNAUDITED) (Parenthetical) Sheet http://neutracorp.com/role/ConsolidatedBalanceSheetsParenthetical CONSOLIDATED BALANCE SHEETS (UNAUDITED) (Parenthetical) Statements 3 false false R4.htm 00000004 - Statement - CONSOLIDATED STATEMENTS OF OPERATIONS (UNAUDITED) Sheet http://neutracorp.com/role/ConsolidatedStatementsOfOperations CONSOLIDATED STATEMENTS OF OPERATIONS (UNAUDITED) Statements 4 false false R5.htm 00000005 - Statement - CONSOLIDATED STATEMENTS OF STOCKHOLDERS' DEFICIT (UNAUDITED) Sheet http://neutracorp.com/role/ConsolidatedStatementsOfStockholdersDeficit CONSOLIDATED STATEMENTS OF STOCKHOLDERS' DEFICIT (UNAUDITED) Statements 5 false false R6.htm 00000006 - Statement - CONSOLIDATED STATEMENT OF CHANGES IN MEZZANINE EQUITY (UNAUDITED) Sheet http://neutracorp.com/role/ConsolidatedStatementOfChangesInMezzanineEquity CONSOLIDATED STATEMENT OF CHANGES IN MEZZANINE EQUITY (UNAUDITED) Statements 6 false false R7.htm 00000007 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED) Sheet http://neutracorp.com/role/ConsolidatedStatementsOfCashFlows CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED) Statements 7 false false R8.htm 00000008 - Disclosure - Background Information Sheet http://neutracorp.com/role/BackgroundInformation Background Information Notes 8 false false R9.htm 00000009 - Disclosure - Going Concern Sheet http://neutracorp.com/role/GoingConcern Going Concern Notes 9 false false R10.htm 00000010 - Disclosure - Significant Accounting Policies Sheet http://neutracorp.com/role/SignificantAccountingPolicies Significant Accounting Policies Notes 10 false false R11.htm 00000011 - Disclosure - Property and equipment, net Sheet http://neutracorp.com/role/PropertyAndEquipmentNet Property and equipment, net Notes 11 false false R12.htm 00000012 - Disclosure - Related Party Transactions Sheet http://neutracorp.com/role/RelatedPartyTransactions Related Party Transactions Notes 12 false false R13.htm 00000013 - Disclosure - Advances and Notes Payable Notes http://neutracorp.com/role/AdvancesAndNotesPayable Advances and Notes Payable Notes 13 false false R14.htm 00000014 - Disclosure - Shareholders??? Equity Sheet http://neutracorp.com/role/ShareholdersEquity Shareholders??? Equity Notes 14 false false R15.htm 00000015 - Disclosure - Significant Accounting Policies (Policies) Sheet http://neutracorp.com/role/SignificantAccountingPoliciesPolicies Significant Accounting Policies (Policies) Policies http://neutracorp.com/role/SignificantAccountingPolicies 15 false false R16.htm 00000016 - Disclosure - Property and equipment, net (Tables) Sheet http://neutracorp.com/role/PropertyAndEquipmentNetTables Property and equipment, net (Tables) Tables http://neutracorp.com/role/PropertyAndEquipmentNet 16 false false R17.htm 00000017 - Disclosure - Going Concern (Details Narrative) Sheet http://neutracorp.com/role/GoingConcernDetailsNarrative Going Concern (Details Narrative) Details http://neutracorp.com/role/GoingConcern 17 false false R18.htm 00000018 - Disclosure - Significant Accounting Policies (Details Narrative) Sheet http://neutracorp.com/role/SignificantAccountingPoliciesDetailsNarrative Significant Accounting Policies (Details Narrative) Details http://neutracorp.com/role/SignificantAccountingPoliciesPolicies 18 false false R19.htm 00000019 - Disclosure - Property and equipment consist of the following: (Details) Sheet http://neutracorp.com/role/PropertyAndEquipmentConsistOfFollowingDetails Property and equipment consist of the following: (Details) Details 19 false false R20.htm 00000020 - Disclosure - Related Party Transactions (Details Narrative) Sheet http://neutracorp.com/role/RelatedPartyTransactionsDetailsNarrative Related Party Transactions (Details Narrative) Details http://neutracorp.com/role/RelatedPartyTransactions 20 false false R21.htm 00000021 - Disclosure - Advances and Notes Payable (Details Narrative) Notes http://neutracorp.com/role/AdvancesAndNotesPayableDetailsNarrative Advances and Notes Payable (Details Narrative) Details http://neutracorp.com/role/AdvancesAndNotesPayable 21 false false R22.htm 00000022 - Disclosure - Shareholders??? Equity (Details Narrative) Sheet http://neutracorp.com/role/ShareholdersEquityDetailsNarrative Shareholders??? Equity (Details Narrative) Details http://neutracorp.com/role/ShareholdersEquity 22 false false All Reports Book All Reports [ix-0514-Hidden-Fact-Eligible-For-Transform] WARN: 1 fact(s) appearing in ix:hidden were eligible for transformation: us-gaap:PropertyPlantAndEquipmentUsefulLife - form_10-q.htm 90 form_10-q.htm ex_21.htm ex_31-1.htm ex_32-1.htm ntrr-20230430.xsd ntrr-20230430_cal.xml ntrr-20230430_def.xml ntrr-20230430_lab.xml ntrr-20230430_pre.xml http://fasb.org/us-gaap/2023 http://xbrl.sec.gov/dei/2023 true true JSON 39 MetaLinks.json IDEA: XBRL DOCUMENT { "instance": { "form_10-q.htm": { "axisCustom": 0, "axisStandard": 7, "baseTaxonomies": { "http://fasb.org/us-gaap/2023": 339, "http://xbrl.sec.gov/dei/2023": 27 }, "contextCount": 96, "dts": { "calculationLink": { "local": [ "ntrr-20230430_cal.xml" ] }, "definitionLink": { "local": [ "ntrr-20230430_def.xml" ] }, "inline": { "local": [ "form_10-q.htm" ] }, "labelLink": { "local": [ "ntrr-20230430_lab.xml" ] }, "presentationLink": { "local": [ "ntrr-20230430_pre.xml" ] }, "schema": { "local": [ "ntrr-20230430.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd", "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-roles-2023.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-types-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-roles-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-types-2023.xsd", "https://xbrl.sec.gov/country/2023/country-2023.xsd", "https://xbrl.sec.gov/dei/2023/dei-2023.xsd" ] } }, "elementCount": 239, "entityCount": 1, "hidden": { "http://fasb.org/us-gaap/2023": 51, "http://neutracorp.com/20230430": 11, "http://xbrl.sec.gov/dei/2023": 5, "total": 67 }, "keyCustom": 25, "keyStandard": 119, "memberCustom": 5, "memberStandard": 12, "nsprefix": "ntrr", "nsuri": "http://neutracorp.com/20230430", "report": { "R1": { "firstAnchor": { "ancestors": [ "span", "b", "p", "div", "body", "html" ], "baseRef": "form_10-q.htm", "contextRef": "From2023-02-01to2023-04-30", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "document", "isDefault": "true", "longName": "00000001 - Document - Cover", "menuCat": "Cover", "order": "1", "role": "http://neutracorp.com/role/Cover", "shortName": "Cover", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "b", "p", "div", "body", "html" ], "baseRef": "form_10-q.htm", "contextRef": "From2023-02-01to2023-04-30", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R10": { "firstAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "form_10-q.htm", "contextRef": "From2023-02-01to2023-04-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SignificantAccountingPoliciesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000010 - Disclosure - Significant Accounting Policies", "menuCat": "Notes", "order": "10", "role": "http://neutracorp.com/role/SignificantAccountingPolicies", "shortName": "Significant Accounting Policies", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "form_10-q.htm", "contextRef": "From2023-02-01to2023-04-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SignificantAccountingPoliciesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R11": { "firstAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "form_10-q.htm", "contextRef": "From2023-02-01to2023-04-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000011 - Disclosure - Property and equipment, net", "menuCat": "Notes", "order": "11", "role": "http://neutracorp.com/role/PropertyAndEquipmentNet", "shortName": "Property and equipment, net", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "form_10-q.htm", "contextRef": "From2023-02-01to2023-04-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R12": { "firstAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "form_10-q.htm", "contextRef": "From2023-02-01to2023-04-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000012 - Disclosure - Related Party Transactions", "menuCat": "Notes", "order": "12", "role": "http://neutracorp.com/role/RelatedPartyTransactions", "shortName": "Related Party Transactions", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "form_10-q.htm", "contextRef": "From2023-02-01to2023-04-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R13": { "firstAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "form_10-q.htm", "contextRef": "From2023-02-01to2023-04-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DebtDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000013 - Disclosure - Advances and Notes Payable", "menuCat": "Notes", "order": "13", "role": "http://neutracorp.com/role/AdvancesAndNotesPayable", "shortName": "Advances and Notes Payable", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "form_10-q.htm", "contextRef": "From2023-02-01to2023-04-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DebtDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R14": { "firstAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "form_10-q.htm", "contextRef": "From2023-02-01to2023-04-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000014 - Disclosure - Shareholders\u2019 Equity", "menuCat": "Notes", "order": "14", "role": "http://neutracorp.com/role/ShareholdersEquity", "shortName": "Shareholders\u2019 Equity", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "form_10-q.htm", "contextRef": "From2023-02-01to2023-04-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R15": { "firstAnchor": { "ancestors": [ "us-gaap:SignificantAccountingPoliciesTextBlock", "div", "body", "html" ], "baseRef": "form_10-q.htm", "contextRef": "From2023-02-01to2023-04-30", "decimals": null, "first": true, "lang": "en-US", "name": "ntrr:InterimFinancialStatementsPolicyTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000015 - Disclosure - Significant Accounting Policies (Policies)", "menuCat": "Policies", "order": "15", "role": "http://neutracorp.com/role/SignificantAccountingPoliciesPolicies", "shortName": "Significant Accounting Policies (Policies)", "subGroupType": "policies", "uniqueAnchor": { "ancestors": [ "us-gaap:SignificantAccountingPoliciesTextBlock", "div", "body", "html" ], "baseRef": "form_10-q.htm", "contextRef": "From2023-02-01to2023-04-30", "decimals": null, "first": true, "lang": "en-US", "name": "ntrr:InterimFinancialStatementsPolicyTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R16": { "firstAnchor": { "ancestors": [ "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock", "div", "body", "html" ], "baseRef": "form_10-q.htm", "contextRef": "From2023-02-01to2023-04-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:PropertyPlantAndEquipmentTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000016 - Disclosure - Property and equipment, net (Tables)", "menuCat": "Tables", "order": "16", "role": "http://neutracorp.com/role/PropertyAndEquipmentNetTables", "shortName": "Property and equipment, net (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock", "div", "body", "html" ], "baseRef": "form_10-q.htm", "contextRef": "From2023-02-01to2023-04-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:PropertyPlantAndEquipmentTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R17": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "div", "body", "html" ], "baseRef": "form_10-q.htm", "contextRef": "From2023-02-01to2023-04-30", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:NetIncomeLoss", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000017 - Disclosure - Going Concern (Details Narrative)", "menuCat": "Details", "order": "17", "role": "http://neutracorp.com/role/GoingConcernDetailsNarrative", "shortName": "Going Concern (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "p", "us-gaap:SubstantialDoubtAboutGoingConcernTextBlock", "div", "body", "html" ], "baseRef": "form_10-q.htm", "contextRef": "AsOf2023-04-30", "decimals": "0", "lang": null, "name": "ntrr:WorkingCapital", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R18": { "firstAnchor": { "ancestors": [ "span", "span", "p", "us-gaap:InventoryFinishedGoodsPolicy", "us-gaap:SignificantAccountingPoliciesTextBlock", "div", "body", "html" ], "baseRef": "form_10-q.htm", "contextRef": "AsOf2023-04-30", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:InventoryValuationReserves", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000018 - Disclosure - Significant Accounting Policies (Details Narrative)", "menuCat": "Details", "order": "18", "role": "http://neutracorp.com/role/SignificantAccountingPoliciesDetailsNarrative", "shortName": "Significant Accounting Policies (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "p", "us-gaap:InventoryFinishedGoodsPolicy", "us-gaap:SignificantAccountingPoliciesTextBlock", "div", "body", "html" ], "baseRef": "form_10-q.htm", "contextRef": "AsOf2023-04-30", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:InventoryValuationReserves", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R19": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:PropertyPlantAndEquipmentTextBlock", "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock", "div", "body", "html" ], "baseRef": "form_10-q.htm", "contextRef": "AsOf2023-04-30", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:PropertyPlantAndEquipmentGross", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000019 - Disclosure - Property and equipment consist of the following: (Details)", "menuCat": "Details", "order": "19", "role": "http://neutracorp.com/role/PropertyAndEquipmentConsistOfFollowingDetails", "shortName": "Property and equipment consist of the following: (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:PropertyPlantAndEquipmentTextBlock", "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock", "div", "body", "html" ], "baseRef": "form_10-q.htm", "contextRef": "AsOf2023-04-30", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:PropertyPlantAndEquipmentGross", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R2": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "div", "body", "html" ], "baseRef": "form_10-q.htm", "contextRef": "AsOf2023-04-30", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "00000002 - Statement - CONSOLIDATED BALANCE SHEETS (UNAUDITED)", "menuCat": "Statements", "order": "2", "role": "http://neutracorp.com/role/ConsolidatedBalanceSheets", "shortName": "CONSOLIDATED BALANCE SHEETS (UNAUDITED)", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "div", "body", "html" ], "baseRef": "form_10-q.htm", "contextRef": "AsOf2023-04-30", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R20": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "div", "body", "html" ], "baseRef": "form_10-q.htm", "contextRef": "AsOf2023-04-30", "decimals": "0", "first": true, "lang": null, "name": "ntrr:AdvancesPayableToRelatedParty", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000020 - Disclosure - Related Party Transactions (Details Narrative)", "menuCat": "Details", "order": "20", "role": "http://neutracorp.com/role/RelatedPartyTransactionsDetailsNarrative", "shortName": "Related Party Transactions (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "p", "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "div", "body", "html" ], "baseRef": "form_10-q.htm", "contextRef": "From2023-02-012023-04-30_srt_ChiefExecutiveOfficerMember", "decimals": "0", "lang": null, "name": "us-gaap:SalariesAndWages", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R21": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "div", "body", "html" ], "baseRef": "form_10-q.htm", "contextRef": "AsOf2023-04-30", "decimals": "0", "first": true, "lang": null, "name": "ntrr:AdvancesPayable", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000021 - Disclosure - Advances and Notes Payable (Details Narrative)", "menuCat": "Details", "order": "21", "role": "http://neutracorp.com/role/AdvancesAndNotesPayableDetailsNarrative", "shortName": "Advances and Notes Payable (Details Narrative)", "subGroupType": "details", "uniqueAnchor": null }, "R22": { "firstAnchor": { "ancestors": [ "span", "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "form_10-q.htm", "contextRef": "AsOf2023-04-30", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:PreferredStockParOrStatedValuePerShare", "reportCount": 1, "unitRef": "USDPShares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000022 - Disclosure - Shareholders\u2019 Equity (Details Narrative)", "menuCat": "Details", "order": "22", "role": "http://neutracorp.com/role/ShareholdersEquityDetailsNarrative", "shortName": "Shareholders\u2019 Equity (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "p", "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "div", "body", "html" ], "baseRef": "form_10-q.htm", "contextRef": "AsOf2022-02-23", "decimals": "INF", "lang": null, "name": "us-gaap:PreferredStockShareSubscriptions", "reportCount": 1, "unique": true, "unitRef": "Shares", "xsiNil": "false" } }, "R3": { "firstAnchor": { "ancestors": [ "span", "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "form_10-q.htm", "contextRef": "AsOf2023-04-30", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:PreferredStockParOrStatedValuePerShare", "reportCount": 1, "unitRef": "USDPShares", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "00000003 - Statement - CONSOLIDATED BALANCE SHEETS (UNAUDITED) (Parenthetical)", "menuCat": "Statements", "order": "3", "role": "http://neutracorp.com/role/ConsolidatedBalanceSheetsParenthetical", "shortName": "CONSOLIDATED BALANCE SHEETS (UNAUDITED) (Parenthetical)", "subGroupType": "parenthetical", "uniqueAnchor": { "ancestors": [ "span", "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "form_10-q.htm", "contextRef": "AsOf2023-04-30", "decimals": "INF", "lang": null, "name": "us-gaap:CommonStockParOrStatedValuePerShare", "reportCount": 1, "unique": true, "unitRef": "USDPShares", "xsiNil": "false" } }, "R4": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "div", "body", "html" ], "baseRef": "form_10-q.htm", "contextRef": "From2023-02-01to2023-04-30", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:Revenues", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "00000004 - Statement - CONSOLIDATED STATEMENTS OF OPERATIONS (UNAUDITED)", "menuCat": "Statements", "order": "4", "role": "http://neutracorp.com/role/ConsolidatedStatementsOfOperations", "shortName": "CONSOLIDATED STATEMENTS OF OPERATIONS (UNAUDITED)", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "div", "body", "html" ], "baseRef": "form_10-q.htm", "contextRef": "From2023-02-01to2023-04-30", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:Revenues", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R5": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "form_10-q.htm", "contextRef": "AsOf2023-01-31_us-gaap_CommonStockMember", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:StockholdersEquity", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "00000005 - Statement - CONSOLIDATED STATEMENTS OF STOCKHOLDERS' DEFICIT (UNAUDITED)", "menuCat": "Statements", "order": "5", "role": "http://neutracorp.com/role/ConsolidatedStatementsOfStockholdersDeficit", "shortName": "CONSOLIDATED STATEMENTS OF STOCKHOLDERS' DEFICIT (UNAUDITED)", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "form_10-q.htm", "contextRef": "AsOf2023-01-31_us-gaap_CommonStockMember", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:StockholdersEquity", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R6": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "div", "body", "html" ], "baseRef": "form_10-q.htm", "contextRef": "AsOf2023-01-31_us-gaap_SeriesGPreferredStockMember", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:StockholdersEquity", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "00000006 - Statement - CONSOLIDATED STATEMENT OF CHANGES IN MEZZANINE EQUITY (UNAUDITED)", "menuCat": "Statements", "order": "6", "role": "http://neutracorp.com/role/ConsolidatedStatementOfChangesInMezzanineEquity", "shortName": "CONSOLIDATED STATEMENT OF CHANGES IN MEZZANINE EQUITY (UNAUDITED)", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "div", "body", "html" ], "baseRef": "form_10-q.htm", "contextRef": "AsOf2023-01-31_us-gaap_SeriesGPreferredStockMember", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:StockholdersEquity", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R7": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "div", "body", "html" ], "baseRef": "form_10-q.htm", "contextRef": "From2023-02-01to2023-04-30", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:NetIncomeLoss", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "00000007 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED)", "menuCat": "Statements", "order": "7", "role": "http://neutracorp.com/role/ConsolidatedStatementsOfCashFlows", "shortName": "CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED)", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "div", "body", "html" ], "baseRef": "form_10-q.htm", "contextRef": "From2023-02-01to2023-04-30", "decimals": "0", "lang": null, "name": "us-gaap:Depreciation", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R8": { "firstAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "form_10-q.htm", "contextRef": "From2023-02-01to2023-04-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:NatureOfOperations", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000008 - Disclosure - Background Information", "menuCat": "Notes", "order": "8", "role": "http://neutracorp.com/role/BackgroundInformation", "shortName": "Background Information", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "form_10-q.htm", "contextRef": "From2023-02-01to2023-04-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:NatureOfOperations", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R9": { "firstAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "form_10-q.htm", "contextRef": "From2023-02-01to2023-04-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SubstantialDoubtAboutGoingConcernTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000009 - Disclosure - Going Concern", "menuCat": "Notes", "order": "9", "role": "http://neutracorp.com/role/GoingConcern", "shortName": "Going Concern", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "form_10-q.htm", "contextRef": "From2023-02-01to2023-04-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SubstantialDoubtAboutGoingConcernTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } } }, "segmentCount": 17, "tag": { "dei_AmendmentDescription": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Description of changes contained within amended document.", "label": "Amendment Description" } } }, "localname": "AmendmentDescription", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://neutracorp.com/role/Cover" ], "xbrltype": "stringItemType" }, "dei_AmendmentFlag": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.", "label": "Amendment Flag" } } }, "localname": "AmendmentFlag", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://neutracorp.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_AnnualInformationForm": { "auth_ref": [ "r403" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag with value true on a form if it is an annual report containing an annual information form.", "label": "Annual Information Form" } } }, "localname": "AnnualInformationForm", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://neutracorp.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_AuditedAnnualFinancialStatements": { "auth_ref": [ "r403" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag with value true on a form if it is an annual report containing audited financial statements.", "label": "Audited Annual Financial Statements" } } }, "localname": "AuditedAnnualFinancialStatements", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://neutracorp.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_CityAreaCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Area code of city", "label": "City Area Code" } } }, "localname": "CityAreaCode", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://neutracorp.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_CountryRegion": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Region code of country", "label": "Country Region" } } }, "localname": "CountryRegion", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://neutracorp.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_CoverAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Cover page.", "label": "Cover [Abstract]" } } }, "localname": "CoverAbstract", "nsuri": "http://xbrl.sec.gov/dei/2023", "xbrltype": "stringItemType" }, "dei_CurrentFiscalYearEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "End date of current fiscal year in the format --MM-DD.", "label": "Current Fiscal Year End Date" } } }, "localname": "CurrentFiscalYearEndDate", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://neutracorp.com/role/Cover" ], "xbrltype": "gMonthDayItemType" }, "dei_DocumentAccountingStandard": { "auth_ref": [ "r402" ], "lang": { "en-us": { "role": { "documentation": "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'.", "label": "Document Accounting Standard" } } }, "localname": "DocumentAccountingStandard", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://neutracorp.com/role/Cover" ], "xbrltype": "accountingStandardItemType" }, "dei_DocumentAnnualReport": { "auth_ref": [ "r400", "r402", "r403" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as an annual report.", "label": "Document Annual Report" } } }, "localname": "DocumentAnnualReport", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://neutracorp.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentFiscalPeriodFocus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.", "label": "Document Fiscal Period Focus" } } }, "localname": "DocumentFiscalPeriodFocus", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://neutracorp.com/role/Cover" ], "xbrltype": "fiscalPeriodItemType" }, "dei_DocumentFiscalYearFocus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.", "label": "Document Fiscal Year Focus" } } }, "localname": "DocumentFiscalYearFocus", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://neutracorp.com/role/Cover" ], "xbrltype": "gYearItemType" }, "dei_DocumentPeriodEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.", "label": "Document Period End Date" } } }, "localname": "DocumentPeriodEndDate", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://neutracorp.com/role/Cover" ], "xbrltype": "dateItemType" }, "dei_DocumentPeriodStartDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The start date of the period covered in the document, in YYYY-MM-DD format.", "label": "Document Period Start Date" } } }, "localname": "DocumentPeriodStartDate", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://neutracorp.com/role/Cover" ], "xbrltype": "dateItemType" }, "dei_DocumentQuarterlyReport": { "auth_ref": [ "r401" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as an quarterly report.", "label": "Document Quarterly Report" } } }, "localname": "DocumentQuarterlyReport", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://neutracorp.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentRegistrationStatement": { "auth_ref": [ "r389" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as a registration statement.", "label": "Document Registration Statement" } } }, "localname": "DocumentRegistrationStatement", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://neutracorp.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentShellCompanyEventDate": { "auth_ref": [ "r402" ], "lang": { "en-us": { "role": { "documentation": "Date of event requiring a shell company report.", "label": "Document Shell Company Event Date" } } }, "localname": "DocumentShellCompanyEventDate", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://neutracorp.com/role/Cover" ], "xbrltype": "dateItemType" }, "dei_DocumentShellCompanyReport": { "auth_ref": [ "r402" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act.", "label": "Document Shell Company Report" } } }, "localname": "DocumentShellCompanyReport", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://neutracorp.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentTransitionReport": { "auth_ref": [ "r404" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as a transition report.", "label": "Document Transition Report" } } }, "localname": "DocumentTransitionReport", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://neutracorp.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentType": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.", "label": "Document Type" } } }, "localname": "DocumentType", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://neutracorp.com/role/Cover" ], "xbrltype": "submissionTypeItemType" }, "dei_DocumentsIncorporatedByReferenceTextBlock": { "auth_ref": [ "r392" ], "lang": { "en-us": { "role": { "documentation": "Documents incorporated by reference.", "label": "Documents Incorporated by Reference [Text Block]" } } }, "localname": "DocumentsIncorporatedByReferenceTextBlock", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://neutracorp.com/role/Cover" ], "xbrltype": "textBlockItemType" }, "dei_EntityAddressAddressLine1": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 1 such as Attn, Building Name, Street Name", "label": "Entity Address, Address Line One" } } }, "localname": "EntityAddressAddressLine1", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://neutracorp.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressAddressLine2": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 2 such as Street or Suite number", "label": "Entity Address, Address Line Two" } } }, "localname": "EntityAddressAddressLine2", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://neutracorp.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressAddressLine3": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 3 such as an Office Park", "label": "Entity Address, Address Line Three" } } }, "localname": "EntityAddressAddressLine3", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://neutracorp.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCityOrTown": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the City or Town", "label": "Entity Address, City or Town" } } }, "localname": "EntityAddressCityOrTown", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://neutracorp.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCountry": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "ISO 3166-1 alpha-2 country code.", "label": "Entity Address, Country" } } }, "localname": "EntityAddressCountry", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://neutracorp.com/role/Cover" ], "xbrltype": "countryCodeItemType" }, "dei_EntityAddressPostalZipCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Code for the postal or zip code", "label": "Entity Address, Postal Zip Code" } } }, "localname": "EntityAddressPostalZipCode", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://neutracorp.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressStateOrProvince": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the state or province.", "label": "Entity Address, State or Province" } } }, "localname": "EntityAddressStateOrProvince", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://neutracorp.com/role/Cover" ], "xbrltype": "stateOrProvinceItemType" }, "dei_EntityBankruptcyProceedingsReportingCurrent": { "auth_ref": [ "r395" ], "lang": { "en-us": { "role": { "documentation": "For registrants involved in bankruptcy proceedings during the preceding five years, the value Yes indicates that the registrant has filed all documents and reports required to be filed by Section 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court; the value No indicates the registrant has not. Registrants not involved in bankruptcy proceedings during the preceding five years should not report this element.", "label": "Entity Bankruptcy Proceedings, Reporting Current" } } }, "localname": "EntityBankruptcyProceedingsReportingCurrent", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://neutracorp.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityCentralIndexKey": { "auth_ref": [ "r391" ], "lang": { "en-us": { "role": { "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.", "label": "Entity Central Index Key" } } }, "localname": "EntityCentralIndexKey", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://neutracorp.com/role/Cover" ], "xbrltype": "centralIndexKeyItemType" }, "dei_EntityCommonStockSharesOutstanding": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.", "label": "Entity Common Stock, Shares Outstanding" } } }, "localname": "EntityCommonStockSharesOutstanding", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://neutracorp.com/role/Cover" ], "xbrltype": "sharesItemType" }, "dei_EntityCurrentReportingStatus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.", "label": "Entity Current Reporting Status" } } }, "localname": "EntityCurrentReportingStatus", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://neutracorp.com/role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_EntityEmergingGrowthCompany": { "auth_ref": [ "r391" ], "lang": { "en-us": { "role": { "documentation": "Indicate if registrant meets the emerging growth company criteria.", "label": "Entity Emerging Growth Company" } } }, "localname": "EntityEmergingGrowthCompany", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://neutracorp.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityExTransitionPeriod": { "auth_ref": [ "r408" ], "lang": { "en-us": { "role": { "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.", "label": "Elected Not To Use the Extended Transition Period" } } }, "localname": "EntityExTransitionPeriod", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://neutracorp.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityFileNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.", "label": "Entity File Number" } } }, "localname": "EntityFileNumber", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://neutracorp.com/role/Cover" ], "xbrltype": "fileNumberItemType" }, "dei_EntityFilerCategory": { "auth_ref": [ "r391" ], "lang": { "en-us": { "role": { "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.", "label": "Entity Filer Category" } } }, "localname": "EntityFilerCategory", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://neutracorp.com/role/Cover" ], "xbrltype": "filerCategoryItemType" }, "dei_EntityIncorporationStateCountryCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Two-character EDGAR code representing the state or country of incorporation.", "label": "Entity Incorporation, State or Country Code" } } }, "localname": "EntityIncorporationStateCountryCode", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://neutracorp.com/role/Cover" ], "xbrltype": "edgarStateCountryItemType" }, "dei_EntityInteractiveDataCurrent": { "auth_ref": [ "r405" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).", "label": "Entity Interactive Data Current" } } }, "localname": "EntityInteractiveDataCurrent", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://neutracorp.com/role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_EntityPrimarySicNumber": { "auth_ref": [ "r403" ], "lang": { "en-us": { "role": { "documentation": "Primary Standard Industrial Classification (SIC) Number for the Entity.", "label": "Entity Primary SIC Number" } } }, "localname": "EntityPrimarySicNumber", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://neutracorp.com/role/Cover" ], "xbrltype": "sicNumberItemType" }, "dei_EntityPublicFloat": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter.", "label": "Entity Public Float" } } }, "localname": "EntityPublicFloat", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://neutracorp.com/role/Cover" ], "xbrltype": "monetaryItemType" }, "dei_EntityRegistrantName": { "auth_ref": [ "r391" ], "lang": { "en-us": { "role": { "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.", "label": "Entity Registrant Name" } } }, "localname": "EntityRegistrantName", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://neutracorp.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityShellCompany": { "auth_ref": [ "r391" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.", "label": "Entity Shell Company" } } }, "localname": "EntityShellCompany", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://neutracorp.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntitySmallBusiness": { "auth_ref": [ "r391" ], "lang": { "en-us": { "role": { "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).", "label": "Entity Small Business" } } }, "localname": "EntitySmallBusiness", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://neutracorp.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityTaxIdentificationNumber": { "auth_ref": [ "r391" ], "lang": { "en-us": { "role": { "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.", "label": "Entity Tax Identification Number" } } }, "localname": "EntityTaxIdentificationNumber", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://neutracorp.com/role/Cover" ], "xbrltype": "employerIdItemType" }, "dei_EntityVoluntaryFilers": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.", "label": "Entity Voluntary Filers" } } }, "localname": "EntityVoluntaryFilers", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://neutracorp.com/role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_EntityWellKnownSeasonedIssuer": { "auth_ref": [ "r406" ], "lang": { "en-us": { "role": { "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.", "label": "Entity Well-known Seasoned Issuer" } } }, "localname": "EntityWellKnownSeasonedIssuer", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://neutracorp.com/role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_Extension": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Extension number for local phone number.", "label": "Extension" } } }, "localname": "Extension", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://neutracorp.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_LocalPhoneNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Local phone number for entity.", "label": "Local Phone Number" } } }, "localname": "LocalPhoneNumber", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://neutracorp.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_NoTradingSymbolFlag": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a security having no trading symbol.", "label": "No Trading Symbol Flag" } } }, "localname": "NoTradingSymbolFlag", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://neutracorp.com/role/Cover" ], "xbrltype": "trueItemType" }, "dei_OtherReportingStandardItemNumber": { "auth_ref": [ "r402" ], "lang": { "en-us": { "role": { "documentation": "\"Item 17\" or \"Item 18\" specified when the basis of accounting is neither US GAAP nor IFRS.", "label": "Other Reporting Standard Item Number" } } }, "localname": "OtherReportingStandardItemNumber", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://neutracorp.com/role/Cover" ], "xbrltype": "otherReportingStandardItemNumberItemType" }, "dei_PreCommencementIssuerTenderOffer": { "auth_ref": [ "r396" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.", "label": "Pre-commencement Issuer Tender Offer" } } }, "localname": "PreCommencementIssuerTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://neutracorp.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_PreCommencementTenderOffer": { "auth_ref": [ "r397" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.", "label": "Pre-commencement Tender Offer" } } }, "localname": "PreCommencementTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://neutracorp.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_Security12bTitle": { "auth_ref": [ "r390" ], "lang": { "en-us": { "role": { "documentation": "Title of a 12(b) registered security.", "label": "Title of 12(b) Security" } } }, "localname": "Security12bTitle", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://neutracorp.com/role/Cover" ], "xbrltype": "securityTitleItemType" }, "dei_Security12gTitle": { "auth_ref": [ "r394" ], "lang": { "en-us": { "role": { "documentation": "Title of a 12(g) registered security.", "label": "Title of 12(g) Security" } } }, "localname": "Security12gTitle", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://neutracorp.com/role/Cover" ], "xbrltype": "securityTitleItemType" }, "dei_SecurityExchangeName": { "auth_ref": [ "r393" ], "lang": { "en-us": { "role": { "documentation": "Name of the Exchange on which a security is registered.", "label": "Security Exchange Name" } } }, "localname": "SecurityExchangeName", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://neutracorp.com/role/Cover" ], "xbrltype": "edgarExchangeCodeItemType" }, "dei_SecurityReportingObligation": { "auth_ref": [ "r398" ], "lang": { "en-us": { "role": { "documentation": "15(d), indicating whether the security has a reporting obligation under that section of the Exchange Act.", "label": "Security Reporting Obligation" } } }, "localname": "SecurityReportingObligation", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://neutracorp.com/role/Cover" ], "xbrltype": "securityReportingObligationItemType" }, "dei_SolicitingMaterial": { "auth_ref": [ "r399" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.", "label": "Soliciting Material" } } }, "localname": "SolicitingMaterial", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://neutracorp.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_TradingSymbol": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Trading symbol of an instrument as listed on an exchange.", "label": "Trading Symbol" } } }, "localname": "TradingSymbol", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://neutracorp.com/role/Cover" ], "xbrltype": "tradingSymbolItemType" }, "dei_WrittenCommunications": { "auth_ref": [ "r407" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.", "label": "Written Communications" } } }, "localname": "WrittenCommunications", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://neutracorp.com/role/Cover" ], "xbrltype": "booleanItemType" }, "ntrr_AccountsPayableRelatedPartyAndAdvancesPayableToRelatedPartyMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The element represents accounts payable related party and advances payable to related party member.", "label": "Accounts Payable Related Party and Advances Payable to Related Party [Member]" } } }, "localname": "AccountsPayableRelatedPartyAndAdvancesPayableToRelatedPartyMember", "nsuri": "http://neutracorp.com/20230430", "presentation": [ "http://neutracorp.com/role/RelatedPartyTransactionsDetailsNarrative" ], "xbrltype": "domainItemType" }, "ntrr_AdvancesPayable": { "auth_ref": [], "calculation": { "http://neutracorp.com/role/ConsolidatedBalanceSheets": { "order": 3.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The element represents advances payable.", "label": "Advances payable" } } }, "localname": "AdvancesPayable", "nsuri": "http://neutracorp.com/20230430", "presentation": [ "http://neutracorp.com/role/AdvancesAndNotesPayableDetailsNarrative", "http://neutracorp.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "ntrr_AdvancesPayableToRelatedParty": { "auth_ref": [], "calculation": { "http://neutracorp.com/role/ConsolidatedBalanceSheets": { "order": 4.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The element represents advances payable to related party.", "label": "Advances payable to related party" } } }, "localname": "AdvancesPayableToRelatedParty", "nsuri": "http://neutracorp.com/20230430", "presentation": [ "http://neutracorp.com/role/ConsolidatedBalanceSheets", "http://neutracorp.com/role/RelatedPartyTransactionsDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "ntrr_ConversionofSeriesGpreferredstock": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The element represents conversionof series G preferred stock.", "label": "Conversion of Series G preferred stock" } } }, "localname": "ConversionofSeriesGpreferredstock", "nsuri": "http://neutracorp.com/20230430", "presentation": [ "http://neutracorp.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "ntrr_DeemedDividendOnSeriesGPreferredStock": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The element represents deemed dividend on series g preferred stock.", "label": "Dividends on Series G preferred stock" } } }, "localname": "DeemedDividendOnSeriesGPreferredStock", "nsuri": "http://neutracorp.com/20230430", "presentation": [ "http://neutracorp.com/role/ConsolidatedStatementsOfStockholdersDeficit" ], "xbrltype": "monetaryItemType" }, "ntrr_DeityCorporationMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The element represents deity corporation member.", "label": "Deity Corporation [Member]" } } }, "localname": "DeityCorporationMember", "nsuri": "http://neutracorp.com/20230430", "presentation": [ "http://neutracorp.com/role/RelatedPartyTransactionsDetailsNarrative", "http://neutracorp.com/role/SignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "domainItemType" }, "ntrr_DividendsPayableCurrentAndNoncurrent1": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The element represents dividends payable current and noncurrent1.", "label": "Accrured dividends" } } }, "localname": "DividendsPayableCurrentAndNoncurrent1", "nsuri": "http://neutracorp.com/20230430", "presentation": [ "http://neutracorp.com/role/ShareholdersEquityDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "ntrr_EarningsLossPerShareBasicAndDiluted": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The element represents earnings loss per share basic and diluted.", "label": "Net loss per common share" } } }, "localname": "EarningsLossPerShareBasicAndDiluted", "nsuri": "http://neutracorp.com/20230430", "presentation": [ "http://neutracorp.com/role/ConsolidatedStatementsOfOperations" ], "xbrltype": "perShareItemType" }, "ntrr_ExpensesPaidOnCompanysBehalf": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The element represents expenses paid on companys behalf.", "label": "Expenses paid" } } }, "localname": "ExpensesPaidOnCompanysBehalf", "nsuri": "http://neutracorp.com/20230430", "presentation": [ "http://neutracorp.com/role/RelatedPartyTransactionsDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "ntrr_InterimFinancialStatementsPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The element represents interim financial statements policy text block.", "label": "Interim Financial Statements" } } }, "localname": "InterimFinancialStatementsPolicyTextBlock", "nsuri": "http://neutracorp.com/20230430", "presentation": [ "http://neutracorp.com/role/SignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "ntrr_LoanAgreement": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The element represents loan agreement.", "label": "Loan agreement" } } }, "localname": "LoanAgreement", "nsuri": "http://neutracorp.com/20230430", "presentation": [ "http://neutracorp.com/role/AdvancesAndNotesPayableDetailsNarrative", "http://neutracorp.com/role/RelatedPartyTransactionsDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "ntrr_MezzanineEquityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "MEZZANINE EQUITY" } } }, "localname": "MezzanineEquityAbstract", "nsuri": "http://neutracorp.com/20230430", "presentation": [ "http://neutracorp.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "ntrr_MezzanineEquityPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The element represents mezzanine equity policy text block.", "label": "Mezzanine equity" } } }, "localname": "MezzanineEquityPolicyTextBlock", "nsuri": "http://neutracorp.com/20230430", "presentation": [ "http://neutracorp.com/role/SignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "ntrr_MonthlyIntrestPayment": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The element represents monthly intrest payment.", "label": "Monthly interest payment", "verboseLabel": "Monthly Intrest Payment" } } }, "localname": "MonthlyIntrestPayment", "nsuri": "http://neutracorp.com/20230430", "presentation": [ "http://neutracorp.com/role/AdvancesAndNotesPayableDetailsNarrative", "http://neutracorp.com/role/RelatedPartyTransactionsDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "ntrr_MrJimMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The element represents mr jim member.", "label": "Mr Jim [Member]" } } }, "localname": "MrJimMember", "nsuri": "http://neutracorp.com/20230430", "presentation": [ "http://neutracorp.com/role/RelatedPartyTransactionsDetailsNarrative", "http://neutracorp.com/role/SignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "domainItemType" }, "ntrr_OtherLiabilityCurrentRelatedParty": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The element represents other liability current related party.", "label": "Due to related party" } } }, "localname": "OtherLiabilityCurrentRelatedParty", "nsuri": "http://neutracorp.com/20230430", "presentation": [ "http://neutracorp.com/role/RelatedPartyTransactionsDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "ntrr_PreferedStockConvertedIntoCommonStock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The element represents prefered stock converted into common stock.", "label": "Prefered stock converted into common stock" } } }, "localname": "PreferedStockConvertedIntoCommonStock", "nsuri": "http://neutracorp.com/20230430", "presentation": [ "http://neutracorp.com/role/ShareholdersEquityDetailsNarrative" ], "xbrltype": "sharesItemType" }, "ntrr_PreferedStockConvertedIntoCommonStock1": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The element represents prefered stock converted into common stock1.", "label": "Prefered Stock Converted into Common Stock", "verboseLabel": "Prefered stock converted into common stock" } } }, "localname": "PreferedStockConvertedIntoCommonStock1", "nsuri": "http://neutracorp.com/20230430", "presentation": [ "http://neutracorp.com/role/ShareholdersEquityDetailsNarrative" ], "xbrltype": "sharesItemType" }, "ntrr_PreferredStockSharesOutstanding1": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The element represents preferred stock shares outstanding1.", "label": "Shares outstanding" } } }, "localname": "PreferredStockSharesOutstanding1", "nsuri": "http://neutracorp.com/20230430", "presentation": [ "http://neutracorp.com/role/ShareholdersEquityDetailsNarrative" ], "xbrltype": "sharesItemType" }, "ntrr_ProceedsFromAdvanceFromRelatedParty": { "auth_ref": [], "calculation": { "http://neutracorp.com/role/ConsolidatedStatementsOfCashFlows": { "order": 2.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The element represents proceeds from advance from related party.", "label": "Proceeds from advance from related party", "verboseLabel": "Advanced receive from investor" } } }, "localname": "ProceedsFromAdvanceFromRelatedParty", "nsuri": "http://neutracorp.com/20230430", "presentation": [ "http://neutracorp.com/role/ConsolidatedStatementsOfCashFlows", "http://neutracorp.com/role/RelatedPartyTransactionsDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "ntrr_RecentlyAdoptedAccountingPronouncementsPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The element represents recently adopted accounting pronouncements policy text block.", "label": "Recently Adopted Accounting Pronouncements" } } }, "localname": "RecentlyAdoptedAccountingPronouncementsPolicyTextBlock", "nsuri": "http://neutracorp.com/20230430", "presentation": [ "http://neutracorp.com/role/SignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "ntrr_SeriesGPreferredStock": { "auth_ref": [], "calculation": { "http://neutracorp.com/role/ConsolidatedBalanceSheets": { "order": 2.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The element represents series g preferred stock.", "label": "Series G preferred stock; $1.00 stated value, 0 shares and 35,200 shares issued and outstanding at April 30, 2023 and January 31, 2023, respectively" } } }, "localname": "SeriesGPreferredStock", "nsuri": "http://neutracorp.com/20230430", "presentation": [ "http://neutracorp.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "ntrr_SeriesGPreferredStockConvertedToCommonStock": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The element represents series g preferred stock converted to common stock.", "label": "Series G preferred stock converted to common stock" } } }, "localname": "SeriesGPreferredStockConvertedToCommonStock", "nsuri": "http://neutracorp.com/20230430", "presentation": [ "http://neutracorp.com/role/ConsolidatedStatementOfChangesInMezzanineEquity" ], "xbrltype": "monetaryItemType" }, "ntrr_SeriesGPreferredStockConvertedToCommonStock1": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The element represents series g preferred stock converted to common stock1.", "label": "Series G Preferred Stock Converted to Common Stock" } } }, "localname": "SeriesGPreferredStockConvertedToCommonStock1", "nsuri": "http://neutracorp.com/20230430", "presentation": [ "http://neutracorp.com/role/ConsolidatedStatementOfChangesInMezzanineEquity" ], "xbrltype": "sharesItemType" }, "ntrr_StockSubscribedButNotIssuedMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The element represents stock subscribed but not issued member.", "label": "Stock Subscribed but Not Issued [Member]" } } }, "localname": "StockSubscribedButNotIssuedMember", "nsuri": "http://neutracorp.com/20230430", "presentation": [ "http://neutracorp.com/role/ConsolidatedStatementsOfStockholdersDeficit" ], "xbrltype": "domainItemType" }, "ntrr_StockSubscriptionsReceived": { "auth_ref": [], "calculation": { "http://neutracorp.com/role/ConsolidatedStatementsOfCashFlows": { "order": 1.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The element represents stock subscriptions received.", "label": "Stock subscriptions received" } } }, "localname": "StockSubscriptionsReceived", "nsuri": "http://neutracorp.com/20230430", "presentation": [ "http://neutracorp.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "ntrr_TotalWeightedAverageNumberOfShareOutstandingBasicAndDiluted": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The element represents total weighted average number of share outstanding basic and diluted.", "label": "Weighted average shares outstanding \u2013 basic and diluted" } } }, "localname": "TotalWeightedAverageNumberOfShareOutstandingBasicAndDiluted", "nsuri": "http://neutracorp.com/20230430", "presentation": [ "http://neutracorp.com/role/ConsolidatedStatementsOfOperations" ], "xbrltype": "sharesItemType" }, "ntrr_UnpaidCompensation": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The element represents unpaid compensation.", "label": "Unpaid compensation" } } }, "localname": "UnpaidCompensation", "nsuri": "http://neutracorp.com/20230430", "presentation": [ "http://neutracorp.com/role/RelatedPartyTransactionsDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "ntrr_UnsecuredLoanIntrest": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The element represents unsecured loan intrest.", "label": "Unsecured loan interest", "verboseLabel": "Unsecured Loan Intrest" } } }, "localname": "UnsecuredLoanIntrest", "nsuri": "http://neutracorp.com/20230430", "presentation": [ "http://neutracorp.com/role/AdvancesAndNotesPayableDetailsNarrative", "http://neutracorp.com/role/RelatedPartyTransactionsDetailsNarrative" ], "xbrltype": "percentItemType" }, "ntrr_VIVISCorporationMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The element represents v i v i s corporation member.", "label": "VIVIS Corporation [Member]" } } }, "localname": "VIVISCorporationMember", "nsuri": "http://neutracorp.com/20230430", "presentation": [ "http://neutracorp.com/role/ShareholdersEquityDetailsNarrative" ], "xbrltype": "domainItemType" }, "ntrr_WorkingCapital": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The element represents working capital.", "label": "Working capital" } } }, "localname": "WorkingCapital", "nsuri": "http://neutracorp.com/20230430", "presentation": [ "http://neutracorp.com/role/GoingConcernDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "srt_ChiefExecutiveOfficerMember": { "auth_ref": [ "r421" ], "lang": { "en-us": { "role": { "label": "Chief Executive Officer [Member]" } } }, "localname": "ChiefExecutiveOfficerMember", "nsuri": "http://fasb.org/srt/2023", "presentation": [ "http://neutracorp.com/role/RelatedPartyTransactionsDetailsNarrative", "http://neutracorp.com/role/ShareholdersEquityDetailsNarrative", "http://neutracorp.com/role/SignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "domainItemType" }, "srt_ConsolidatedEntitiesAxis": { "auth_ref": [ "r120", "r209", "r210", "r211", "r212", "r237", "r367", "r423", "r426", "r427" ], "lang": { "en-us": { "role": { "label": "Consolidated Entities [Axis]" } } }, "localname": "ConsolidatedEntitiesAxis", "nsuri": "http://fasb.org/srt/2023", "presentation": [ "http://neutracorp.com/role/ShareholdersEquityDetailsNarrative" ], "xbrltype": "stringItemType" }, "srt_ConsolidatedEntitiesDomain": { "auth_ref": [ "r120", "r209", "r210", "r211", "r212", "r237", "r367", "r423", "r426", "r427" ], "localname": "ConsolidatedEntitiesDomain", "nsuri": "http://fasb.org/srt/2023", "presentation": [ "http://neutracorp.com/role/ShareholdersEquityDetailsNarrative" ], "xbrltype": "domainItemType" }, "srt_TitleOfIndividualAxis": { "auth_ref": [ "r421", "r431" ], "lang": { "en-us": { "role": { "label": "Title of Individual [Axis]" } } }, "localname": "TitleOfIndividualAxis", "nsuri": "http://fasb.org/srt/2023", "presentation": [ "http://neutracorp.com/role/RelatedPartyTransactionsDetailsNarrative", "http://neutracorp.com/role/ShareholdersEquityDetailsNarrative", "http://neutracorp.com/role/SignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "stringItemType" }, "srt_TitleOfIndividualWithRelationshipToEntityDomain": { "auth_ref": [], "localname": "TitleOfIndividualWithRelationshipToEntityDomain", "nsuri": "http://fasb.org/srt/2023", "presentation": [ "http://neutracorp.com/role/RelatedPartyTransactionsDetailsNarrative", "http://neutracorp.com/role/ShareholdersEquityDetailsNarrative", "http://neutracorp.com/role/SignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_AccountingPoliciesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Accounting Policies [Abstract]" } } }, "localname": "AccountingPoliciesAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "xbrltype": "stringItemType" }, "us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent": { "auth_ref": [ "r8" ], "calculation": { "http://neutracorp.com/role/ConsolidatedBalanceSheets": { "order": 1.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying values as of the balance sheet date of obligations incurred through that date and due within one year (or the operating cycle, if longer), including liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received, taxes, interest, rent and utilities, accrued salaries and bonuses, payroll taxes and fringe benefits.", "label": "Accounts payable and accrued expenses" } } }, "localname": "AccountsPayableAndAccruedLiabilitiesCurrent", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://neutracorp.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccountsPayableCurrent": { "auth_ref": [ "r7", "r376" ], "calculation": { "http://neutracorp.com/role/ConsolidatedBalanceSheets": { "order": 2.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Accounts payable to related party" } } }, "localname": "AccountsPayableCurrent", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://neutracorp.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment": { "auth_ref": [ "r28", "r96", "r260" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services.", "label": "Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment", "negatedLabel": "Less: accumulated depreciation" } } }, "localname": "AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://neutracorp.com/role/PropertyAndEquipmentConsistOfFollowingDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AdditionalPaidInCapitalCommonStock": { "auth_ref": [ "r49" ], "calculation": { "http://neutracorp.com/role/ConsolidatedBalanceSheets": { "order": 3.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Value received from shareholders in common stock-related transactions that are in excess of par value or stated value and amounts received from other stock-related transactions. Includes only common stock transactions (excludes preferred stock transactions). May be called contributed capital, capital in excess of par, capital surplus, or paid-in capital.", "label": "Additional paid-in capital" } } }, "localname": "AdditionalPaidInCapitalCommonStock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://neutracorp.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AdditionalPaidInCapitalMember": { "auth_ref": [ "r202", "r203", "r204", "r279", "r417", "r418", "r419", "r429", "r438" ], "lang": { "en-us": { "role": { "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders.", "label": "Additional Paid-in Capital [Member]" } } }, "localname": "AdditionalPaidInCapitalMember", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://neutracorp.com/role/ConsolidatedStatementsOfStockholdersDeficit" ], "xbrltype": "domainItemType" }, "us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Adjustments to reconcile net loss to net cash used in operating activities:" } } }, "localname": "AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://neutracorp.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_Assets": { "auth_ref": [ "r73", "r97", "r119", "r144", "r151", "r155", "r160", "r164", "r165", "r166", "r167", "r168", "r169", "r170", "r171", "r172", "r209", "r211", "r222", "r253", "r313", "r376", "r388", "r424", "r425", "r433" ], "calculation": { "http://neutracorp.com/role/ConsolidatedBalanceSheets": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.", "label": "Assets", "totalLabel": "TOTAL ASSETS" } } }, "localname": "Assets", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://neutracorp.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AssetsCurrent": { "auth_ref": [ "r92", "r102", "r119", "r160", "r164", "r165", "r166", "r167", "r168", "r169", "r170", "r171", "r172", "r209", "r211", "r222", "r376", "r424", "r425", "r433" ], "calculation": { "http://neutracorp.com/role/ConsolidatedBalanceSheets": { "order": 1.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.", "label": "Assets, Current", "totalLabel": "Total current assets" } } }, "localname": "AssetsCurrent", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://neutracorp.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AssetsCurrentAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "CURRENT ASSETS" } } }, "localname": "AssetsCurrentAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://neutracorp.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_BalanceSheetLocationAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Information by location on balance sheet (statement of financial position).", "label": "Balance Sheet Location [Axis]" } } }, "localname": "BalanceSheetLocationAxis", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://neutracorp.com/role/RelatedPartyTransactionsDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_BalanceSheetLocationDomain": { "auth_ref": [ "r38", "r39" ], "lang": { "en-us": { "role": { "documentation": "Location in the balance sheet (statement of financial position)." } } }, "localname": "BalanceSheetLocationDomain", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://neutracorp.com/role/RelatedPartyTransactionsDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_BasisOfAccountingPolicyPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).", "label": "Basis of Presentation" } } }, "localname": "BasisOfAccountingPolicyPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://neutracorp.com/role/SignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_CashAndCashEquivalentsAtCarryingValue": { "auth_ref": [ "r18", "r94", "r369" ], "calculation": { "http://neutracorp.com/role/ConsolidatedBalanceSheets": { "order": 1.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.", "label": "Cash and cash equivalents" } } }, "localname": "CashAndCashEquivalentsAtCarryingValue", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://neutracorp.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations": { "auth_ref": [ "r18", "r61", "r115" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including, but not limited to, disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.", "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations", "periodEndLabel": "Cash and cash equivalents at end of period", "periodStartLabel": "Cash and cash equivalents at beginning of period" } } }, "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://neutracorp.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect": { "auth_ref": [ "r0", "r61" ], "calculation": { "http://neutracorp.com/role/ConsolidatedStatementsOfCashFlows": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; excluding effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.", "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect", "totalLabel": "NET CHANGE IN CASH AND CASH EQUIVALENTS" } } }, "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://neutracorp.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_ClassOfStockDomain": { "auth_ref": [ "r89", "r98", "r99", "r100", "r119", "r135", "r136", "r139", "r140", "r142", "r143", "r160", "r164", "r166", "r167", "r168", "r171", "r172", "r185", "r186", "r189", "r192", "r199", "r222", "r271", "r272", "r273", "r274", "r279", "r280", "r281", "r282", "r283", "r284", "r285", "r286", "r287", "r288", "r289", "r290", "r301", "r322", "r345", "r360", "r361", "r362", "r363", "r364", "r409", "r415", "r420" ], "lang": { "en-us": { "role": { "documentation": "Share of stock differentiated by the voting rights the holder receives. Examples include, but are not limited to, common stock, redeemable preferred stock, nonredeemable preferred stock, and convertible stock." } } }, "localname": "ClassOfStockDomain", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://neutracorp.com/role/ConsolidatedBalanceSheets", "http://neutracorp.com/role/ConsolidatedBalanceSheetsParenthetical", "http://neutracorp.com/role/ConsolidatedStatementsOfStockholdersDeficit", "http://neutracorp.com/role/ShareholdersEquityDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_ClassOfStockLineItems": { "auth_ref": [ "r98", "r99", "r100", "r142", "r185", "r186", "r187", "r189", "r192", "r197", "r199", "r271", "r272", "r273", "r274", "r375", "r409", "r415" ], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Class of Stock [Line Items]" } } }, "localname": "ClassOfStockLineItems", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://neutracorp.com/role/ShareholdersEquityDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_CommitmentsAndContingencies": { "auth_ref": [ "r13", "r43", "r254", "r300" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.", "label": "COMMITMENTS AND CONTINGENCIES" } } }, "localname": "CommitmentsAndContingencies", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://neutracorp.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_CommitmentsAndContingenciesPolicyTextBlock": { "auth_ref": [ "r29", "r366" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for commitments and contingencies, which may include policies for recognizing and measuring loss and gain contingencies.", "label": "Commitments and Contingencies" } } }, "localname": "CommitmentsAndContingenciesPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://neutracorp.com/role/SignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_CommonStockMember": { "auth_ref": [ "r377", "r378", "r379", "r381", "r382", "r383", "r384", "r417", "r418", "r429", "r436", "r438" ], "lang": { "en-us": { "role": { "documentation": "Stock that is subordinate to all other stock of the issuer.", "label": "Common Stock [Member]" } } }, "localname": "CommonStockMember", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://neutracorp.com/role/ConsolidatedStatementsOfStockholdersDeficit" ], "xbrltype": "domainItemType" }, "us-gaap_CommonStockParOrStatedValuePerShare": { "auth_ref": [ "r48" ], "lang": { "en-us": { "role": { "documentation": "Face amount or stated value per share of common stock.", "label": "Common stock, par value (in dollars per share)" } } }, "localname": "CommonStockParOrStatedValuePerShare", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://neutracorp.com/role/ConsolidatedBalanceSheetsParenthetical" ], "xbrltype": "perShareItemType" }, "us-gaap_CommonStockSharesAuthorizedUnlimited": { "auth_ref": [ "r14" ], "lang": { "en-us": { "role": { "documentation": "Indicates that the number of common shares permitted to be issued by an entity's charter and bylaws is unlimited. The acceptable value is \"Unlimited\".", "label": "Common stock, shares authorized, unlimited" } } }, "localname": "CommonStockSharesAuthorizedUnlimited", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://neutracorp.com/role/ConsolidatedBalanceSheetsParenthetical" ], "xbrltype": "authorizedUnlimitedItemType" }, "us-gaap_CommonStockSharesIssued": { "auth_ref": [ "r48" ], "lang": { "en-us": { "role": { "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.", "label": "Common stock, issued" } } }, "localname": "CommonStockSharesIssued", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://neutracorp.com/role/ConsolidatedBalanceSheetsParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockSharesOutstanding": { "auth_ref": [ "r6", "r48", "r301", "r319", "r438", "r439" ], "lang": { "en-us": { "role": { "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.", "label": "Common stock, outstanding" } } }, "localname": "CommonStockSharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://neutracorp.com/role/ConsolidatedBalanceSheetsParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockValue": { "auth_ref": [ "r48", "r256", "r376" ], "calculation": { "http://neutracorp.com/role/ConsolidatedBalanceSheets": { "order": 1.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.", "label": "Common stock, $0.001 par value; unlimited shares authorized; 2,917,899,124 and 2,743,575,314 shares issued and outstanding at April 30, 2023 and January 31, 2023, respectively" } } }, "localname": "CommonStockValue", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://neutracorp.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_ConsolidationPolicyTextBlock": { "auth_ref": [ "r37", "r371" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy regarding (1) the principles it follows in consolidating or combining the separate financial statements, including the principles followed in determining the inclusion or exclusion of subsidiaries or other entities in the consolidated or combined financial statements and (2) its treatment of interests (for example, common stock, a partnership interest or other means of exerting influence) in other entities, for example consolidation or use of the equity or cost methods of accounting. The accounting policy may also address the accounting treatment for intercompany accounts and transactions, noncontrolling interest, and the income statement treatment in consolidation for issuances of stock by a subsidiary.", "label": "Consolidated Financial Statements" } } }, "localname": "ConsolidationPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://neutracorp.com/role/SignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_ConvertiblePreferredStockMember": { "auth_ref": [ "r185", "r186", "r189", "r381", "r382", "r383", "r384" ], "lang": { "en-us": { "role": { "documentation": "Preferred stock that may be exchanged into common shares or other types of securities at the owner's option.", "label": "Convertible Preferred Stock [Member]" } } }, "localname": "ConvertiblePreferredStockMember", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://neutracorp.com/role/ShareholdersEquityDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_CostOfGoodsAndServicesSold": { "auth_ref": [ "r56", "r238" ], "calculation": { "http://neutracorp.com/role/ConsolidatedStatementsOfOperations": { "order": 2.0, "parentTag": "us-gaap_GrossProfit", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities.", "label": "Cost of goods sold" } } }, "localname": "CostOfGoodsAndServicesSold", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://neutracorp.com/role/ConsolidatedStatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_CostsAndExpensesRelatedParty": { "auth_ref": [ "r57" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Costs of sales and operating expenses for the period incurred from transactions with related parties.", "label": "Commission expense" } } }, "localname": "CostsAndExpensesRelatedParty", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://neutracorp.com/role/RelatedPartyTransactionsDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_CumulativeDividends": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cumulative cash dividends distributed to shareholders.", "label": "Cumulative dividends received" } } }, "localname": "CumulativeDividends", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://neutracorp.com/role/ShareholdersEquityDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_DebtDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Debt Disclosure [Abstract]" } } }, "localname": "DebtDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "xbrltype": "stringItemType" }, "us-gaap_DebtDisclosureTextBlock": { "auth_ref": [ "r68", "r117", "r173", "r174", "r175", "r176", "r177", "r178", "r179", "r180", "r181", "r182", "r183" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.", "label": "Advances and Notes Payable" } } }, "localname": "DebtDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://neutracorp.com/role/AdvancesAndNotesPayable" ], "xbrltype": "textBlockItemType" }, "us-gaap_Depreciation": { "auth_ref": [ "r4", "r27" ], "calculation": { "http://neutracorp.com/role/ConsolidatedStatementsOfCashFlows": { "order": 2.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.", "label": "Depreciation [Default Label]", "verboseLabel": "Depreciation" } } }, "localname": "Depreciation", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://neutracorp.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_DepreciationAndAmortization": { "auth_ref": [ "r4", "r27" ], "calculation": { "http://neutracorp.com/role/ConsolidatedStatementsOfOperations": { "order": 1.0, "parentTag": "us-gaap_OtherNonoperatingIncomeExpense", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The current period expense charged against earnings on long-lived, physical assets not used in production, and which are not intended for resale, to allocate or recognize the cost of such assets over their useful lives; or to record the reduction in book value of an intangible asset over the benefit period of such asset; or to reflect consumption during the period of an asset that is not used in production.", "label": "Depreciation" } } }, "localname": "DepreciationAndAmortization", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://neutracorp.com/role/ConsolidatedStatementsOfOperations", "http://neutracorp.com/role/SignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_DividendsPayableCurrent": { "auth_ref": [ "r10" ], "calculation": { "http://neutracorp.com/role/ConsolidatedBalanceSheets": { "order": 5.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying value as of the balance sheet date of dividends declared but unpaid on equity securities issued by the entity and outstanding. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Dividends payable on Series G preferred stock" } } }, "localname": "DividendsPayableCurrent", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://neutracorp.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_DividendsPayableCurrentAndNoncurrent": { "auth_ref": [ "r45", "r46", "r74", "r385", "r435" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying value as of the balance sheet date of dividends declared but unpaid on equity securities issued by the entity and outstanding.", "label": "Dividends payable" } } }, "localname": "DividendsPayableCurrentAndNoncurrent", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://neutracorp.com/role/ShareholdersEquityDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_DividendsPreferredStock": { "auth_ref": [ "r2", "r72" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of paid and unpaid preferred stock dividends declared with the form of settlement in cash, stock and payment-in-kind (PIK).", "label": "Dividends, Preferred Stock", "negatedLabel": "Dividends on Series G convertible preferred stock" } } }, "localname": "DividendsPreferredStock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://neutracorp.com/role/ConsolidatedStatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_EarningsPerSharePolicyTextBlock": { "auth_ref": [ "r20", "r21" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements.", "label": "Earnings (Loss) per Common Share" } } }, "localname": "EarningsPerSharePolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://neutracorp.com/role/SignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_EquipmentMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Tangible personal property used to produce goods and services.", "label": "Equipment [Member]" } } }, "localname": "EquipmentMember", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://neutracorp.com/role/PropertyAndEquipmentConsistOfFollowingDetails", "http://neutracorp.com/role/SignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_EquityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Equity [Abstract]" } } }, "localname": "EquityAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "xbrltype": "stringItemType" }, "us-gaap_EquityComponentDomain": { "auth_ref": [ "r6", "r90", "r105", "r106", "r107", "r121", "r122", "r123", "r125", "r130", "r132", "r141", "r161", "r162", "r200", "r202", "r203", "r204", "r206", "r207", "r213", "r214", "r215", "r216", "r217", "r218", "r220", "r223", "r224", "r225", "r226", "r227", "r228", "r230", "r265", "r266", "r267", "r279", "r345" ], "lang": { "en-us": { "role": { "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc." } } }, "localname": "EquityComponentDomain", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://neutracorp.com/role/ConsolidatedStatementsOfStockholdersDeficit" ], "xbrltype": "domainItemType" }, "us-gaap_FinancingReceivableAccruedInterestWriteoff": { "auth_ref": [ "r163" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of writeoff of accrued interest on financing receivable recognized by reversing interest income.", "label": "Accrued interest" } } }, "localname": "FinancingReceivableAccruedInterestWriteoff", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://neutracorp.com/role/AdvancesAndNotesPayableDetailsNarrative", "http://neutracorp.com/role/RelatedPartyTransactionsDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_GeneralAndAdministrativeExpense": { "auth_ref": [ "r58", "r324" ], "calculation": { "http://neutracorp.com/role/ConsolidatedStatementsOfOperations": { "order": 3.0, "parentTag": "us-gaap_OtherNonoperatingIncomeExpense", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.", "label": "General and administrative expenses" } } }, "localname": "GeneralAndAdministrativeExpense", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://neutracorp.com/role/ConsolidatedStatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_GrossProfit": { "auth_ref": [ "r55", "r119", "r144", "r150", "r154", "r156", "r160", "r164", "r165", "r166", "r167", "r168", "r169", "r170", "r171", "r172", "r222", "r374", "r424" ], "calculation": { "http://neutracorp.com/role/ConsolidatedStatementsOfOperations": { "order": 1.0, "parentTag": "us-gaap_OperatingIncomeLoss", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity.", "label": "Gross Profit", "totalLabel": "Gross margin" } } }, "localname": "GrossProfit", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://neutracorp.com/role/ConsolidatedStatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments": { "auth_ref": [ "r144", "r150", "r154", "r156", "r263", "r374" ], "calculation": { "http://neutracorp.com/role/ConsolidatedStatementsOfOperations": { "order": 1.0, "parentTag": "us-gaap_NetIncomeLoss", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of income (loss) from continuing operations before deduction of income tax expense (benefit) and income (loss) attributable to noncontrolling interest, and addition of income (loss) from equity method investments.", "label": "Net loss before income taxes" } } }, "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://neutracorp.com/role/ConsolidatedStatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeStatementAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Income Statement [Abstract]" } } }, "localname": "IncomeStatementAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "xbrltype": "stringItemType" }, "us-gaap_IncomeTaxExpenseBenefit": { "auth_ref": [ "r78", "r87", "r131", "r132", "r148", "r205", "r208", "r264" ], "calculation": { "http://neutracorp.com/role/ConsolidatedStatementsOfOperations": { "order": 2.0, "parentTag": "us-gaap_NetIncomeLoss", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.", "label": "Income Tax Expense (Benefit)", "negatedLabel": "Provision for income taxes" } } }, "localname": "IncomeTaxExpenseBenefit", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://neutracorp.com/role/ConsolidatedStatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeTaxesPaidNet": { "auth_ref": [ "r19" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income, net of any cash received during the current period as refunds for the overpayment of taxes.", "label": "Taxes" } } }, "localname": "IncomeTaxesPaidNet", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://neutracorp.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities": { "auth_ref": [ "r3" ], "calculation": { "http://neutracorp.com/role/ConsolidatedStatementsOfCashFlows": { "order": 4.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period in the amounts payable to vendors for goods and services received and the amount of obligations and expenses incurred but not paid.", "label": "Accounts payable and accrued liabilities" } } }, "localname": "IncreaseDecreaseInAccountsPayableAndAccruedLiabilities", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://neutracorp.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInAccountsPayableRelatedParties": { "auth_ref": [ "r3" ], "calculation": { "http://neutracorp.com/role/ConsolidatedStatementsOfCashFlows": { "order": 5.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period in the obligations due for goods and services provided by the following types of related parties: a parent company and its subsidiaries, subsidiaries of a common parent, an entity and trust for the benefit of employees, such as pension and profit-sharing trusts that are managed by or under the trusteeship of the entities' management, an entity and its principal owners, management, or member of their immediate families, affiliates, or other parties with the ability to exert significant influence.", "label": "Increase (Decrease) in Accounts Payable, Related Parties", "verboseLabel": "Accounts payable to related party" } } }, "localname": "IncreaseDecreaseInAccountsPayableRelatedParties", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://neutracorp.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInInterestPayableNet": { "auth_ref": [ "r3" ], "calculation": { "http://neutracorp.com/role/ConsolidatedStatementsOfCashFlows": { "order": 6.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period in interest payable, which represents the amount owed to note holders, bond holders, and other parties for interest earned on loans or credit extended to the reporting entity.", "label": "Increase (Decrease) in Interest Payable, Net", "verboseLabel": "Accrued interest payable" } } }, "localname": "IncreaseDecreaseInInterestPayableNet", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://neutracorp.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInInventories": { "auth_ref": [ "r3" ], "calculation": { "http://neutracorp.com/role/ConsolidatedStatementsOfCashFlows": { "order": 3.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities.", "label": "Increase (Decrease) in Inventories", "negatedLabel": "Inventory" } } }, "localname": "IncreaseDecreaseInInventories", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://neutracorp.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInOperatingCapitalAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Changes in operating assets and liabilities" } } }, "localname": "IncreaseDecreaseInOperatingCapitalAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://neutracorp.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_InterestExpense": { "auth_ref": [ "r40", "r77", "r108", "r147", "r229", "r330", "r386", "r437" ], "calculation": { "http://neutracorp.com/role/ConsolidatedStatementsOfOperations": { "order": 1.0, "parentTag": "us-gaap_NonoperatingIncomeExpense", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of the cost of borrowed funds accounted for as interest expense.", "label": "Interest Expense", "negatedLabel": "Interest expense" } } }, "localname": "InterestExpense", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://neutracorp.com/role/ConsolidatedStatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_InterestPaidNet": { "auth_ref": [ "r111", "r113", "r114" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.", "label": "Interest" } } }, "localname": "InterestPaidNet", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://neutracorp.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_InterestPayableCurrent": { "auth_ref": [ "r10" ], "calculation": { "http://neutracorp.com/role/ConsolidatedBalanceSheets": { "order": 6.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying value as of the balance sheet date of [accrued] interest payable on all forms of debt, including trade payables, that has been incurred and is unpaid. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Accrued interest payable" } } }, "localname": "InterestPayableCurrent", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://neutracorp.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_InventoryFinishedGoodsPolicy": { "auth_ref": [ "r25" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for the basis and manner that goods are added and removed from inventory awaiting sale (finished goods). If inventory is carried at cost, this disclosure includes the nature of the cost elements included in inventory and how cost is determined (such as FIFO, LIFO, average).", "label": "Inventory Finished Goods, Policy [Policy Text Block]", "verboseLabel": "Inventory" } } }, "localname": "InventoryFinishedGoodsPolicy", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://neutracorp.com/role/SignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_InventoryNet": { "auth_ref": [ "r101", "r370", "r376" ], "calculation": { "http://neutracorp.com/role/ConsolidatedBalanceSheets": { "order": 2.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.", "label": "Inventory" } } }, "localname": "InventoryNet", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://neutracorp.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_InventoryValuationReserves": { "auth_ref": [ "r26", "r413" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of valuation reserve for inventory.", "label": "Valuation allowance recognized" } } }, "localname": "InventoryValuationReserves", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://neutracorp.com/role/SignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_InvestmentOwnedBalancePrincipalAmount": { "auth_ref": [ "r291", "r292", "r354", "r357", "r359", "r379" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of principal of investment owned.", "label": "Principal amount balance", "verboseLabel": "Loan agreement" } } }, "localname": "InvestmentOwnedBalancePrincipalAmount", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://neutracorp.com/role/AdvancesAndNotesPayableDetailsNarrative", "http://neutracorp.com/role/RelatedPartyTransactionsDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_Liabilities": { "auth_ref": [ "r9", "r119", "r160", "r164", "r165", "r166", "r167", "r168", "r169", "r170", "r171", "r172", "r210", "r211", "r212", "r222", "r299", "r373", "r388", "r424", "r433", "r434" ], "calculation": { "http://neutracorp.com/role/ConsolidatedBalanceSheets": { "order": 1.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.", "label": "Liabilities", "totalLabel": "TOTAL LIABILITIES" } } }, "localname": "Liabilities", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://neutracorp.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesAndStockholdersEquity": { "auth_ref": [ "r53", "r75", "r258", "r376", "r416", "r422", "r430" ], "calculation": { "http://neutracorp.com/role/ConsolidatedBalanceSheets": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.", "label": "Liabilities and Equity", "totalLabel": "TOTAL LIABILITIES, MEZZANINE EQUITY AND STOCKHOLDERS' DEFICIT" } } }, "localname": "LiabilitiesAndStockholdersEquity", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://neutracorp.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesAndStockholdersEquityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "LIABILITIES, MEZZANINE EQUITY AND STOCKHOLDERS' DEFICIT" } } }, "localname": "LiabilitiesAndStockholdersEquityAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://neutracorp.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_LiabilitiesCurrent": { "auth_ref": [ "r11", "r93", "r119", "r160", "r164", "r165", "r166", "r167", "r168", "r169", "r170", "r171", "r172", "r210", "r211", "r212", "r222", "r376", "r424", "r433", "r434" ], "calculation": { "http://neutracorp.com/role/ConsolidatedBalanceSheets": { "order": 1.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.", "label": "Liabilities, Current", "totalLabel": "Total current liabilities" } } }, "localname": "LiabilitiesCurrent", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://neutracorp.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesCurrentAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Current Liabilities" } } }, "localname": "LiabilitiesCurrentAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://neutracorp.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_LongTermNotesPayable": { "auth_ref": [ "r12" ], "calculation": { "http://neutracorp.com/role/ConsolidatedBalanceSheets": { "order": 2.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying value as of the balance sheet date of notes payable (with maturities initially due after one year or beyond the operating cycle if longer), excluding current portion.", "label": "Notes payable, related party" } } }, "localname": "LongTermNotesPayable", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://neutracorp.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_NatureOfOperations": { "auth_ref": [ "r79", "r88" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for the nature of an entity's business, major products or services, principal markets including location, and the relative importance of its operations in each business and the basis for the determination, including but not limited to, assets, revenues, or earnings. For an entity that has not commenced principal operations, disclosures about the risks and uncertainties related to the activities in which the entity is currently engaged and an understanding of what those activities are being directed toward.", "label": "Background Information" } } }, "localname": "NatureOfOperations", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://neutracorp.com/role/BackgroundInformation" ], "xbrltype": "textBlockItemType" }, "us-gaap_NetCashProvidedByUsedInFinancingActivities": { "auth_ref": [ "r112" ], "calculation": { "http://neutracorp.com/role/ConsolidatedStatementsOfCashFlows": { "order": 2.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.", "label": "Net Cash Provided by (Used in) Financing Activities", "totalLabel": "NET CASH PROVIDED BY FINANCING ACTIVITIES" } } }, "localname": "NetCashProvidedByUsedInFinancingActivities", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://neutracorp.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "CASH FLOWS FROM FINANCING ACTIVITIES" } } }, "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://neutracorp.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_NetCashProvidedByUsedInOperatingActivities": { "auth_ref": [ "r61", "r62", "r63" ], "calculation": { "http://neutracorp.com/role/ConsolidatedStatementsOfCashFlows": { "order": 1.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect", "weight": 1.0 } }, "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.", "label": "Net Cash Provided by (Used in) Operating Activities", "totalLabel": "NET CASH USED IN OPERATING ACTIVITIES" } } }, "localname": "NetCashProvidedByUsedInOperatingActivities", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://neutracorp.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "CASH FLOW FROM OPERATING ACTIVITIES:" } } }, "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://neutracorp.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_NetIncomeLoss": { "auth_ref": [ "r54", "r63", "r76", "r91", "r103", "r104", "r107", "r119", "r124", "r126", "r127", "r128", "r129", "r131", "r132", "r137", "r144", "r150", "r154", "r156", "r160", "r164", "r165", "r166", "r167", "r168", "r169", "r170", "r171", "r172", "r221", "r222", "r262", "r321", "r343", "r344", "r374", "r386", "r424" ], "calculation": { "http://neutracorp.com/role/ConsolidatedStatementsOfCashFlows": { "order": 1.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 }, "http://neutracorp.com/role/ConsolidatedStatementsOfOperations": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.", "label": "Net loss", "negatedLabel": "Net loss", "totalLabel": "NET LOSS" } } }, "localname": "NetIncomeLoss", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://neutracorp.com/role/ConsolidatedStatementsOfCashFlows", "http://neutracorp.com/role/ConsolidatedStatementsOfOperations", "http://neutracorp.com/role/ConsolidatedStatementsOfStockholdersDeficit", "http://neutracorp.com/role/GoingConcernDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic": { "auth_ref": [ "r110", "r126", "r127", "r128", "r129", "r133", "r134", "r138", "r140", "r144", "r150", "r154", "r156", "r374" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities; of income (loss) available to common shareholders.", "label": "Net loss available to common shareholders" } } }, "localname": "NetIncomeLossAvailableToCommonStockholdersBasic", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://neutracorp.com/role/ConsolidatedStatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_NoncashInvestingAndFinancingItemsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Noncash investing and financing transactions:" } } }, "localname": "NoncashInvestingAndFinancingItemsAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://neutracorp.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_NonoperatingIncomeExpense": { "auth_ref": [ "r59" ], "calculation": { "http://neutracorp.com/role/ConsolidatedStatementsOfOperations": { "order": 2.0, "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).", "label": "Nonoperating Income (Expense)", "totalLabel": "Total other income (expense)" } } }, "localname": "NonoperatingIncomeExpense", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://neutracorp.com/role/ConsolidatedStatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingExpensesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "OPERATING EXPENSES" } } }, "localname": "OperatingExpensesAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://neutracorp.com/role/ConsolidatedStatementsOfOperations" ], "xbrltype": "stringItemType" }, "us-gaap_OperatingIncomeLoss": { "auth_ref": [ "r144", "r150", "r154", "r156", "r374" ], "calculation": { "http://neutracorp.com/role/ConsolidatedStatementsOfOperations": { "order": 1.0, "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The net result for the period of deducting operating expenses from operating revenues.", "label": "Operating Income (Loss)", "totalLabel": "LOSS FROM OPERATIONS" } } }, "localname": "OperatingIncomeLoss", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://neutracorp.com/role/ConsolidatedStatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Organization, Consolidation and Presentation of Financial Statements [Abstract]" } } }, "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "xbrltype": "stringItemType" }, "us-gaap_OtherNonoperatingIncomeExpense": { "auth_ref": [ "r60" ], "calculation": { "http://neutracorp.com/role/ConsolidatedStatementsOfOperations": { "order": 2.0, "parentTag": "us-gaap_OperatingIncomeLoss", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of income (expense) related to nonoperating activities, classified as other.", "label": "Other Nonoperating Income (Expense)", "negatedTotalLabel": "Total operating expenses" } } }, "localname": "OtherNonoperatingIncomeExpense", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://neutracorp.com/role/ConsolidatedStatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherNonoperatingIncomeExpenseAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "OTHER INCOME (EXPENSE)" } } }, "localname": "OtherNonoperatingIncomeExpenseAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://neutracorp.com/role/ConsolidatedStatementsOfOperations" ], "xbrltype": "stringItemType" }, "us-gaap_PreferredStockDividendRatePercentage": { "auth_ref": [ "r186", "r353", "r355", "r356", "r358" ], "lang": { "en-us": { "role": { "documentation": "The percentage rate used to calculate dividend payments on preferred stock.", "label": "Preferred stock, dividend rate, percentage" } } }, "localname": "PreferredStockDividendRatePercentage", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://neutracorp.com/role/ShareholdersEquityDetailsNarrative" ], "xbrltype": "percentItemType" }, "us-gaap_PreferredStockParOrStatedValuePerShare": { "auth_ref": [ "r47", "r185" ], "lang": { "en-us": { "role": { "documentation": "Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.", "label": "Preferred stock, par value (in dollars per share)" } } }, "localname": "PreferredStockParOrStatedValuePerShare", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://neutracorp.com/role/ConsolidatedBalanceSheetsParenthetical", "http://neutracorp.com/role/ShareholdersEquityDetailsNarrative" ], "xbrltype": "perShareItemType" }, "us-gaap_PreferredStockShareSubscriptions": { "auth_ref": [ "r47" ], "lang": { "en-us": { "role": { "documentation": "The number of nonredeemable preferred stock (shares) (or preferred stock redeemable solely at the option of the issuer) allocated to investors to buy shares of a new issue of preferred stock before they are offered to the public. When stock is sold on a subscription basis, the issuer does not initially receive the total proceeds. In general, the issuer does not issue the shares to the investor until it receives the entire proceeds.", "label": "Number of shares sold" } } }, "localname": "PreferredStockShareSubscriptions", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://neutracorp.com/role/ShareholdersEquityDetailsNarrative" ], "xbrltype": "sharesItemType" }, "us-gaap_PreferredStockSharesAuthorized": { "auth_ref": [ "r47", "r301" ], "lang": { "en-us": { "role": { "documentation": "The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.", "label": "Preferred stock, authorized" } } }, "localname": "PreferredStockSharesAuthorized", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://neutracorp.com/role/ConsolidatedBalanceSheetsParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_PreferredStockSharesIssued": { "auth_ref": [ "r47", "r185" ], "lang": { "en-us": { "role": { "documentation": "Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.", "label": "Preferred stock, issued" } } }, "localname": "PreferredStockSharesIssued", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://neutracorp.com/role/ConsolidatedBalanceSheetsParenthetical", "http://neutracorp.com/role/ShareholdersEquityDetailsNarrative" ], "xbrltype": "sharesItemType" }, "us-gaap_PreferredStockSharesOutstanding": { "auth_ref": [ "r47", "r301", "r319", "r438", "r439" ], "lang": { "en-us": { "role": { "documentation": "Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.", "label": "Preferred stock, outstanding" } } }, "localname": "PreferredStockSharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://neutracorp.com/role/ConsolidatedBalanceSheetsParenthetical", "http://neutracorp.com/role/ShareholdersEquityDetailsNarrative" ], "xbrltype": "sharesItemType" }, "us-gaap_PreferredStockSharesSubscribedButUnissuedValue": { "auth_ref": [ "r47" ], "calculation": { "http://neutracorp.com/role/ConsolidatedBalanceSheets": { "order": 4.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of subscription received from investors who have been allocated nonredeemable preferred stock or preferred stock redeemable solely at the option of the issuer.", "label": "Preferred stock subscribed but not issued" } } }, "localname": "PreferredStockSharesSubscribedButUnissuedValue", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://neutracorp.com/role/ConsolidatedBalanceSheets", "http://neutracorp.com/role/RelatedPartyTransactionsDetailsNarrative", "http://neutracorp.com/role/SignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_PreferredStockValue": { "auth_ref": [ "r47", "r255", "r376" ], "calculation": { "http://neutracorp.com/role/ConsolidatedBalanceSheets": { "order": 2.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.", "label": "Preferred stock, value" } } }, "localname": "PreferredStockValue", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://neutracorp.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_PreferredStockVotingRights": { "auth_ref": [ "r33", "r47" ], "lang": { "en-us": { "role": { "documentation": "Description of voting rights of nonredeemable preferred stock. Includes eligibility to vote and votes per share owned. Include also, if any, unusual voting rights.", "label": "Description of voting rights" } } }, "localname": "PreferredStockVotingRights", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://neutracorp.com/role/ShareholdersEquityDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_ProceedsFromIssuanceOfPreferredStockAndPreferenceStock": { "auth_ref": [ "r1" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Proceeds from issuance of capital stock which provides for a specific dividend that is paid to the shareholders before any dividends to common stockholders and which takes precedence over common stockholders in the event of liquidation.", "label": "Proceeds from Issuance of Preferred Stock and Preference Stock", "verboseLabel": "Cash proceeds" } } }, "localname": "ProceedsFromIssuanceOfPreferredStockAndPreferenceStock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://neutracorp.com/role/ShareholdersEquityDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromNotesPayable": { "auth_ref": [ "r16" ], "calculation": { "http://neutracorp.com/role/ConsolidatedStatementsOfCashFlows": { "order": 3.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The cash inflow from a borrowing supported by a written promise to pay an obligation.", "label": "Proceeds from issuance of note payable" } } }, "localname": "ProceedsFromNotesPayable", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://neutracorp.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromRepaymentsOfDebt": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The net cash inflow or outflow in aggregate debt due to repayments and proceeds from additional borrowings.", "label": "Cash proceeds" } } }, "localname": "ProceedsFromRepaymentsOfDebt", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://neutracorp.com/role/ShareholdersEquityDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_PropertyPlantAndEquipmentAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Property, Plant and Equipment [Abstract]" } } }, "localname": "PropertyPlantAndEquipmentAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "xbrltype": "stringItemType" }, "us-gaap_PropertyPlantAndEquipmentByTypeAxis": { "auth_ref": [ "r5" ], "lang": { "en-us": { "role": { "documentation": "Information by type of long-lived, physical assets used to produce goods and services and not intended for resale.", "label": "Long-Lived Tangible Asset [Axis]" } } }, "localname": "PropertyPlantAndEquipmentByTypeAxis", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://neutracorp.com/role/PropertyAndEquipmentConsistOfFollowingDetails", "http://neutracorp.com/role/SignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock": { "auth_ref": [ "r66", "r82", "r85", "r86" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.", "label": "Property, Plant and Equipment Disclosure [Text Block]", "verboseLabel": "Property and equipment, net" } } }, "localname": "PropertyPlantAndEquipmentDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://neutracorp.com/role/PropertyAndEquipmentNet" ], "xbrltype": "textBlockItemType" }, "us-gaap_PropertyPlantAndEquipmentGross": { "auth_ref": [ "r67", "r95", "r261" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.", "label": "Total property and equipment" } } }, "localname": "PropertyPlantAndEquipmentGross", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://neutracorp.com/role/PropertyAndEquipmentConsistOfFollowingDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_PropertyPlantAndEquipmentLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Property, Plant and Equipment [Line Items]" } } }, "localname": "PropertyPlantAndEquipmentLineItems", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://neutracorp.com/role/PropertyAndEquipmentConsistOfFollowingDetails", "http://neutracorp.com/role/SignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_PropertyPlantAndEquipmentNet": { "auth_ref": [ "r5", "r252", "r261", "r376" ], "calculation": { "http://neutracorp.com/role/ConsolidatedBalanceSheets": { "order": 2.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.", "label": "Property and equipment, net" } } }, "localname": "PropertyPlantAndEquipmentNet", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://neutracorp.com/role/ConsolidatedBalanceSheets", "http://neutracorp.com/role/PropertyAndEquipmentConsistOfFollowingDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_PropertyPlantAndEquipmentPolicyTextBlock": { "auth_ref": [ "r5", "r82", "r85", "r259" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.", "label": "Property and Equipment, net" } } }, "localname": "PropertyPlantAndEquipmentPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://neutracorp.com/role/SignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_PropertyPlantAndEquipmentTextBlock": { "auth_ref": [ "r5" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.", "label": "Property and equipment consist of the following:" } } }, "localname": "PropertyPlantAndEquipmentTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://neutracorp.com/role/PropertyAndEquipmentNetTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_PropertyPlantAndEquipmentTypeDomain": { "auth_ref": [ "r67" ], "lang": { "en-us": { "role": { "documentation": "Listing of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale. Examples include land, buildings, machinery and equipment, and other types of furniture and equipment including, but not limited to, office equipment, furniture and fixtures, and computer equipment and software." } } }, "localname": "PropertyPlantAndEquipmentTypeDomain", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://neutracorp.com/role/PropertyAndEquipmentConsistOfFollowingDetails", "http://neutracorp.com/role/SignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_PropertyPlantAndEquipmentUsefulLife": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Useful life of long lived, physical assets used in the normal conduct of business and not intended for resale, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Examples include, but not limited to, land, buildings, machinery and equipment, office equipment, furniture and fixtures, and computer equipment.", "label": "Useful life" } } }, "localname": "PropertyPlantAndEquipmentUsefulLife", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://neutracorp.com/role/SignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "durationItemType" }, "us-gaap_RelatedPartyDomain": { "auth_ref": [ "r201", "r234", "r235", "r294", "r295", "r296", "r297", "r298", "r318", "r320", "r352" ], "lang": { "en-us": { "role": { "documentation": "Related parties include affiliates; other entities for which investments are accounted for by the equity method by the entity; trusts for benefit of employees; and principal owners, management, and members of immediate families. It also may include other parties with which the entity may control or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests." } } }, "localname": "RelatedPartyDomain", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://neutracorp.com/role/RelatedPartyTransactionsDetailsNarrative", "http://neutracorp.com/role/SignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_RelatedPartyTransactionLineItems": { "auth_ref": [ "r325", "r326", "r329" ], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Related Party Transaction [Line Items]" } } }, "localname": "RelatedPartyTransactionLineItems", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://neutracorp.com/role/RelatedPartyTransactionsDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_RelatedPartyTransactionsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Related Party Transactions [Abstract]" } } }, "localname": "RelatedPartyTransactionsAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "xbrltype": "stringItemType" }, "us-gaap_RelatedPartyTransactionsByRelatedPartyAxis": { "auth_ref": [ "r201", "r234", "r235", "r239", "r240", "r241", "r242", "r243", "r244", "r245", "r246", "r247", "r248", "r249", "r250", "r294", "r295", "r296", "r297", "r298", "r318", "r320", "r352", "r432" ], "lang": { "en-us": { "role": { "documentation": "Information by type of related party. Related parties include, but not limited to, affiliates; other entities for which investments are accounted for by the equity method by the entity; trusts for benefit of employees; and principal owners, management, and members of immediate families. It also may include other parties with which the entity may control or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests.", "label": "Related Party, Type [Axis]" } } }, "localname": "RelatedPartyTransactionsByRelatedPartyAxis", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://neutracorp.com/role/RelatedPartyTransactionsDetailsNarrative", "http://neutracorp.com/role/SignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_RelatedPartyTransactionsDisclosureTextBlock": { "auth_ref": [ "r231", "r232", "r233", "r235", "r236", "r276", "r277", "r278", "r327", "r328", "r329", "r349", "r351" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates.", "label": "Related Party Transactions" } } }, "localname": "RelatedPartyTransactionsDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://neutracorp.com/role/RelatedPartyTransactions" ], "xbrltype": "textBlockItemType" }, "us-gaap_RepaymentsOfNotesPayable": { "auth_ref": [ "r17" ], "calculation": { "http://neutracorp.com/role/ConsolidatedStatementsOfCashFlows": { "order": 4.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow for a borrowing supported by a written promise to pay an obligation.", "label": "Repayments of Notes Payable", "negatedLabel": "Repayments on notes payable" } } }, "localname": "RepaymentsOfNotesPayable", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://neutracorp.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_RetainedEarningsAccumulatedDeficit": { "auth_ref": [ "r50", "r72", "r257", "r268", "r269", "r275", "r302", "r376" ], "calculation": { "http://neutracorp.com/role/ConsolidatedBalanceSheets": { "order": 5.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of accumulated undistributed earnings (deficit).", "label": "Accumulated deficit" } } }, "localname": "RetainedEarningsAccumulatedDeficit", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://neutracorp.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_RetainedEarningsMember": { "auth_ref": [ "r90", "r121", "r122", "r123", "r125", "r130", "r132", "r161", "r162", "r202", "r203", "r204", "r206", "r207", "r213", "r215", "r216", "r218", "r220", "r265", "r267", "r279", "r438" ], "lang": { "en-us": { "role": { "documentation": "Accumulated undistributed earnings (deficit).", "label": "Retained Earnings [Member]" } } }, "localname": "RetainedEarningsMember", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://neutracorp.com/role/ConsolidatedStatementsOfStockholdersDeficit" ], "xbrltype": "domainItemType" }, "us-gaap_RevenueRecognitionPolicyTextBlock": { "auth_ref": [ "r323", "r368", "r372" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for revenue. Includes revenue from contract with customer and from other sources.", "label": "Revenue [Policy Text Block]" } } }, "localname": "RevenueRecognitionPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://neutracorp.com/role/SignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_RevenueRemainingPerformanceObligationPercentage": { "auth_ref": [ "r410" ], "lang": { "en-us": { "role": { "documentation": "Percentage of remaining performance obligation to total remaining performance obligation not recognized as revenue.", "label": "Revenue, remaining performance obligation, percentage" } } }, "localname": "RevenueRemainingPerformanceObligationPercentage", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://neutracorp.com/role/RelatedPartyTransactionsDetailsNarrative", "http://neutracorp.com/role/SignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "percentItemType" }, "us-gaap_Revenues": { "auth_ref": [ "r109", "r119", "r145", "r146", "r149", "r152", "r153", "r157", "r158", "r159", "r160", "r164", "r165", "r166", "r167", "r168", "r169", "r170", "r171", "r172", "r222", "r251", "r424" ], "calculation": { "http://neutracorp.com/role/ConsolidatedStatementsOfOperations": { "order": 1.0, "parentTag": "us-gaap_GrossProfit", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).", "label": "REVENUE" } } }, "localname": "Revenues", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://neutracorp.com/role/ConsolidatedStatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_SalariesAndWages": { "auth_ref": [ "r414" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of expense for salary and wage arising from service rendered by nonofficer employee. Excludes allocated cost, labor-related nonsalary expense, and direct and overhead labor cost included in cost of good and service sold.", "label": "Salary expense" } } }, "localname": "SalariesAndWages", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://neutracorp.com/role/RelatedPartyTransactionsDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_SalesCommissionsAndFees": { "auth_ref": [ "r58" ], "calculation": { "http://neutracorp.com/role/ConsolidatedStatementsOfOperations": { "order": 2.0, "parentTag": "us-gaap_OtherNonoperatingIncomeExpense", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Primarily represents commissions incurred in the period based upon the sale by commissioned employees or third parties of the entity's goods or services, and fees for sales assistance or product enhancements performed by third parties (such as a distributor or value added reseller).", "label": "Sales commissions" } } }, "localname": "SalesCommissionsAndFees", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://neutracorp.com/role/ConsolidatedStatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_ScheduleOfPropertyPlantAndEquipmentTable": { "auth_ref": [ "r5" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.", "label": "Property, Plant and Equipment [Table]" } } }, "localname": "ScheduleOfPropertyPlantAndEquipmentTable", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://neutracorp.com/role/PropertyAndEquipmentConsistOfFollowingDetails", "http://neutracorp.com/role/SignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable": { "auth_ref": [ "r41", "r42", "r325", "r326", "r329" ], "lang": { "en-us": { "role": { "documentation": "Schedule of quantitative and qualitative information pertaining to related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates.", "label": "Schedule of Related Party Transactions, by Related Party [Table]" } } }, "localname": "ScheduleOfRelatedPartyTransactionsByRelatedPartyTable", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://neutracorp.com/role/RelatedPartyTransactionsDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfStockByClassTable": { "auth_ref": [ "r30", "r31", "r32", "r33", "r34", "r35", "r36", "r70", "r71", "r72", "r98", "r99", "r100", "r142", "r185", "r186", "r187", "r189", "r192", "r197", "r199", "r271", "r272", "r273", "r274", "r375", "r409", "r415" ], "lang": { "en-us": { "role": { "documentation": "Schedule detailing information related to equity by class of stock. Class of stock includes common, convertible, and preferred stocks which are not redeemable or redeemable solely at the option of the issuer. It also includes preferred stock with redemption features that are solely within the control of the issuer and mandatorily redeemable stock if redemption is required to occur only upon liquidation or termination of the reporting entity.", "label": "Schedule of Stock by Class [Table]" } } }, "localname": "ScheduleOfStockByClassTable", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://neutracorp.com/role/ShareholdersEquityDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_SeriesAPreferredStockMember": { "auth_ref": [ "r411", "r412", "r428" ], "lang": { "en-us": { "role": { "documentation": "Series A preferred stock.", "label": "Series A Preferred Stock [Member]" } } }, "localname": "SeriesAPreferredStockMember", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://neutracorp.com/role/ConsolidatedBalanceSheets", "http://neutracorp.com/role/ConsolidatedBalanceSheetsParenthetical", "http://neutracorp.com/role/ConsolidatedStatementsOfStockholdersDeficit", "http://neutracorp.com/role/ShareholdersEquityDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_SeriesBPreferredStockMember": { "auth_ref": [ "r411", "r412", "r428" ], "lang": { "en-us": { "role": { "documentation": "Series B preferred stock.", "label": "Series B Preferred Stock [Member]" } } }, "localname": "SeriesBPreferredStockMember", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://neutracorp.com/role/ConsolidatedBalanceSheets", "http://neutracorp.com/role/ConsolidatedBalanceSheetsParenthetical", "http://neutracorp.com/role/ConsolidatedStatementsOfStockholdersDeficit", "http://neutracorp.com/role/ShareholdersEquityDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_SeriesCPreferredStockMember": { "auth_ref": [ "r411", "r412", "r428" ], "lang": { "en-us": { "role": { "documentation": "Series C preferred stock.", "label": "Series C Preferred Stock [Member]" } } }, "localname": "SeriesCPreferredStockMember", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://neutracorp.com/role/ConsolidatedBalanceSheets", "http://neutracorp.com/role/ConsolidatedBalanceSheetsParenthetical", "http://neutracorp.com/role/ConsolidatedStatementsOfStockholdersDeficit", "http://neutracorp.com/role/ShareholdersEquityDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_SeriesEPreferredStockMember": { "auth_ref": [ "r411", "r412", "r428" ], "lang": { "en-us": { "role": { "documentation": "Series E preferred stock.", "label": "Series E Preferred Stock [Member]" } } }, "localname": "SeriesEPreferredStockMember", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://neutracorp.com/role/ConsolidatedBalanceSheets", "http://neutracorp.com/role/ConsolidatedBalanceSheetsParenthetical", "http://neutracorp.com/role/ConsolidatedStatementsOfStockholdersDeficit", "http://neutracorp.com/role/ShareholdersEquityDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_SeriesFPreferredStockMember": { "auth_ref": [ "r411", "r412", "r428" ], "lang": { "en-us": { "role": { "documentation": "Series F preferred stock.", "label": "Series F Preferred Stock [Member]" } } }, "localname": "SeriesFPreferredStockMember", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://neutracorp.com/role/ConsolidatedBalanceSheets", "http://neutracorp.com/role/ConsolidatedBalanceSheetsParenthetical", "http://neutracorp.com/role/ConsolidatedStatementsOfStockholdersDeficit", "http://neutracorp.com/role/ShareholdersEquityDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_SeriesGPreferredStockMember": { "auth_ref": [ "r411", "r412", "r428" ], "lang": { "en-us": { "role": { "documentation": "Series G preferred stock.", "label": "Series G Preferred Stock [Member]" } } }, "localname": "SeriesGPreferredStockMember", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://neutracorp.com/role/ConsolidatedBalanceSheetsParenthetical", "http://neutracorp.com/role/ConsolidatedStatementOfChangesInMezzanineEquity", "http://neutracorp.com/role/ShareholdersEquityDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_SharesOutstanding": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of shares issued which are neither cancelled nor held in the treasury.", "label": "Shares, Outstanding", "periodEndLabel": "Ending balance (in shares)", "periodStartLabel": "Beginning balance (in shares)" } } }, "localname": "SharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://neutracorp.com/role/ConsolidatedStatementOfChangesInMezzanineEquity", "http://neutracorp.com/role/ConsolidatedStatementsOfStockholdersDeficit" ], "xbrltype": "sharesItemType" }, "us-gaap_SignificantAccountingPoliciesTextBlock": { "auth_ref": [ "r64", "r116" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for all significant accounting policies of the reporting entity.", "label": "Significant Accounting Policies" } } }, "localname": "SignificantAccountingPoliciesTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://neutracorp.com/role/SignificantAccountingPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_StatementClassOfStockAxis": { "auth_ref": [ "r89", "r98", "r99", "r100", "r119", "r135", "r136", "r139", "r140", "r142", "r143", "r160", "r164", "r166", "r167", "r168", "r171", "r172", "r185", "r186", "r189", "r192", "r199", "r222", "r271", "r272", "r273", "r274", "r279", "r280", "r281", "r282", "r283", "r284", "r285", "r286", "r287", "r288", "r289", "r290", "r301", "r322", "r345", "r360", "r361", "r362", "r363", "r364", "r409", "r415", "r420" ], "lang": { "en-us": { "role": { "documentation": "Information by the different classes of stock of the entity.", "label": "Class of Stock [Axis]" } } }, "localname": "StatementClassOfStockAxis", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://neutracorp.com/role/ConsolidatedBalanceSheets", "http://neutracorp.com/role/ConsolidatedBalanceSheetsParenthetical", "http://neutracorp.com/role/ConsolidatedStatementOfChangesInMezzanineEquity", "http://neutracorp.com/role/ConsolidatedStatementsOfStockholdersDeficit", "http://neutracorp.com/role/ShareholdersEquityDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_StatementEquityComponentsAxis": { "auth_ref": [ "r6", "r15", "r90", "r105", "r106", "r107", "r121", "r122", "r123", "r125", "r130", "r132", "r141", "r161", "r162", "r200", "r202", "r203", "r204", "r206", "r207", "r213", "r214", "r215", "r216", "r217", "r218", "r220", "r223", "r224", "r225", "r226", "r227", "r228", "r230", "r265", "r266", "r267", "r279", "r345" ], "lang": { "en-us": { "role": { "documentation": "Information by component of equity.", "label": "Equity Components [Axis]" } } }, "localname": "StatementEquityComponentsAxis", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://neutracorp.com/role/ConsolidatedStatementsOfStockholdersDeficit" ], "xbrltype": "stringItemType" }, "us-gaap_StatementLineItems": { "auth_ref": [ "r121", "r122", "r123", "r141", "r238", "r270", "r290", "r293", "r294", "r295", "r296", "r297", "r298", "r301", "r304", "r305", "r306", "r307", "r308", "r309", "r310", "r311", "r312", "r314", "r315", "r316", "r317", "r318", "r320", "r323", "r324", "r331", "r332", "r333", "r334", "r335", "r336", "r337", "r338", "r339", "r340", "r341", "r342", "r345", "r380" ], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Statement [Line Items]" } } }, "localname": "StatementLineItems", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://neutracorp.com/role/ConsolidatedBalanceSheets", "http://neutracorp.com/role/ConsolidatedBalanceSheetsParenthetical", "http://neutracorp.com/role/ConsolidatedStatementOfChangesInMezzanineEquity", "http://neutracorp.com/role/ConsolidatedStatementsOfStockholdersDeficit" ], "xbrltype": "stringItemType" }, "us-gaap_StatementOfCashFlowsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Statement of Cash Flows [Abstract]" } } }, "localname": "StatementOfCashFlowsAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "xbrltype": "stringItemType" }, "us-gaap_StatementOfFinancialPositionAbstract": { "auth_ref": [], "localname": "StatementOfFinancialPositionAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "xbrltype": "stringItemType" }, "us-gaap_StatementOfStockholdersEquityAbstract": { "auth_ref": [], "localname": "StatementOfStockholdersEquityAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "xbrltype": "stringItemType" }, "us-gaap_StatementTable": { "auth_ref": [ "r121", "r122", "r123", "r141", "r238", "r270", "r290", "r293", "r294", "r295", "r296", "r297", "r298", "r301", "r304", "r305", "r306", "r307", "r308", "r309", "r310", "r311", "r312", "r314", "r315", "r316", "r317", "r318", "r320", "r323", "r324", "r331", "r332", "r333", "r334", "r335", "r336", "r337", "r338", "r339", "r340", "r341", "r342", "r345", "r380" ], "lang": { "en-us": { "role": { "documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed.", "label": "Statement [Table]" } } }, "localname": "StatementTable", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://neutracorp.com/role/ConsolidatedBalanceSheets", "http://neutracorp.com/role/ConsolidatedBalanceSheetsParenthetical", "http://neutracorp.com/role/ConsolidatedStatementOfChangesInMezzanineEquity", "http://neutracorp.com/role/ConsolidatedStatementsOfStockholdersDeficit" ], "xbrltype": "stringItemType" }, "us-gaap_StockIssuedDuringPeriodSharesNewIssues": { "auth_ref": [ "r6", "r47", "r48", "r72", "r271", "r345", "r361" ], "lang": { "en-us": { "role": { "documentation": "Number of new stock issued during the period.", "label": "Common stock issued for preferred stock conversions (in shares)" } } }, "localname": "StockIssuedDuringPeriodSharesNewIssues", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://neutracorp.com/role/ConsolidatedStatementsOfStockholdersDeficit" ], "xbrltype": "sharesItemType" }, "us-gaap_StockIssuedDuringPeriodValueIssuedForServices": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Value of stock issued in lieu of cash for services contributed to the entity. Value of the stock issued includes, but is not limited to, services contributed by vendors and founders.", "label": "Stock Issued During Period, Value, Issued for Services", "verboseLabel": "Preferred stock subscribed but not issued" } } }, "localname": "StockIssuedDuringPeriodValueIssuedForServices", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://neutracorp.com/role/ConsolidatedStatementsOfStockholdersDeficit" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockIssuedDuringPeriodValueNewIssues": { "auth_ref": [ "r6", "r47", "r48", "r72", "r279", "r345", "r361", "r387" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering.", "label": "Common stock issued for preferred stock conversions" } } }, "localname": "StockIssuedDuringPeriodValueNewIssues", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://neutracorp.com/role/ConsolidatedStatementsOfStockholdersDeficit" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockholdersEquity": { "auth_ref": [ "r48", "r51", "r52", "r65", "r303", "r319", "r346", "r347", "r376", "r388", "r416", "r422", "r430", "r438" ], "calculation": { "http://neutracorp.com/role/ConsolidatedBalanceSheets": { "order": 3.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of equity (deficit) attributable to parent. Excludes temporary equity and equity attributable to noncontrolling interest.", "label": "Equity, Attributable to Parent", "periodEndLabel": "Ending balance, value", "periodStartLabel": "Beginning balance, value", "totalLabel": "TOTAL STOCKHOLDERS' DEFICIT" } } }, "localname": "StockholdersEquity", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://neutracorp.com/role/ConsolidatedBalanceSheets", "http://neutracorp.com/role/ConsolidatedStatementOfChangesInMezzanineEquity", "http://neutracorp.com/role/ConsolidatedStatementsOfStockholdersDeficit" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockholdersEquityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "STOCKHOLDERS' DEFICIT" } } }, "localname": "StockholdersEquityAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://neutracorp.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_StockholdersEquityNoteDisclosureTextBlock": { "auth_ref": [ "r69", "r118", "r184", "r186", "r188", "r189", "r190", "r191", "r192", "r193", "r194", "r195", "r196", "r198", "r200", "r219", "r348", "r350", "r365" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for equity.", "label": "Shareholders\u2019 Equity" } } }, "localname": "StockholdersEquityNoteDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://neutracorp.com/role/ShareholdersEquity" ], "xbrltype": "textBlockItemType" }, "us-gaap_SubsequentEventsPolicyPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for reporting subsequent events.", "label": "Subsequent events" } } }, "localname": "SubsequentEventsPolicyPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://neutracorp.com/role/SignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_SubstantialDoubtAboutGoingConcernTextBlock": { "auth_ref": [ "r44" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure when substantial doubt is raised about the ability to continue as a going concern. Includes, but is not limited to, principal conditions or events that raised substantial doubt about the ability to continue as a going concern, management's evaluation of the significance of those conditions or events in relation to the ability to meet its obligations, and management's plans that alleviated or are intended to mitigate the conditions or events that raise substantial doubt about the ability to continue as a going concern.", "label": "Going Concern" } } }, "localname": "SubstantialDoubtAboutGoingConcernTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://neutracorp.com/role/GoingConcern" ], "xbrltype": "textBlockItemType" }, "us-gaap_SupplementalCashFlowInformationAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Cash paid during the period for:" } } }, "localname": "SupplementalCashFlowInformationAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://neutracorp.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_UseOfEstimates": { "auth_ref": [ "r22", "r23", "r24", "r80", "r81", "r83", "r84" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.", "label": "Use of Estimates" } } }, "localname": "UseOfEstimates", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://neutracorp.com/role/SignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" } }, "unitCount": 4 } }, "std_ref": { "r0": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "230", "Topic": "830", "URI": "https://asc.fasb.org//1943274/2147481877/830-230-45-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r1": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-14", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r10": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.20)", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r100": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(29))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r101": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(6))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r102": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(9))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r103": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-1A", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r104": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-1B", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r105": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-4", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r106": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-5", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r107": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r108": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(210.5-03(11))", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r109": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(1))", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r11": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.21)", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r110": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 6.B)", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-5", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r111": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "230", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-17", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r112": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r113": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "230", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-25", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r114": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r115": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-8", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r116": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "235", "URI": "https://asc.fasb.org//1943274/2147483426/235-10-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r117": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(c))", "Topic": "235", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r118": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(e)(1))", "Topic": "235", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r119": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(g)(1)(ii))", "Topic": "235", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r12": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.22)", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r120": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.12-04(a))", "Topic": "235", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r121": { "Name": "Accounting Standards Codification", "Paragraph": "23", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-23", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r122": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r123": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-5", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r124": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(2)", "Topic": "250", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r125": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(3)", "Topic": "250", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r126": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "250", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-11", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r127": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-11", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r128": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r129": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-4", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r13": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.25)", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r130": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-7", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r131": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-8", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r132": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-9", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r133": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-10", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r134": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-11", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r135": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r136": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r137": { "Name": "Accounting Standards Codification", "Paragraph": "60B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "260", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-60B", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r138": { "Name": "Accounting Standards Codification", "Paragraph": "60B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "260", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-60B", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r139": { "Name": "Accounting Standards Codification", "Paragraph": "60B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "260", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-60B", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r14": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.29)", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r140": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "260", "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r141": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "272", "URI": "https://asc.fasb.org//1943274/2147483014/272-10-45-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r142": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "272", "URI": "https://asc.fasb.org//1943274/2147482987/272-10-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r143": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "272", "URI": "https://asc.fasb.org//1943274/2147482987/272-10-50-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r144": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r145": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r146": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r147": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r148": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r149": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r15": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.29-31)", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r150": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r151": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r152": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r153": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r154": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r155": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r156": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r157": { "Name": "Accounting Standards Codification", "Paragraph": "40", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-40", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r158": { "Name": "Accounting Standards Codification", "Paragraph": "41", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-41", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r159": { "Name": "Accounting Standards Codification", "Paragraph": "42", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-42", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r16": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-14", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r160": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "323", "URI": "https://asc.fasb.org//1943274/2147481687/323-10-50-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r161": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "326", "URI": "https://asc.fasb.org//1943274/2147479654/326-10-65-4", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r162": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(c)(2)", "Topic": "326", "URI": "https://asc.fasb.org//1943274/2147479654/326-10-65-5", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r163": { "Name": "Accounting Standards Codification", "Paragraph": "3D", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "326", "URI": "https://asc.fasb.org//1943274/2147479319/326-20-50-3D", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r164": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(i))", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r165": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r166": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(iv))", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r167": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(5))", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r168": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(i))", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r169": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r17": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-15", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r170": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r171": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iv))", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r172": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(5))", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r173": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r174": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(g)", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r175": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(h)", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r176": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(i)", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r177": { "Name": "Accounting Standards Codification", "Paragraph": "1C", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1C", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r178": { "Name": "Accounting Standards Codification", "Paragraph": "1C", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1C", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r179": { "Name": "Accounting Standards Codification", "Paragraph": "1C", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1C", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r18": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-4", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r180": { "Name": "Accounting Standards Codification", "Paragraph": "1E", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1E", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r181": { "Name": "Accounting Standards Codification", "Paragraph": "1I", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1I", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r182": { "Name": "Accounting Standards Codification", "Paragraph": "1I", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1I", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r183": { "Name": "Accounting Standards Codification", "Paragraph": "1I", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1I", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r184": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r185": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r186": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r187": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r188": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(g)", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r189": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r19": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r190": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(i)", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r191": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-14", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r192": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-14", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r193": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-14", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r194": { "Name": "Accounting Standards Codification", "Paragraph": "16", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-16", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r195": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-18", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r196": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-18", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r197": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-18", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r198": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-18", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r199": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r2": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "405", "Topic": "942", "URI": "https://asc.fasb.org//1943274/2147481071/942-405-45-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r20": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "260", "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r200": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.3-04)", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147480008/505-10-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r201": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(n)", "Topic": "715", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r202": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480336/718-10-65-15", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r203": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(f)(1)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480336/718-10-65-15", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r204": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(f)(2)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480336/718-10-65-15", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r205": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-10", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r206": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)(2)", "Topic": "740", "URI": "https://asc.fasb.org//1943274/2147482615/740-10-65-8", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r207": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)(3)", "Topic": "740", "URI": "https://asc.fasb.org//1943274/2147482615/740-10-65-8", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r208": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB TOPIC 6.I.7)", "Topic": "740", "URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r209": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "810", "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-25", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r21": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r210": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "810", "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-25", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r211": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(bb)", "Topic": "810", "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r212": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "810", "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r213": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "20", "Subparagraph": "(e)", "Topic": "815", "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r214": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "20", "Subparagraph": "(h)(1)", "Topic": "815", "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r215": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "20", "Subparagraph": "(h)(1)(i)", "Topic": "815", "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r216": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "20", "Subparagraph": "(h)(1)(iii)", "Topic": "815", "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r217": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "20", "Subparagraph": "(h)(1)(iv)", "Topic": "815", "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r218": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "20", "Subparagraph": "(i)(3)", "Topic": "815", "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r219": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "40", "Subparagraph": "(a)", "Topic": "815", "URI": "https://asc.fasb.org//1943274/2147480237/815-40-50-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r22": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-4", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r220": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(e)(3)", "Topic": "815", "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r221": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(f)", "Topic": "815", "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r222": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "825", "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-28", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r223": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "830", "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-17", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r224": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "830", "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r225": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(b)", "Topic": "830", "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r226": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(c)", "Topic": "830", "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r227": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(d)", "Topic": "830", "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r228": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "830", "URI": "https://asc.fasb.org//1943274/2147481674/830-30-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r229": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "835", "URI": "https://asc.fasb.org//1943274/2147483013/835-20-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r23": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-8", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r230": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(a)(3)(iii)(03)", "Topic": "848", "URI": "https://asc.fasb.org//1943274/2147483550/848-10-65-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r231": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "850", "URI": "https://asc.fasb.org//850/tableOfContent", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r232": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "850", "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r233": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "850", "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r234": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "850", "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r235": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "850", "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r236": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "850", "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r237": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "852", "URI": "https://asc.fasb.org//1943274/2147481435/852-10-45-14", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r238": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 11.L)", "Topic": "924", "URI": "https://asc.fasb.org//1943274/2147479941/924-10-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r239": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(a)", "Topic": "932", "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-15", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r24": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-9", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r240": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(b)", "Topic": "932", "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-15", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r241": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(a)", "Topic": "932", "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-20", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r242": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(b)", "Topic": "932", "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-20", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r243": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(a)", "Topic": "932", "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-28", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r244": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(b)", "Topic": "932", "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-28", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r245": { "Name": "Accounting Standards Codification", "Paragraph": "33", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(a)", "Topic": "932", "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-33", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r246": { "Name": "Accounting Standards Codification", "Paragraph": "33", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(b)", "Topic": "932", "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-33", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r247": { "Name": "Accounting Standards Codification", "Paragraph": "35A", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(a)", "Topic": "932", "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-35A", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r248": { "Name": "Accounting Standards Codification", "Paragraph": "35A", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(b)", "Topic": "932", "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-35A", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r249": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(c)(1)", "Topic": "932", "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-8", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r25": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "330", "URI": "https://asc.fasb.org//1943274/2147483080/330-10-50-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r250": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(c)(2)", "Topic": "932", "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-8", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r251": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "235", "Subparagraph": "(SX 210.9-05(b)(2))", "Topic": "942", "URI": "https://asc.fasb.org//1943274/2147479557/942-235-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r252": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "360", "Topic": "942", "URI": "https://asc.fasb.org//1943274/2147480842/942-360-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r253": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(12))", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r254": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(19))", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r255": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(21))", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r256": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(22))", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r257": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r258": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(25))", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r259": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(8)(a))", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r26": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB TOPIC 5.BB)", "Topic": "330", "URI": "https://asc.fasb.org//1943274/2147480581/330-10-S99-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r260": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(8)(b))", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r261": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(8))", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r262": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(18))", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r263": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(8))", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r264": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(9))", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r265": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(e)", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r266": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(f)(1)", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r267": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(f)(2)", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r268": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(g)(2)(i)", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r269": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(h)(2)", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r27": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "360", "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r270": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.6-03(d))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r271": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.6-03(i)(1))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r272": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.6-03(i)(2)(i))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r273": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.6-03(i)(2)(ii))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r274": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.6-03(i)(2))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r275": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480990/946-20-50-11", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r276": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480990/946-20-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r277": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480990/946-20-50-5", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r278": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480990/946-20-50-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r279": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "45", "SubTopic": "205", "Subparagraph": "(a)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480767/946-205-45-4", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r28": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "360", "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r280": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "205", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r281": { "Name": "Accounting Standards Codification", "Paragraph": "27", "Publisher": "FASB", "Section": "50", "SubTopic": "205", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-27", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r282": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "205", "Subparagraph": "(a)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r283": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "205", "Subparagraph": "(b)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r284": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "205", "Subparagraph": "(c)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r285": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "205", "Subparagraph": "(d)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r286": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "205", "Subparagraph": "(e)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r287": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "205", "Subparagraph": "(f)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r288": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "205", "Subparagraph": "(g)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r289": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "205", "Subparagraph": "(h)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r29": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "460", "URI": "https://asc.fasb.org//1943274/2147482425/460-10-50-8", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r290": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "45", "SubTopic": "210", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480555/946-210-45-4", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r291": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "210", "Subparagraph": "(a)(1)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r292": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "210", "Subparagraph": "(c)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r293": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(1))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r294": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(12)(b)(1))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r295": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(12)(b)(2))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r296": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(12)(b)(3))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r297": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(13)(a)(2))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r298": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(13)(a)(3))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r299": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(14))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r3": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r30": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(CFRR 211.02)", "Topic": "480", "URI": "https://asc.fasb.org//1943274/2147480244/480-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r300": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(15))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r301": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(16)(a))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r302": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(17))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r303": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(19))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r304": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(2)(a))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r305": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(2)(b))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r306": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(3)(a))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r307": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(3)(b))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r308": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(3)(c))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r309": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(6)(b))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r31": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147481142/505-10-45-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r310": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(6)(c))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r311": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(6)(d))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r312": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(6)(e))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r313": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(8))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r314": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(9)(b))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r315": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(9)(c))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r316": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(9)(d))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r317": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(9)(e))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r318": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-05(2))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r319": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-05(4))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r32": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-10", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r320": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "220", "Subparagraph": "(b)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483581/946-220-45-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r321": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "45", "SubTopic": "220", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483581/946-220-45-7", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r322": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "220", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483580/946-220-50-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r323": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-07(1))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r324": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-07(2)(a))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r325": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-07(2)(c)(2)(i))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r326": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-07(2)(c)(2)(ii))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r327": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-07(2)(c))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r328": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-07(2)(e))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r329": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-07(2)(g)(3))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r33": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-3", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r330": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-07(3))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r331": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-07(7)(a)(1))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r332": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-07(7)(a)(2))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r333": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-07(7)(a)(3))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r334": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-07(7)(a)(5))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r335": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-07(7)(a)(6))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r336": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-07(7)(a)(7))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r337": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-07(7)(c)(1))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r338": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-07(7)(c)(2))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r339": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-07(7)(c)(3))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r34": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-4", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r340": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-07(7)(c)(5))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r341": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-07(7)(c)(6))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r342": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-07(7)(c)(7))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r343": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-07(9))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r344": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-09(1)(d))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r345": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-09(4)(b))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r346": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-09(6))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r347": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-09(7))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r348": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(a)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147481062/946-235-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r349": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(c)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147481062/946-235-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r35": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-5", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r350": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(d)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147481062/946-235-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r351": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(e)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147481062/946-235-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r352": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "310", "Subparagraph": "(d)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480833/946-310-45-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r353": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12(Column A)(Footnote 4))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r354": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12(Column B))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r355": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12A(Column A)(Footnote 3))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r356": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 3))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r357": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12B(Column B))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r358": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-14(Column A)(Footnote 3))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r359": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-14(Column B))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r36": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-8", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r360": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "505", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147481004/946-505-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r361": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "505", "Subparagraph": "(a)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147481004/946-505-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r362": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "505", "Subparagraph": "(b)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147481004/946-505-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r363": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "505", "Subparagraph": "(c)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147481004/946-505-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r364": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "505", "Subparagraph": "(d)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147481004/946-505-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r365": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "505", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147481004/946-505-50-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r366": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "450", "Topic": "954", "URI": "https://asc.fasb.org//1943274/2147480598/954-450-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r367": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Footnote 4))", "Topic": "970", "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r368": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "235", "URI": "https://asc.fasb.org//1943274/2147483426/235-10-50-4", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r369": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147483467/210-10-45-1", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r37": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "810", "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r370": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147483467/210-10-45-1", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r371": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "235", "URI": "https://asc.fasb.org//1943274/2147483426/235-10-50-4", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r372": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "235", "URI": "https://asc.fasb.org//1943274/2147483426/235-10-50-4", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r373": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r374": { "Name": "Accounting Standards Codification", "Paragraph": "31", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-31", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r375": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r376": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "852", "URI": "https://asc.fasb.org//1943274/2147481372/852-10-55-10", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r377": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "210", "Subparagraph": "(b)(1)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-1", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r378": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "210", "Subparagraph": "(a)(1)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r379": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "55", "SubTopic": "210", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480493/946-210-55-1", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r38": { "Name": "Accounting Standards Codification", "Paragraph": "4A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "815", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4A", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r380": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "310", "Subparagraph": "(d)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480833/946-310-45-1", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r381": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12(Column A)(Footnote 2)(i))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r382": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12A(Column A)(Footnote 2))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-2", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r383": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 1)(a))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r384": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-14(Column A)(Footnote 2))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r385": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "405", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480191/946-405-45-2", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r386": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "55", "SubTopic": "830", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480167/946-830-55-10", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r387": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "55", "SubTopic": "830", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480167/946-830-55-11", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r388": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "55", "SubTopic": "830", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480167/946-830-55-12", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r389": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r39": { "Name": "Accounting Standards Codification", "Paragraph": "4B", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "815", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4B", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r390": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r391": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-2", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r392": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-23", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r393": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "d1-1", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r394": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "g", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r395": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12, 13, 15d", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r396": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "13e", "Subsection": "4c", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r397": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14d", "Subsection": "2b", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r398": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "15", "Subsection": "d", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r399": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14a", "Subsection": "12", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r4": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r40": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "835", "URI": "https://asc.fasb.org//1943274/2147482925/835-30-45-3", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r400": { "Name": "Form 10-K", "Number": "249", "Publisher": "SEC", "Section": "310", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r401": { "Name": "Form 10-Q", "Number": "240", "Publisher": "SEC", "Section": "308", "Subsection": "a", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r402": { "Name": "Form 20-F", "Number": "249", "Publisher": "SEC", "Section": "220", "Subsection": "f", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r403": { "Name": "Form 40-F", "Number": "249", "Publisher": "SEC", "Section": "240", "Subsection": "f", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r404": { "Name": "Forms 10-K, 10-Q, 20-F", "Number": "240", "Publisher": "SEC", "Section": "13", "Subsection": "a-1", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r405": { "Name": "Regulation S-T", "Number": "232", "Publisher": "SEC", "Section": "405", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r406": { "Name": "Securities Act", "Number": "230", "Publisher": "SEC", "Section": "405", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r407": { "Name": "Securities Act", "Number": "230", "Publisher": "SEC", "Section": "425", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r408": { "Name": "Securities Act", "Number": "7A", "Publisher": "SEC", "Section": "B", "Subsection": "2", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r409": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "272", "URI": "https://asc.fasb.org//1943274/2147483014/272-10-45-3", "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef" }, "r41": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "850", "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r410": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(1)", "Topic": "606", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-13", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r411": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(27)(b))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r412": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(28))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r413": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(6))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r414": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(4))", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r415": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(d))", "Topic": "235", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r416": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(g)(1)(ii))", "Topic": "235", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r417": { "Name": "Accounting Standards Codification", "Paragraph": "23", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-23", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r418": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-24", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r419": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-5", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r42": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "850", "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-3", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r420": { "Name": "Accounting Standards Codification", "Paragraph": "55", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "260", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-55", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r421": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "310", "URI": "https://asc.fasb.org//1943274/2147481990/310-10-45-13", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r422": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "323", "URI": "https://asc.fasb.org//1943274/2147481687/323-10-50-3", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r423": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(i))", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r424": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(ii))", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r425": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(iii))", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r426": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(iv))", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r427": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iv))", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r428": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-2", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r429": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(e)(3)", "Topic": "815", "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r43": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03.17)", "Topic": "942", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r430": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "825", "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-28", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r431": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "850", "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-2", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r432": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "850", "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-3", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r433": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "852", "URI": "https://asc.fasb.org//1943274/2147481404/852-10-50-7", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r434": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "852", "URI": "https://asc.fasb.org//1943274/2147481404/852-10-50-7", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r435": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(15)(a))", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r436": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "45", "SubTopic": "205", "Subparagraph": "(a)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480767/946-205-45-4", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r437": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "220", "Subparagraph": "(i)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483581/946-220-45-3", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r438": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-09(4)(b))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r439": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-09(7))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r44": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "SubTopic": "40", "Topic": "205", "URI": "https://asc.fasb.org//205-40/tableOfContent", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r45": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(20))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r46": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(24))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r47": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(28))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r48": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(29))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r49": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30)(a)(1))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r5": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "360", "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r50": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30)(a)(3))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r51": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r52": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(31))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r53": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(32))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r54": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(20))", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r55": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.1,2)", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r56": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.2(a),(d))", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r57": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.2)", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r58": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.4)", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r59": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.7)", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r6": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r60": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.9)", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r61": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-24", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r62": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-25", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r63": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r64": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "235", "URI": "https://asc.fasb.org//235/tableOfContent", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r65": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 4.E)", "Topic": "310", "URI": "https://asc.fasb.org//1943274/2147480418/310-10-S99-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r66": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "360", "URI": "https://asc.fasb.org//360/tableOfContent", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r67": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "360", "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r68": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "470", "URI": "https://asc.fasb.org//470/tableOfContent", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r69": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "505", "URI": "https://asc.fasb.org//505/tableOfContent", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r7": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19(a))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r70": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-6", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r71": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-7", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r72": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.3-04)", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147480008/505-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r73": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(11))", "Topic": "942", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r74": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(15)(5))", "Topic": "942", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r75": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(23))", "Topic": "942", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r76": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(22))", "Topic": "942", "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r77": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04.9)", "Topic": "942", "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r78": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "740", "URI": "https://asc.fasb.org//1943274/2147482659/740-20-45-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r79": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "275", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r8": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19,20)", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r80": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "275", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r81": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "275", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r82": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "360", "Subparagraph": "(d)", "Topic": "958", "URI": "https://asc.fasb.org//1943274/2147480321/958-360-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r83": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-11", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r84": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-12", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r85": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "360", "Topic": "958", "URI": "https://asc.fasb.org//1943274/2147480321/958-360-50-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r86": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "360", "Topic": "958", "URI": "https://asc.fasb.org//1943274/2147480321/958-360-50-7", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r87": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(h))", "Topic": "235", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r88": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "275", "URI": "https://asc.fasb.org//275/tableOfContent", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r89": { "Name": "Regulation S-K (SK)", "Number": "229", "Paragraph": "(a)", "Publisher": "SEC", "Section": "1402", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r9": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19-26)", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r90": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "105", "URI": "https://asc.fasb.org//1943274/2147479343/105-10-65-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r91": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "205", "URI": "https://asc.fasb.org//1943274/2147483499/205-20-50-7", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r92": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147483467/210-10-45-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r93": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147483467/210-10-45-5", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r94": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(1))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r95": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(13))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r96": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(14))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r97": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(18))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r98": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(27)(b))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r99": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(28))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" } }, "version": "2.2" } ZIP 40 0001161697-23-000369-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001161697-23-000369-xbrl.zip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